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Abstract 
 
 
Retinal degenerative disorders are the leading cause of vision impairment in developed 
countries. In many cases, photoreceptor degeneration occurs as a consequence of Retinal 
Pigment Epithelium (RPE) dysfunction. This is the case of Age-related Macular 
Degeneration (AMD) where progressive degeneration typically occurs, stemming from 
inadequate maintenance of the RPE cells. A crucial feature of this internal preservation is 
the ability to properly degrade and/or recycle the protein- and lipid- content which result 
from daily processing of Photoreceptor Outer Segments (POS). Degradation and recycling 
of cellular components are the main responsibilities attributed to lysosomes and 
remarkably, many age-related diseases stem from improper lysosomal health. 
Human Pluripotent Stem cells (hPSc) can be used as starting material to obtain reliable 
in vitro models of human RPE, providing direct access to identification of the initial events 
of many retinal degenerative diseases. Stem cell proliferation potential is virtually 
limitless, therefore hPSc differentiation into RPE paves the way for the standard 
production of reliable human RPE lines, without the hurdles of available, but unreliable 
RPE cell lines or the hardships of establishing RPE primary cultures. 
The present work focuses on the development and characterization of a human RPE in 
vitro model, derived from pluripotent stem cells, with the ultimate goal of studying 
retinopathies’ early events. This model was then used to explore the importance of the 
lysosome in intracellular cargo processing and the role of lysosomal dysfunction in age-
related disorders, in particular in the case of AMD. 
Accordingly, a stem cell differentiation protocol was optimized and a comprehensive 
characterization of the obtained hPSc-RPE cells was performed. Based on this cellular 
model, POS-induced lysosomal dysfunction is proposed as a tool, which can be used to 
recapitulate AMD disease features. 
Furthermore, a drug-based model featuring chloroquine-induced hPSc-RPE 
degeneration through lysosomal dysfunction was establish and characterized. In particular, 
cells were subjected to extended time-course chloroquine treatments and lysosomal 
function was thoroughly characterized. Specifically, cells were submitted to acute, 
continued and chronic treatments and shown to respond differently throughout these time 
courses. Firstly, chloroquine (CQ) dosage was titrated, based on viability assays, in order 
to establish under-lethal regimens considering experimental temporal settings. Nuclear 
translocation of lysosome-regulator transcription factors was verified. Moreover, a 
thorough characterization featuring relevant lysosomal properties was covered, including 
i 
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their ability to degrade phagocytic, endocytic and autophagy cargoes, their cathepsin 
proteolytic activity and luminal acidity. Furthermore, lysosomal exocytosis was verified 
upon CQ treatment and, upon study of the RPE ultrastructure, is suggested as a key disease 
initiation event. Whenever possible, results obtained with hESc-RPE were repeated using 
primary RPE cell lines, human and porcine, reinforcing and extrapolating crucial findings 
to general RPE cell biology. 
Ultimately, RPE cellular models were shown to recapitulate crucial features of age-
related retinal degeneration, in particular, subcellular deposit formation, which constitutes 
the defining feature underlying AMD’s early events. 
Additionally, in the supplementary material, a side-project developed throughout the 
course of the PhD is presented. Specifically, this study regards VEGF regulation in a 
mouse RPE line, and in particular VEGF titration by Rab-regulated endocytic trafficking 
of the VEGFR2. 
Overall, this study opens new avenues to explore in vitro cellular models of RPE to 
dissect the molecular mechanisms of degeneration and also to explore new therapeutic 
approaches aiming to restore lysosomal function and ultimately pave the way for in vivo 
studies. 
 
 
Keywords: Retinal Pigment Epithelium, differentiation, pluripotent stem cells, 
degeneration, cell-based models, lysosome dysfunction. 
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Resumo 
 
 
As doenças degenerativas da retina são as principais responsáveis pela perda de visão, 
nos países desenvolvidos. Frequentemente, a degeneração dos fotorrecetores ocorre 
devido à perda de função do Epitélio Pigmentar da Retina (RPE). A Degenerescência 
Macular relacionada com a idade (DMI) é uma doença degenerativa da área central da 
retina (mácula) que provoca uma perda progressiva da visão central. Pensa-se que a 
disfunção do RPE está na origem desta doença. Em particular, pensa-se que a conservação 
da função lisossomal destas células é de extrema importância no contexto de doença. O 
RPE é responsável por degradar e reutilizar componentes celulares, como proteínas e 
lípidos, que resultam do processamento diário dos terminais dos fotorrecetores, 
necessários ao bom funcionamento celular e ao processo visual. O declínio da função 
lisossomal tem sido apontado como estando envolvido numa série de doenças crónicas 
relacionadas com a idade. 
As células estaminais pluripotentes (hPSc) podem ser usadas como matéria prima para 
obter modelos de RPE in vitro fiáveis, que permitem ter acesso direto para identificar os 
mecanismos iniciais de doenças degenerativas da retina. O potencial de proliferação das 
células estaminais é praticamente ilimitado, pelo que a diferenciação destas células para 
RPE permite estabelecer uma produção sistemática de linhas humanas de RPE. Isto 
permite ultrapassar obstáculos existentes com as linhas de RPE disponíveis menos fiáveis 
ou mais difíceis de obter por culturas primárias. 
O trabalho aqui apresentado visou o desenvolvimento e a caracterização de um 
modelo in vitro de RPE derivado de células estaminais pluripotentes, com o objetivo final 
de estudar os eventos que estão na origem das retinopatias. Este modelo foi usado para 
explorar a importância da função lisossomal no processamento de material intracelular e, 
sobretudo, o papel da disfunção lisossomal em doenças do envelhecimento, com 
particular ênfase na DMI. 
Assim, foram otimizados protocolos de diferenciação de células estaminais em RPE 
e as células obtidas (hPSc-RPE) foram caracterizadas em detalhe. Baseado neste modelo 
celular, a disfunção lisossomal causada pelo processamento dos terminais externos dos 
fotorrecetores é proposta aqui como ferramenta de estudo, por reproduzir características 
chave da DMI. 
Para além disso, foi também implementado e caracterizado um modelo de disfunção 
lisossomal farmacológico, com base no tratamento de hPSc-RPE com cloroquina. Em 
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particular, as células foram submetidas a regimes prolongados de exposição a este 
fármaco e a função lisossomal foi avaliada em vários períodos de estímulo. 
Nomeadamente, as células foram sujeitas a tratamentos agudos, continuados ou crónicos 
e foram demonstradas respostas diferenciadas, consoante os intervalos avaliados. Em 
primeiro lugar, as doses de cloroquina foram estabelecidas, com base em ensaios de 
viabilidade, de forma a escolher um regime não letal para as células, durante os tempos 
de estudo. Posteriormente, foi verificada a translocação nuclear de fatores de transcrição 
reguladores da função lisossomal. De seguida, as propriedades características dos 
lisossomas foram avaliadas, incluindo a capacidade de degradação de cargas fagocíticas, 
endocíticas e provenientes de autofagia, a atividade proteolítica das catepsinas e a acidez 
luminal. Para além disso, observou-se exocitose de lisossomas após tratamento com 
cloroquina, e com base na ultraestrutura do RPE, foi proposto que este seja um evento 
chave no desenvolvimento de doença. Vários dos resultados obtidos com hPSc-RPE 
foram confirmados em linhas primárias de RPE, humanas e de porco, de forma a reforçar 
e extrapolar as conclusões do estudo e relacionar com a biologia celular do RPE em geral. 
Por fim, os modelos celulares de RPE demonstraram reproduzir caraterísticas 
fundamentais de doenças degenerativas da retina relacionadas com o envelhecimento, 
nomeadamente com o aparecimento de depósitos subcelulares, tipicamente usados como 
identificadores de DMI. 
Adicionalmente, na secção de material suplementar, é apresentado um trabalho 
complementar, desenvolvido durante o percurso do doutoramento. Este trabalho consiste 
em estudos sobre o fator de crescimento endotelial vascular (VEGF) e sobre a sua 
regulação por parte de proteínas Rab do tráfego intracelular do recetor VEGFR2. 
Globalmente, este estudo abre portas a novas perspetivas para explorar modelos 
celulares de RPE, de forma a dissecar os mecanismos moleculares de degeneração por 
detrás das doenças da retina. Para além disso, os modelos aqui desenvolvidos têm o 
potencial para serem utilizados para estudar novas abordagens terapêuticas, de forma a 
restaurar a função lisossomal, e abrir caminho para estudos in vivo. 
 
Palavras-chave: Epitélio Pigmentar da Retina, diferenciação, células estaminais 
pluripotentes, modelos celulares de doença, disfunção lisossomal. 
 
 
  v 
 
 
 
 
 
Publications 
 
The work described herein resulted in the following outputs. 
Presenting author is highlighted in bold. Contributions from this thesis’s author are underlined. 
 
Papers	in	Peer-reviewed	International	Scientific	Journals	
Cardoso MH, Hall M, Falcão AS, Escrevente C, Santos G, Tenreiro S, Futter CE, Seabra 
MC, Chloroquine-induced hESc-RPE Model of Lysosomal Dysfunction (Manuscript in 
preparation) 
 
Cardoso MH, Rodrigues IP, Maia S, Pires CF, Portal MD, Strauss O, Seabra MC, 
Ramalho JS, VEGF titration by RabGTPase-regulated trafficking of VEGFR2 in RPE 
(Manuscript in preparation) 
 
Oral	Communications	
Hall M, Cardoso MH, Falcão AS, Escrevente C, Tenreiro S, Wavre S, Meschede I, 
Burgoyne T, Seabra MC, Futter CE, Modelling lysosome dysfunction in the retinal 
pigment epithelium in early AMD, Pro-retina Meeting 2018, Germany, Apr 2018 
Cardoso MH, Tenreiro S, Falcão AS, Escrevente C, Seabra MC. Planning WP4 – 
Biological validation of BrM and CVN models, Biomembrane Consortium Meeting, 
Warsaw, Poland, Mar 2018 
Cardoso MH, Hall M, Futter CE, Seabra MC. hESc-derived RPE: model of 
Lysosome Dysfunction, ProRegeM Annual Meeting, CEDOC/NMS UNL, Dec 2017. 
Cardoso MH, Hall M, Futter CE, Seabra MC. hESc-derived RPE: model of 
Lysosome Dysfunction, CEDOC Casual Friday with Science Seminar, Nov 2017. 
Cardoso MH, Hall M, Futter CE, Seabra MC. Retinal Pigment Epithelium cell-
based therapies and Disease Mechanisms, II Retiro de Estudantes de Doutoramento do 
CEDOC, Sep 2017 
Cardoso MH, Tenreiro S, Falcão AS, Escrevente C, Seabra MC. Biological 
validation of BrM and CVN models, Biomembrane Consortium Meeting, Pisa, Italy, Sep 
2017 
Cardoso, MH, Retinal Pigment Epithelium cell-based therapies and Disease 
Mechanisms, ProRegeM Annual Meeting, CEDOC/NMS UNL, Jan 2017 
Cardoso, MH, Retinal Pigment Epithelium cell-based therapies and Disease 
Mechanisms, II Retiro de Estudantes de Doutoramento do CEDOC, Sep 2016 
  vi 
Cardoso MH, Maia S, Ramalho J, Barona T, Seabra MC, Differentiation Of Human 
Embryonic Stem Cells Into Retinal Pigment Epithelium, 19th Symposium of Biology 
Students in Europe – SymBioSE, Jul 2016, Vila Real, Portugal 
M. Rocha, S. Maia, D. Santos, MH. Cardoso, J. Ramalho, M. Martins, M. Seabra & 
T. Barona, Image software and statistical analysis applied to expression of RAB25 in 
breast cancer, International Conference on Clinical and BioEngineering for Women’s 
Health, Porto, Portugal, 2015 
Cardoso MH, Reprogramming Fibroblasts into Retinal Pigment Epithelium cells, 
ProRegeM Annual Meeting, University of Algarve, Portugal, 2015 
 
Poster	Presentations	
Cardoso MH, Hall M, Falcão AS, Escrevente C, Tenreiro S, Futter CE, Seabra MC, 
Lysosomal dysfunction in the retinal pigmented epithelium and the pathogenesis of age-
related macular degeneration, 2nd Small Meeting on Endocytic Trafficking and 
Signaling, Braga, Portugal, July 2018 
Hall M, Falcão AS, Escrevente C, Cardoso MH, Santos G, Tenreiro S, Futter CE, 
Seabra MC, Lysosomal dysfunction in the retinal pigmented epithelium and the 
pathogenesis of age-related macular degeneration, Gordon Research Conference on 
Lysosomes and Endocytosis, Andover, United States, Jun 2018 
Cardoso MH, Hall M, Falcão AS, Escrevente C, Tenreiro S, Futter CE, Seabra MC, 
hESc-derived RPE model of chronic lysosome dysfunction, Embo Lysosomes and 
Metabolism workshop, Naples, Italy, May 2018 
Falcão AS, Escrevente C, Cardoso MH, Santos G, Tenreiro S, Seabra MC, Using 
photoreceptor outer segments autofluorescence to measure lysosomal dysfunction in pig 
and human retinal pigmented epithelial cells, Embo Lysosomes and Metabolism 
workshop, Naples, Italy, May 2018 
Hall M, Cardoso MH, Falcão AS, Escrevente C, Tenreiro S, Seabra MC, Futter CE, 
Modelling lysosome dysfunction in the retinal pigment epithelium in the development of 
early AMD, Institute of Ophthalmology Meeting 2018, London, UK, Apr 2018 
 
  vii 
 
 
 
 
 
 
 
Contents 
	
ABSTRACT	..............................................................................................................................	I	
RESUMO	...............................................................................................................................	III	
PUBLICATIONS	.......................................................................................................................	V	
PAPERS	IN	PEER-REVIEWED	INTERNATIONAL	SCIENTIFIC	JOURNALS	..........................................................	V	
ORAL	COMMUNICATIONS	................................................................................................................	V	
POSTER	PRESENTATIONS	................................................................................................................	VI	
CONTENTS	...........................................................................................................................	VII	
LIST	OF	FIGURES	...................................................................................................................	XI	
LIST	OF	TABLES	....................................................................................................................	XV	
ABBREVIATIONS	................................................................................................................	XVII	
CHAPTER	1	
INTRODUCTION	.....................................................................................................................	1	
1.1	EYE	STRUCTURE	AND	VISUAL	FUNCTION	......................................................................................	1	
1.1.1	THE	RETINA	AND	THE	RETINAL	PIGMENT	EPITHELIUM	.................................................................	2	
1.1.2	FUNCTION	OF	THE	RPE	.........................................................................................................	3	
1.2	AGE-RELATED	MACULAR	DEGENERATION	...................................................................................	4	
1.2.1	CLINICAL	STANDPOINT	..........................................................................................................	5	
1.2.2	AMD	CELL	BIOLOGY	.............................................................................................................	6	
1.2.3	TREATMENT	OPTIONS	...........................................................................................................	7	
1.3	PLURIPOTENT	STEM	CELL-DERIVED	RPE	......................................................................................	8	
1.3.1	DEVELOPMENT	AND	PATTERNING	OF	THE	EYE	...........................................................................	8	
1.3.2	SIGNALING	PATHWAYS	IN	EYE	DEVELOPMENT	............................................................................	9	
1.3.3	THE	PROMISE	OF	HPSC-RPE’S	THERAPEUTIC	POTENTIAL	...........................................................	11	
1.3.4	USING	HPSC-RPE	TO	MODEL	DISEASE	...................................................................................	14	
1.4	AGING	AND	LYSOSOME	DYSFUNCTION	......................................................................................	15	
1.4.1	MAIN	TRAFFICKING	PATHWAYS	TO	THE	LYSOSOME	...................................................................	15	
ENDOCYTOSIS	............................................................................................................................	16	
PHAGOCYTOSIS	..........................................................................................................................	17	
AUTOPHAGY	..............................................................................................................................	18	
1.4.2	POINT	OF	CONVERGENCE:	THE	LYSOSOME	.............................................................................	21	
1.4.3	LYSOSOME	BIOGENESIS	AND	REGULATION	..............................................................................	23	
1.4.4	THE	DYNAMIC	NATURE	OF	LYSOSOMES	..................................................................................	24	
1.4.5	LYSOSOMAL	DYSFUNCTION	..................................................................................................	27	
1.4.6	LYSOSOMES	IN	RETINAL	DEGENERATION	................................................................................	29	
1.5	FINAL	REMARKS	...................................................................................................................	31	
	
	
  viii 
CHAPTER	2	
MATERIALS	AND	METHODS	.................................................................................................	33	
2.1	CELL	CULTURE	AND	MAINTENANCE	..........................................................................................	33	
2.1.1	HUMAN	EMBRYONIC	STEM	CELLS	(HESC)	...............................................................................	33	
2.1.2	HUMAN	RPE	FROM	LONZA	(LONZA	HRPE)	............................................................................	33	
2.1.3	PORCINE	RPE	PRIMARY	CULTURES	AND	MAINTENANCE	(PRPE)	..................................................	33	
2.1.4	HESC-RPE	DIFFERENTIATION	AND	MAINTENANCE	....................................................................	34	
2.1.5	ARPE19	..........................................................................................................................	35	
2.2	POS	ISOLATION	FROM	PORCINE	EYES	.......................................................................................	35	
2.3	PHAGOCYTOSIS	ASSAYS	..........................................................................................................	35	
2.4	CHLOROQUINE	TREATMENTS	...................................................................................................	35	
2.5	POLARITY	ASSESSMENT	OF	RPE	MONOLAYERS	...........................................................................	36	
2.6	RNA	ISOLATION	AND	REVERSE	TRANSCRIPTASE	(RT)-PCR	...........................................................	36	
2.7	VIABILITY	ASSAYS	-	LACTATE	DEHYDROGENASE	(LDH)	.................................................................	36	
2.8	EXOSOMES	ISOLATION	...........................................................................................................	36	
2.9	FLOW	CYTOMETRY	................................................................................................................	36	
2.10	ß-HEXOSAMINIDASE	RELEASE	................................................................................................	36	
2.11	DRUGS	AND	DYES	...............................................................................................................	37	
2.12	IMAGE	ANALYSIS	AND	STATISTICS	..........................................................................................	37	
2.13	ANTIBODIES	USED	...............................................................................................................	38	
2.14	PROTEIN	LYSATES	AND	WESTERN	BLOT	..................................................................................	38	
2.15	IMMUNOFLUORESCENCE	......................................................................................................	39	
2.16	LIGHT	MICROSCOPY	............................................................................................................	39	
2.17	TRANSMISSION	ELECTRON	MICROSCOPY	.................................................................................	39	
2.17.1	FIXATION	AND	EMBEDDING	...............................................................................................	39	
2.17.2	ULTRATHIN	SECTIONING	...................................................................................................	40	
2.17.3	FORMVAR	COATING	OF	COPPER	GRIDS	................................................................................	40	
2.17.4	IMMUNOGOLD	LABELLING	OF	ULTRATHIN	CRYOSECTIONS	........................................................	40	
2.17.5	IMAGING	........................................................................................................................	41	
CHAPTER	3	
PLURIPOTENT	STEM	CELL-DERIVED	......................................................................................	43	
RETINAL	PIGMENT	EPITHELIUM	...........................................................................................	43	
DEVELOPMENT	AND	ESTABLISHMENT	OF	A	DISEASE	MODEL	...............................................	43	
3.1	RPE	DIFFERENTIATION	PROCESS	.............................................................................................	43	
3.2	FROM	STEM	CELLS	TO	RPE	–	DIFFERENTIATION	PROTOCOL	IMPLEMENTATION	................................	45	
3.2.1	MOUSE	RPE	DIFFERENTIATION	.............................................................................................	45	
3.2.2	HUMAN	RPE	DIFFERENTIATION	PROCESS	................................................................................	48	
SPONTANEOUS	DIFFERENTIATION	METHOD	.....................................................................................	49	
DIRECTED	DIFFERENTIATION	METHOD	............................................................................................	50	
3.3	HESC-RPE	CHARACTERIZATION	...............................................................................................	52	
3.3.1	RPE	MORPHOLOGY	AND	POLARIZATION	................................................................................	52	
3.3.2	RPE	GENE	EXPRESSION	AND	MOLECULAR	MARKERS	...............................................................	55	
3.3.3	FUNCTIONAL	CHARACTERIZATION	OF	HESC-RPE	.....................................................................	57	
MELANOGENESIS	........................................................................................................................	57	
SECRETION	................................................................................................................................	59	
PHAGOCYTIC	ABILITY	...................................................................................................................	60	
3.4	HESC-RPE	PROCESSING	OF	PHAGOCYTIC	CARGO	.......................................................................	62	
3.4.1	HESC-RPE	PHAGOCYTIC	ABILITY	...........................................................................................	62	
3.4.2	LONZA	HRPE	AND	PRPE	PHAGOCYTIC	ABILITY	........................................................................	63	
  ix 
3.4.3	POS-DERIVED	AUTOFLUORESCENCE	......................................................................................	65	
3.5	MODEL	OF	POS-INDUCED	LYSOSOMAL	DYSFUNCTION	................................................................	68	
CHAPTER	4	
CHLOROQUINE-INDUCED	HESC-RPE	MODEL	OF	LYSOSOMAL	DYSFUNCTION	........................	71	
4.1	SIGNIFICANCE	OF	LYSOSOMAL	PH	............................................................................................	71	
4.1.1	UNDERSTANDING	CHLOROQUINE-INDUCED	RETINOPATHY	........................................................	72	
4.1.2	MODELING	CQ-INDUCED	LYSOSOMAL	DYSFUNCTION	..............................................................	73	
4.2	CHLOROQUINE	TITRATION	-	LDH	VIABILITY	ASSAYS	.....................................................................	74	
4.2.1	CHLOROQUINE-INDUCED	PIGMENTATION	MODIFICATIONS	.......................................................	78	
4.3	CHLOROQUINE-INDUCED	MIT	TFS	NUCLEAR	TRANSLOCATION	.....................................................	80	
4.4	CQ-INDUCED	IMPAIRMENT	OF	PHAGOCYTIC	CARGO	DIGESTION	...................................................	84	
4.5	CQ-INDUCED	IMPAIRMENT	OF	DEGRADATIVE	ABILITY	.................................................................	89	
4.6	CQ	STIMULATES	CATHEPSIN	B	AND	L	PROTEOLYTIC	ACTIVITY	........................................................	94	
4.7	CQ-INDUCED	DISTURBANCE	OF	CATHEPSIN	D	ACTIVITY	AND	EXPRESSION	........................................	98	
4.8	CQ-INDUCED	ALTERATION	OF	LYSOSOMAL	ACIDITY	..................................................................	107	
4.9	ENDOCYTIC	PATHWAY	AND	AUTOPHAGY	IMPAIRMENT	..............................................................	111	
4.10	CQ-INDUCED	LYSOSOMAL	EXOCYTOSIS	.................................................................................	121	
3.11	FINAL	CONCLUSION:	MODEL	OF	CQ-INDUCED	LYSOSOMAL	DYSFUNCTION	IN	RPE	.......................	123	
CHAPTER	5	
CONCLUSION	AND	FUTURE	PERSPECTIVES	.........................................................................	129	
CHAPTER	6	
REFERENCES	......................................................................................................................	141	
CHAPTER	7	
SUPPLEMENTARY	MATERIAL	.............................................................................................	157	
 
 
  x 
  xi 
 
 
 
 
 
 
 
List of Figures 
 
Figure 1. 1 - Schematic representation of eye structure with focus on the retina. ............ 2	
Figure 1. 2 - Schematic representation of the RPE main functions. ................................. 3	
Figure 1. 3 - Schematic representation of normal macula and AMD. .............................. 4	
Figure 1. 4 - Progressive image distortion and central vision loss, caused by AMD. ...... 5	
Figure 1. 5 - Schematic representation of young and aged RPE ...................................... 6	
Figure 1. 6 - Schematic representation of eye developmental.. ........................................ 9	
Figure 1. 7 - Representation of the signaling pathways regulating RPE patterning ....... 11	
Figure 1. 8 - RPE can be obtained through differentiation of hES cells or iPS cells. .... 12	
Figure 1. 9 - Representation showing stem cell research for RPE replacement ............. 13	
Figure 1. 10 - Schematic representation of the endocytic organelle identity .................. 17	
Figure 1. 11 - Schematic representation of the phagocytosis by RPE ............................ 18	
Figure 1. 12 - Schematic representation of the main molecular players of autophagy ... 19	
Figure 1. 13 - Representation pathways converging at the lysosome ............................. 20	
Figure 1. 14 – Main functions of Lysosomes ................................................................. 21	
Figure 1. 15 - MiT family members control fundamental processes .............................. 24	
Figure 1. 16 - Lysosomes are very dynamic, continuously fusing and reforming. ......... 25	
Figure 1. 17 - The lysosome cycles as it fuses and reforms back. .................................. 26	
Figure 1. 18 - Normal/healthy RPE versus AMD settings. ............................................. 29	
 
Figure 3. 1 - Cell morphology during early steps of differentiation ............................... 46	
Figure 3. 2 - Differentiating cells self-organized. ........................................................... 46	
Figure 3. 3 - Differentiating cells produced optic cup-like configurations ..................... 47	
Figure 3. 4 - Mouse cells gained RPE-like morphology ................................................. 47	
Figure 3. 5 - Mouse cells display RPE-like morphology and pigmentation ................... 48	
Figure 3. 6 - Undifferentiated H9 embryonic stem cell colony. ..................................... 48	
Figure 3. 7 - Schematic representation of the spontaneous differentiation method ........ 49	
Figure 3. 8 - RPE typical morphology and pigmentation. .............................................. 49	
Figure 3. 9 - Schematic representation of the directed differentiation method .............. 50	
Figure 3. 10 - hES cells differentiation stages, until defining an RPE fate. ................... 51	
Figure 3. 11 - Typical features of mature RPE ............................................................... 51	
Figure 3. 12 - hESc-RPE organizes as a monolayer of polygonal-shaped cells ............. 52	
Figure 3. 13 - hESc-RPE monolayer observed by Transmission Electron Microscopy. 53	
Figure 3. 14 - hESc-RPE cells have similar morphology to Lonza hRPE and to pRPE .... 54	
Figure 3. 15 - Transmission Electron Microscopy images of hESc-RPE and pRPE.. .... 54	
Figure 3. 16 - hESc-RPE become polarized, approximately after two weeks ................ 55	
Figure 3. 17 - hESc-RPE express markers characteristic of mature RPE ....................... 55	
Figure 3. 18 - IF images show hESc-RPE express characteristic RPE markers ............. 56	
Figure 3. 19 - immuno-EM staining showing specific labeling of melanosomes .......... 57	
Figure 3. 20 - Schematic representation of the four stages of melanosome maturation . 58	
Figure 3. 21 - Melanosomes are fully matured in porcine RPE, but not in hESc-RPE .. 58	
  xii 
Figure 3. 22 - hESc-RPE cells secrete VEGF and PEDF in a polarized manner ........... 59	
Figure 3. 23 - hESc-RPE release exosomes into the medium ......................................... 59	
Figure 3. 24 - Isolated porcine POS consist on multi-membrane discs .......................... 60	
Figure 3. 25 - hESc-RPE are able to phagocytose porcine POS ..................................... 61	
Figure 3. 26 - TEM images show hESc-RPE are able to phagocytose porcine POS ..... 61	
Figure 3. 27 - cryo-immuno TEM images show hESc-RPE are able to phagocytose .... 62	
Figure 3. 28 - Schematic representation of the experimental layout .............................. 62	
Figure 3. 29 - Time course of POS processing by hESc-RPE ........................................ 63	
Figure 3. 30 - RET-P1 IF staining and POS-derived autofluorescence in Lonza hRPE 64	
Figure 3. 31 - RET-P1 IF staining and POS-derived autofluorescence in pRPE ........... 64	
Figure 3. 32 - POS-derived autofluorescence in Lonza hRPE by flow cytometry ......... 65	
Figure 3. 33 - Lonza hRPE's and pRPE's POS autofluorescence by flow cytometry ..... 66	
Figure 3. 34 - Lonza hRPE's and pRPE's POS autofluorescence by microscopy ........... 67	
 
Figure 4. 1 - Chloroquine toxicity evaluation for the three RPE lines overnight ........... 74	
Figure 4. 2 - hESc-RPE, Lonza-hRPE and pRPE viability, following 3 days of CQ ..... 75	
Figure 4. 3 - hESc-RPE viability, after being submitted to a week-long CQ treatment . 76	
Figure 4. 4 - Lonza hRPE viability, after being submitted to a week-long CQ .............. 77	
Figure 4. 5 - pRPE viability, upon week-long CQ treatment .......................................... 77	
Figure 4. 6 - hESc-RPE exhibit pigmentation changes, when treated with CQ ............. 79	
Figure 4. 7 - (Auto)fluorescence detection in hESc-RPE, by flow cytometry. .............. 80	
Figure 4. 8 - Acute CQ treatment of hESc-RPE induced TFEB translocation ............... 81	
Figure 4. 9 - Acute CQ treatment induced TFEB translocation to the nucleus .............. 81	
Figure 4. 10 - TFEB, TFE3 and MITF translocate and concentrate at the nucleus ........ 82	
Figure 4. 11 - TFEB, TFE3 and MITF translocate to the nucleus upon continued CQ .. 82	
Figure 4. 12 - TFEB, TFE3 and MITF subcellular localization after 1 week of CQ ...... 83	
Figure 4. 13 - POS accumulation, when hESc-RPE are treated with CQ overnight ...... 84	
Figure 4. 14 - POS accumulation is more evident upon higher CQ concentrations ....... 85	
Figure 4. 15 - Quantification of POS accumulation, with increasing CQ ...................... 85	
Figure 4. 16 - hESc-RPE treated with CQ for three days accumulate rhodopsin ........... 86	
Figure 4. 17 - Quantification of POS accumulation, with increasing CQ. ..................... 87	
Figure 4. 18 - POS accumulate as the result of chronic treatment with CQ ................... 87	
Figure 4. 19 - POS accumulate, in hESc-RPE cells, upon chronic treatment with CQ .. 88	
Figure 4. 20 - hESc-RPE proteolytic ability is not severely altered upon acute CQ ...... 89	
Figure 4. 21 - hESc-RPE degradative ability is not severely impaired by acute CQ. .... 90	
Figure 4. 22 - hESc-RPE degradative ability is compromised after continued CQ. ....... 91	
Figure 4. 23 - Continued CQ treatment impairs degradative ability of hESc-RPE. ....... 92	
Figure 4. 24 - Chronic CQ treatment impairs degradative ability of hESc-RPE ............ 92	
Figure 4. 25 - Chronic CQ treatment severely impairs degradative ability .................... 93	
Figure 4. 26 - Acute CQ treatment causes increase of Cat B and L activity .................. 95	
Figure 4. 27 - CatB activity increases upon acute CQ treatment of hESc-RPE. ............ 96	
Figure 4. 28 - Continued CQ treatment induces CatB and CatL activity ....................... 96	
Figure 4. 29 - Continued CQ treatment alters cellular distribution of CatB activity ...... 97	
Figure 4. 30 - Chronic CQ burden induces CatB and CatL activity in hESc-RPE ......... 98	
Figure 4. 31 - Representation of the human CatD processing steps ............................... 99	
Figure 4. 32 - Acute CQ treatment leads to decreased CatD activity in hESc-RPE ..... 100	
Figure 4. 33 - CatD protein profile is altered by CQ acute treatment of hESc-RPE .... 100	
Figure 4. 34 - CatD total amounts are not altered upon acute CQ treatment. ............... 101	
Figure 4. 35 - The ratio of mature/immature CatD is altered upon acute CQ. ............. 101	
Figure 4. 36 - Continued CQ treatment does not alter CatD activity in hESc-RPE ..... 103	
  xiii 
Figure 4. 37 - Continued CQ treatment does not change CatD protein profile ............ 103	
Figure 4. 38 - Continued CQ treatment causes a slight increase of total CatD ............ 103	
Figure 4. 39 - CatD ratio is altered upon CQ continued treatment of hESc-RPE. ........ 104	
Figure 4. 40 - CatD’s activity is increased by chronic CQ treatment of hESc-RPE ..... 104	
Figure 4. 41 - Chronic CQ alters CatD protein profile in all three RPE lines .............. 105	
Figure 4. 42 - Total CatD is increased by CQ chronic treatment ................................. 105	
Figure 4. 43 - CatD ratio is severely altered by chronic CQ treatment ........................ 106	
Figure 4. 44 - Acute CQ treatment causes increase of LT fluorescence ....................... 107	
Figure 4. 45 - Acute CQ treatment causes increase of LT fluorescence ....................... 108	
Figure 4. 46 - Continued CQ treatment causes increase of LT fluorescence ............... 109	
Figure 4. 47 - Continued CQ treatment causes increase of LT fluorescence ............... 110	
Figure 4. 48 - Chronic CQ burden causes increase of LT fluorescence ....................... 110	
Figure 4. 49 - ApoE protein levels and intracellular distribution are not altered ......... 111	
Figure 4. 50 - ApoE protein levels are not altered upon acute CQ treatment. .............. 112	
Figure 4. 51 - ApoE total amounts are not altered upon acute CQ treatment. .............. 112	
Figure 4. 52 - Acute CQ treatment alters p62 and LC3 protein levels in hESc-RPE. .. 113	
Figure 4. 53 - p62 protein levels are slightly increased in POS-fed hESc-RPE ........... 114	
Figure 4. 54 - Ratio LC3 II/LC3 I is altered upon acute CQ treatment of hESc-RPE .. 114	
Figure 4. 55 - ApoE protein levels and intracellular distribution are not altered ......... 115	
Figure 4. 56 - ApoE accumulates upon continued CQ treatment of hESc-RPE ........... 115	
Figure 4. 57 - ApoE accumulates in hESc-RPE upon continued CQ treatment. .......... 116	
Figure 4. 58 - p62 and LC3 protein levels show autophagy clearance ......................... 116	
Figure 4. 59 - p62 levels do not increase in hESc-RPE upon continuous CQ .............. 117	
Figure 4. 60 - LC3 ratio does not suggest autophagy impairment in hESc-RPE .......... 117	
Figure 4. 61 - ApoE gets accumulated in hESc-RPE cells treated with chronic CQ .... 118	
Figure 4. 62 -  ApoE accumulates upon chronic CQ treatment of both human RPE ... 118	
Figure 4. 63 - ApoE accumulates severely with CQ chronic treatment ........................ 119	
Figure 4. 64 - p62 (in human cells) and LC3 II accumulate after chronic CQ ............. 119	
Figure 4. 65 - p62 accumulates upon chronic CQ treatment ........................................ 120	
Figure 4. 66 - Chronic CQ treatment causes LC3 II to accumulate. ............................. 120	
Figure 4. 67 - Acute CQ treatment leads to basal release of b-hex by hESc-RPE. ...... 121	
Figure 4. 68 - Continued CQ treatments leads to apical and basal release of b-hex. ... 122	
Figure 4. 69 - Chronic CQ burden leads to both apical and basal release of b-hex ...... 123	
Figure 4. 70 - hESc-RPE lose their epithelial integrity, upon CQ treatment.. .............. 124	
Figure 4. 71 - hESc-RPE treated with CQ accumulate large aggregates ...................... 125 
Figure 4. 72 - pRPE cells treated overnight with CQ present subcellular deposits…...126	
 
Figure 5. 1 - The hallmarks of aging functional interconnections ................................ 129	
Figure 5. 2 - RPE model of chloroquine-induced lysosomal dysfunction. ................... 139	
 
 
  xiv 
  xv 
 
 
 
 
 
 
 
List of Tables 
 
Table I: Retinal Differentiation Media Supplements and Reagents…………………34 
Table II: Drugs and Dyes used for Lysosomal dysfunction studies…………………37 
Table III: List of Antibodies used………………………………...…………………38 
Table IV: Summary of findings regarding the hESc-RPE CQ-induced lysosomal 
dysfunction model.………………………………...……………………………………138 
 
 
 
 
 
  xvi 
  xvii 
 
 
 
 
 
 
 
Abbreviations 
 
AD    Alzheimer´s Disease 
AMD   Age-related Macular Degeneration 
AMPK   AMP-activated protein kinase 
Atg   Autophagy-related Protein 
ATP   Adenosine Triphosphate 
b-hex   ß-hexosaminidase 
Baf/ Baf A1  Bafilomycin A1 
Best   Bestrophin 
BMP   Bone Morphogenic Protein 
BrM   Bruch’s Membrane 
BSA   Bovine Serum Albumin 
CatB/L/D   Cathepsin B/L/D 
CHM   Choroideremia 
CLEAR   Coordinated Lysosomal Expression and Regulation 
CNS   Central Nervous System 
CNV   Choroidal Neovascularization 
ConcA   Concanamycin A 
CQ    Chloroquine 
CRALBP (or RLBP1) Retinaldehyde-Binding Protein 1 
DKK1   Dickkopf-related protein 1 
DMEM   Dulbecco's Modified Eagle Medium 
DNA   Deoxyribonucleic Acid 
ECM   Extracellular Matrix 
EE    Early Endosomes 
ELISA   Enzyme-linked Immunosorbent Assay 
EM   Electron Microscopy 
  xviii 
FBS   Fetal Bovine Serum 
FGF   Fibroblast Growth Factor 
GA    Gluteraldehyde 
GFP   Green Fluorescent Protein 
hESc    human Embryonic Stem cells 
HIF1a   Hypoxia-inducible factor 1-alpha 
hiPSc    induced Pluripotent Stem cells 
hPSc   human Pluripotent Stem cells 
IF    Immunofluorescence 
IGF1   Insulin Growth Factor 1 
LAMP   Lysosome-associated Membrane Protein 
LAP   LC3 Associated Phagocytosis 
LC3   Microtubule-associated Proteins 1A/1B light chain 3 
LDH   Lactate Dehydrogenase 
LE    Late Endosomes 
Lonza hRPE  human fetal RPE purchased from Lonza 
LROs   Lysosome-related Organelles 
LSD   Lysosomal Storage Disorder 
LT    LysoTracker 
LYNUS   Lysosomal Nutrient Sensing 
M6PR   Mannose-6-Phosphate Receptors 
MAPK1/ERK2  Mitogen-activated protein kinase 1 
MEFs   Mouse Embryonic Fibroblasts 
MerTK   tyrosine-protein kinase Mer 
miRNA   micro Ribonucleic acid 
MiT/TFE   Microphthalmia Family of Transcription Factors. 
MITF    Microphthalmia-associated Transcription Factor 
MRed   Magic Red 
mTORC   mammalian Target of Rapamycin Complex 
MVBs    Multivesicular Bodies 
NIC   Nicotinamide 
NPC   Niemann-Pick Type C 
OTX1/2    Homeobox protein1/2 
  xix 
PAX6   Paired box protein Pax-6 
PBS   Phosphate Buffered Saline 
PD    Parkinson´s disease 
PEDF   Pigment Epithelium Derived Factor 
PenStrep   Penicillin Streptomycin 
PFA   Paraformaldehyde 
Pi(n)P   Phosphoinositide (n) Phosphate 
POS   Photoreceptor Outer Segments 
pRPE   porcine RPE 
RA    Retinoic Acid / Rheumatoid Arthritis 
Rap   Rapamycin 
RCS   Royal College of Surgeons 
RDM   Retinal Differentiation Medium 
RNA   Ribonucleic acid 
RPE   Retinal Pigment Epithelium 
SD    Standard Deviation 
SFEB   Serum-free Embryoid Body 
Shh   Sonic Hedgehog 
SLE   Systemic Lupus Erythematosus 
SNARE SNAP (Soluble NSF(N-ethylmaleimide-sensitive 
factor) Attachment Protein) REceptor 
SQSTM1   Sequestosome 1 
TEER or TER  Transepithelial Electrical Resistance 
TFEB   Transcription Factor EB 
TFs   Transcription Factors 
TGFβ    Transforming growth factor beta 
TRPML   transient receptor potential cation channel, mucolipin 
TYR   Tyrosinase 
TYRP1   Tyrosinase-related Protein 1 
vATPase    vacuolar ATPase 
VEGF   Vascular Endothelial Growth Factor 
VIP   Vasoactive Intestinal Peptide  
ZO-1   Zonula Occludens 1 
  
  1 
 
 
 
 
 
 
CHAPTER 1 
Introduction 
 
Age-related disorders often result from a combination of factors, still many 
chronic and late onset diseases share common mechanisms of cellular 
homeostasis dysregulation. Many times these diseases manifest in post-mitotic 
cells, due to accumulation of problems through time, up to a state with which the 
cell can no longer cope. 
This thesis focuses on a particular post-mitotic cell type – the Retinal Pigment 
Epithelium – and on the molecular mechanisms of disease associated with age-
related blinding disorders, namely Age-related Macular Degeneration. Human 
Pluripotent Stem cells were used to generate an in-vitro model of RPE. This model 
was then used to study Lysosomal Dysfunction, which is proposed here as a key 
mechanism for retinal degenerative disease onset and progression. 
 
1.1	Eye	structure	and	visual	function	
The vertebrate eye represents an inspiring structure, when it comes to demonstrate the 
great importance of vision as a selective evolutionary advantage. Comprehensive studies 
across a wide range of vertebrate species have demonstrated the conservation of traits from 
the last common ancestor of all jawed vertebrates ~400 million years ago (Kevany et al. 
2010; Fuhrmann 2010). 
The vertebrate eye is composed by the optic apparatus (cornea, lens and iris), the 
photosensitive layer (photoreceptors: rods and cones), and a light absorbing and nurturing 
layer (Retinal Pigment Epithelium or RPE and choroid). The cornea functions as a window 
to the eye, allowing light to penetrate; smooth muscle constitutes the iris and allows for a 
regulated opening of the pupil, and consequently more or less light to enter; light is then 
focused by the lens, passes through the eye ball filling vitreous humor and hits the retina, 
at the back of the eye. 
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1.1.1	The	retina	and	the	Retinal	Pigment	Epithelium	
The human retina is constituted by an inner neural layer, with millions of 
photoreceptors which convert light energy into nerve impulses, and an outer pigmented 
layer, composed of RPE cells, which absorbs scattered light. Besides the photoreceptors, 
the neural layer contains other neurons: ganglion cells, whose axons weave together to 
form the optic nerve; bipolar cells, which have synapses at both ends and establish a bridge 
between photoreceptors and ganglion cells; amacrine cells, which connect with bipolar and 
ganglion cells; and horizontal cells, connected laterally to adjust photoreceptors’ outputs 
in order to adapt vision to both bright and dim light. Glia cells, namely müller cells are also 
present in the neural retina, maintaining homeostasis of the retina, by controlling 
angiogenesis and releasing neurotrophic factors. A schematic representation of the retina, 
depicted in Figure 1. 1. 
 
Figure 1. 1 - Schematic representation of eye structure with focus on the retina. Adapted from (Kolb 1995). 
 
The visual process starts with light collection by photoreceptor cells: rods and cones. 
Rods relay exquisite sensitivity in low-light settings, conveying contrast and definition, 
whereas cones govern ambient light collection and distinction of the different colors, but 
with relatively low sensitivity (Kevany et al. 2010). Each rod and cone is composed of a 
synaptic terminal, an outer segment, an inner segment and a cilium connecting the outer 
and inner segments. The photo pigment opsin (also referred to as rhodopsin) comprises 
>95% of the rods outer segments’ membrane protein. Opsins are G protein-coupled 
receptors that require a bound chromophore 11-cis-retinal to absorb photons. Upon 
absorption of a photon, 11-cis-retinal is converted to all-trans-retinal, conveying the 
pigment its “active” state (Kevany et al. 2010). This photo-excited opsin triggers a signal 
transduction cascade, which amplifies the signal and leads to the shutdown of cation 
channels, thereby hyperpolarizing photoreceptor membrane. This change in membrane 
potential is then sensed by the synapses, resulting in neurotransmitters release, which in 
turn relay information to bipolar and ganglion cells, with lateral interaction of horizontal 
and amacrine cells (Sung & Chuang 2010). Photoreceptors are exposed to photo-oxidative 
products with consequent damage of proteins and lipids. However, they undergo 
continuous daily renewal, with the distal portion of Photoreceptor Outer Segments (POS) 
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discs being shed and replenished at the Inner Segment region, in a mechanism which 
involves transport through the connecting cilium (Burgoyne et al. 2016; Young 1971). At 
the terminal end of POS, the RPE closely contacts and phagocytoses the shed material, 
taking part in the visual cycle. In the RPE, the visual pigment is recycled from all-trans-
retinal back to 11-cis-retinal, which is returned to the outer segments, thus completing the 
visual cycle (Bharti et al. 2010). 
 
1.1.2	Function	of	the	RPE	
The RPE is a single layer of tightly packed and polarized pigmented cells responsible 
for several functions necessary for retinal health (Figure 1. 2).  
 
Figure 1. 2 - Schematic representation of the RPE main functions. PR: Photoreceptors, RPE: Retinal Pigment 
Epithelium; BrM: Bruch’s membrane; O.S.: Outer Segment; M.V.: microvilli (Strauss 2005a). 
 
In particular, RPE cells display high functioning preventive mechanisms against photo 
oxidation: pigment-mediated absorption of scattered light, maintenance of high levels of 
antioxidants which remove chemically reactive species, and also repair of damaged DNA, 
proteins and lipids. These mechanisms allow the RPE to assure structural integrity, while 
balancing photo oxidation from the retinal side and overflow of oxygen from the choroid 
side (Strauss 1995). 
The RPE is responsible for the nourishment of the adjacent neural retina layers and is 
able to efficiently transport nutrients and ions between the retina and choriocapillaris, 
through highly convoluted basal infolds, which convey increased contact surface (Kevany 
et al. 2010; Strauss 1995; Sparrow et al. 2010). At the RPE basal side, establishing a 
selective blood/retina barrier with the choriocapillaris, lays the Bruch’s Membrane (BrM), 
through which metabolic waste products and water excess are removed transcellularly 
towards the bloodstream. This barrier property is essential to maintain the immune 
privilege of the eye. Also, the RPE is responsible for the transport of essential metabolites, 
including glucose, fatty acids and new retinoids from the bloodstream into the retina and it 
is absolutely required for the regeneration of 11-cis-retinal, during the visual cycle (Kevany 
et al. 2010; Keeling et al. 2018). 
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The RPE actively phagocytosis and recycles the POS, on a daily basis. This process is 
regulated by the circadian rhythm and triggered by morning light, even in nocturnal 
animals. It is estimated that the whole length of POS is completely renewed every 10 days, 
a process coordinated by both photoreceptors and RPE (Law et al. 2010; Strauss 2005a). 
Finally, RPE cells secrete important growth factors, such as Pigment Epithelium 
Derived Factor (PEDF) and Vascular Endothelial Growth Factor (VEGF), the latter being 
a crucial survival factor and modulator of vascular permeability and angiogenesis (Sparrow 
et al. 2010; Penn et al. 2008; Strauss 2005a). 
Together, RPE and photoreceptors work as a functional unit, each depending on the 
other. For instance, genetic defects affecting the photoreceptors lead to RPE degeneration 
and vice-versa. In order to allow this close interaction, a tight coordination and structure 
maintenance are necessary. When this balance is not kept, degeneration of both layers 
ensues, jeopardizing the whole visual function. 
 
1.2	Age-related	Macular	Degeneration	
Age-related macular degeneration (AMD) is a retinal degenerative disorder, 
characterized by progressive visual impairment, caused by late-onset degeneration of the 
photoreceptors and retinal pigment epithelium (Al-Zamil & Yassin 2017). It is the leading 
cause of blindness in the developed world. In fact, AMD affects 0.2% of the population 
aged 55 to 64, rising to 11-13% of the population older than 85 years (Evans 2001; de Jong 
2006). 
As the designation suggests, AMD affects primarily the macula region, which 
constitutes the central area of the retina, approximately 4% of the total retina area. It is in 
that central region that the fovea is located, representing an area of tightly packed cone 
photoreceptors. For this reason, the macula is responsible for high-resolution central vision, 
sensible to color upon day light. Remarkably, this area of the retina  has arguably the 
highest metabolic burden of the whole human body (Hageman et al. 1995; Biasutto et al. 
2013). AMD typically progresses into one of two forms: dry AMD, with macular RPE 
atrophy and consequent photoreceptor loss, and wet AMD, characterized by 
neovascularization from the choroid into the retinal space (Figure 1. 3). 
 
Figure 1. 3 - Schematic representation of 1: normal macula, 2: dry AMD and 3: wet AMD. Adapted from ClipArt. 
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1.2.1	Clinical	standpoint	
AMD is often considered as a multifactorial disease, without a fully understood 
pathophysiology. Pathogenesis of AMD is regarded as the result of a combination of 
metabolic, functional, genetic and environmental factors (Hamdi & Kenney 2003). On the 
one hand, with aging, the RPE starts accumulating residual material containing lipofuscin, 
which would normally be eliminated through the choriocapillaris (Guha, Liu, et al. 2014). 
On the other hand, changes of Bruch’s membrane permeability have been associated with 
the accumulation of extruded material (Bhutto & Lutty 2012). Specifically, focal yellow 
deposits termed drusen build up in the extracellular matrix, at the interphase between RPE 
and the inner collagenous layer of the Bruch’s membrane (Figure 1. 3). Besides thickening 
of the Bruch’s membrane, with degeneration of elastin and collagen layers within the 
membrane, it has further been observed that choriocapillaris become thinner, which may 
contribute to the decline in the removal of extracellular material. The elastic layer of the 
Bruch’s membrane is thinner in the foveal region, potentially conveying lowered tissue 
resistance to neovascularization in that area (de Jong 2006). Furthermore, blood/retina 
barrier failure induces local incitement of the innate immunity and disturbs fundamental 
RPE functions (Guha, Liu, et al. 2014). It is also typical to find pigmentary disturbances, 
such as hypo- and hyperpigmentation in AMD patients, still the presence of drusen in the 
macula region is considered to be the hallmark sign of AMD (Al-Zamil & Yassin 2017). 
Dry AMD, also called geographic atrophy, is characterized by a demarcated area of 
hypopigmentation, in which large choroidal vessels are visible and patients experience loss 
of vision as gaps in an image. On the other hand, the wet form of AMD, also called 
exudative, appears as hemorrhagic fluid, originating from choroidal neovascularization 
(CNV). CNV originates from normal choriocapillaris, but invades the subretinal space, the 
RPE and neuroretina, causing retinal detachment (de Jong 2006). If left untreated, wet 
AMD usually causes legal blindness within months after the second eye becomes affected, 
while in the case of dry AMD these events may take years (de Jong 2006; Arunkumar et 
al. 2018; Hageman et al. 1995). Ultimately, patients suffer visual image distortion and, as 
the hemorrhages and scaring continue in the foveal area, progressive vision loss (Figure 1. 
4).  
 
Figure 1. 4 - Progressive image distortion and central vision loss, caused by wet AMD (aoa.org 2017). 
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AMD can be considered at early stage when visual symptoms are inconspicuous, but 
drusen and pigmentary changes are present. When areas of abnormal pigmentation expand, 
associated with larger drusen, the patient is considered at higher risk of developing late 
forms of AMD (de Jong 2006; Mehta 2015). Late AMD may present in both dry or wet 
forms; however, one patient may present a different form in each eye or even both in the 
same eye. Because of similarities with other retinal diseases, AMD is considered to be a 
diagnosis of exclusion. For this reason, and because progression is gradual, research into 
AMD focuses mostly on the development of therapies for the advanced stages, rather than 
initiating events. Diagnosis relies on the identification of macular signs, namely the 
detection of pigmentation alterations and most notably of drusen, whose origin remains 
unknown (de Jong 2006; Mehta 2015). 
 
1.2.2	AMD	cell	biology	
As previously discussed, the RPE plays a pivotal role in the daily uptake of POS and 
their recycling, taking part in the visual cycle. Photoreceptors are particularly susceptible 
to photo oxidation and formation of reactive oxygen species, with consequent peroxidation 
of proteins and lipids. Exposure to bright light has been shown to cause irreversible lesions 
in the central retina, related to the rate of rhodopsin regeneration by the RPE (Frost et al. 
2014). POS phagocytosis and recycling of visual pigment within the RPE leads to the 
appearance of residual undigested bodies, which become substrates for lipofuscin 
formation. Lipofuscin is an autofluorescent cellular waste product, formed by the 
condensation of all-trans-retinal and phosphatidylethanolamine, becoming virtually 
undegradable (Krohne et al. 2010). Aging leads to an accumulation of lipofuscin granules 
which gradually worsens the RPE digestive burden and this is more pronounced at the 
macula region (Kevany et al. 2010; de Jong 2006) (Figure 1. 5).  
 
Figure 1. 5 - Schematic representation of young and aged RPE (de Jong 2006). 
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As depicted, a feature of the aged retina is the thickening of the Bruch’s membrane, 
which accumulates lipids and glycoproteins throughout time (Figure 1. 5). Due to increased 
lipid content, this membrane becomes less permeable, causing a depletion of fluid and 
nutrient transport across and into the retina. Drusen deposits prompt local chronic 
inflammation with dendritic and macrophage invasion from the choroid and consequent 
release of pro-inflammatory cytokines and angiogenic factors (de Jong 2006). Choroidal 
fenestrated vessels also reduce in thickness, decreasing transport of macromolecules and 
causing hypoxia. Local hypoxia stabilizes Hypoxia-inducible factor 1-alpha (HIF1a), 
resulting in pro-angiogenic gene up-regulation, most notably VEGF secretion increase by 
the RPE with consequent neovascularization (de Jong 2006; Ablonczy et al. 2014). 
It is important to mention that membrane-bound residual bodies appear naturally, in 
healthy individuals, with age. These drusen form at the basement membrane of the RPE 
starting at the third-fourth decades of life and basal laminar deposits accumulation follows 
(Hageman et al. 2001). It remains undetermined how or why drusen composition and 
localization may vary, or why some people are more prone to progress to AMD disease 
than others. In aged mice and more severely in mice models of retinal degeneration, RPE 
cells develop some characteristic changes resembling some aspects of AMD: lipofuscin, 
melanolipofuscin, extracellular deposits in the baso-lateral area and loss of basal infoldings 
(Wavre-Shapton et al. 2013; Chen et al. 2009). 
Several risk factors have been linked to AMD, especially age (>60 years), but also 
family history and lifestyle (smoking and diet). Moreover, genetic studies have found 
evidence that polymorphisms in genes that encode complement factors can affect AMD 
risk either by increasing the likelihood of developing it or by protecting against disease 
progression (Evans 2001; de Jong 2006). 
 
1.2.3	Treatment	options	
There are currently few therapeutic options for patients with wet AMD, consisting 
mainly of intraocular injections of VEGF inhibitors. These, however, do not target the 
underlying degeneration, thus the disease is only delayed and there is a high rate of 
recurrence when treatment is discontinued (Aboul Naga et al. 2015; Saeed et al. 2013; Penn 
et al. 2008; Kami et al. 2008; Mandai et al. 2017). The dry form of AMD, which constitutes 
the majority of cases (80-90%), has no current treatment option (Al-Zamil & Yassin 2017). 
Research is being directed towards finding and managing AMD’s early events, with the 
ultimate goal of avoiding loss of RPE, a critical step for disease progression. The fact that 
this unique cell type is affected makes AMD a target for cell-based therapy. Consequently, 
a massive effort has been engaged in the latest years to differentiate RPE from human 
Pluripotent Stem Cells (hPSc) for both in vitro studies and transplantation. 
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1.3	Pluripotent	Stem	cell-derived	RPE	
The emergence of human Embryonic Stem cells (hESc) in 1998 and induced 
Pluripotent Stem cells (hiPSc) in 2006 revolutionized cell-based therapies and was a 
stepping stone for the development of reliable models of disease (Leach & Clegg 2015; 
Song & Bharti 2016; Bharti et al. 2010). 
hES cells are derived from blastocysts and are characterized by their ability to self-
renew indefinitely and to generate differentiated cells of all three germ layers. iPS cells, on 
the other hand, are derived by transdifferentiation or reprogramming of somatic cells, by 
forced expression of pluripotency factors (such as OCT4, SOX2, KLF4 and c-MYC) 
(Takahashi & Yamanaka 2006). iPS cells are also characterized by their competence to 
self-renew and differentiate into all three germ layers. 
Therapeutic approaches to treat and study the mechanisms of retinal degeneration, in 
particular early AMD, are largely lacking. There are models for some types of retinal 
degeneration, but they are not able to fully represent the degeneration mechanism (Jin et 
al. 2012; Housset et al. 2013; Cano et al. 2010; Meyer et al. 2009; Wang & Neufeld 2010; 
Singh, Shen, et al. 2013; Song & Bharti 2016). In order to bridge this need, Pluripotent 
Stem cells come as a revolutionizing concept, as they can be differentiated into retinal cells, 
namely RPE (Reynolds & Lamba 2014; Leach & Clegg 2015). And, because 
differentiation protocols are devised to mimic known developmental cues, they also 
provide valuable information about RPE specification steps in a shorter time frame relative 
to in vivo ocular development (Meyer et al. 2009). 
 
1.3.1	Development	and	patterning	of	the	eye	
Vertebrate eye patterning occurs early in embryonic development. During that time, the 
anterior neural tube ectoderm originates the retina, the iris and ciliary body epithelia, as 
well as the optic nerve, while surface ectoderm gives rise to the exterior components of the 
eye: lens, conjunctival, cornea epithelia, eyelids and lacrimal apparatus. A complex 
conjugation of inductive or inhibitory signals coming from tissue-tissue interaction, cell 
intrinsic factors and activation of transcription factors (TFs) has to occur in a timely 
combination, to ensure correct determination and maintenance of specific cell fate 
(Fuhrmann 2010).  
Initially, the forebrain specifies to become the eye field, located centrally. By 
morphogenic movement of cells, the single eye field is divided, forming bilateral neural 
folds, called optic grooves or sulci. As the neural tube closes, these outgrowing grooves 
become the optic vesicles and their connections to the forebrain form the optic stalk, which 
eventually grows into the optic nerve (Fuhrmann 2010). The stages of eye development are 
depicted in Figure 1. 6. 
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Figure 1. 6 - Schematic representation of eye developmental stages. 1: early unpatterned cells, 2: optic vesicle, 3: optic 
cup (Martínez-Morales et al. 2004). 
 
The exterior portion of each optic vesicle interacts with the surface ectoderm and 
induces that area to form a thickening, called the lens placode, a precursor of the lens 
(Figure 1. 6). At the same time, the optic vesicle also invaginates into a double layered 
structure, called optic cup, which will form the posterior part of the eye and give rise to the 
retina (Kwan et al. 2012). The anterior layer of the optic cup will eventually become the 
iris and ciliary body; the posterior thicker layer will be divided into an inner neural retina 
and outer pigmented coating. The surrounding structures of the eye develop from the 
condensation of the external surface of the optic cup into two layers: the inner pigmented 
and vascular layer, known as the choroid, and the outer fibrous layer, called sclera 
(Martínez-Morales et al. 2004; Fuhrmann 2010).  
In the pre-retina, melanin granules start to appear in the retinal epithelium at four and a 
half weeks of human embryonic development. At about week six, the cells in the innermost 
posterior layer of the optic cup begin to differentiate gradually into photoreceptors, after 
which müller cells and bipolar cells become differentiated, and finally retinal ganglion 
cells. Ganglion cells’ axons tangle together and fill the lumen of the optic stalk as it 
becomes the optic nerve. By eight months of development, all retinal layers are 
recognizable. However, photoreceptor maturation continues after birth, accompanied by 
corresponding improvement of visual acuity (Fuhrmann et al. 2014; Fuhrmann 2010). 
 
1.3.2	Signaling	pathways	in	eye	development	
Eye patterning progresses depending on signaling cascades driven by Fibroblast 
Growth Factor (FGF), Bone Morphogenic Proteins (BMP), Wnt and retinoic acid. For early 
eye patterning events to occur, Wnt/βcatenin antagonists, such as Dickkopf-related protein 
1 (DKK1), as well as direct suppressors of Wnt ligand transcription, such as Homeobox 
protein SIX3, are present and stimulate forebrain development. If this inhibition of 
Wnt/βcatenin is lost or inefficient, there is suppression of eye development, giving rise to 
eyeless or headless embryos, in severe cases (Lagutin et al. 2003; Fuhrmann et al. 2014).  
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Signaling molecules from neighboring tissues can activate or repress a network of TFs, 
which imprint the differentiated state of the retinal layers. A large number of eye 
development regulators are now known, most importantly Microphthalmia-associated 
transcription factor (MITF), Homeobox protein OTX1, OTX2 and Paired box protein Pax-
6 (PAX6) have been proven to be essential (Martínez-Morales et al. 2004).  
One of the earliest RPE specification markers is MITF. Mitf transactivates genes related 
to pigmentation and RPE maturation, such as Tyrosinase (TYR), Tyrosinase-related 
proteins (TYRP), melanosomal proteins and Bestrophin (Best) (Fuhrmann 2010; 
Fuhrmann et al. 2014; Martínez-Morales et al. 2004). Mitf also transactivates expression 
of miRNAs, such as miR-204 and miR211, tightly regulating RPE differentiation and 
homeostasis (Raghunath & Perumal 2015). Without Mitf, pigmentation defects occur and 
RPE transdifferentiates into neural retina (Fuhrmann et al. 2014; Martínez-Morales et al. 
2004). In fact, regulation of MITF is crucial and relies on a combination of several factors, 
for instance Otx2. Low levels of Otx2 result in a decrease of Mitf and consequent 
transdifferentiation. During development, Otx2 is expressed throughout the whole optic 
vesicle, but in the optic cup it regulates RPE specification by interacting with and 
regulating a set of genes involved in such specific RPE functions as melanogenesis (MITF 
and TYR, TYRP1), retinol metabolism, pH regulation and metal concentration (Martinez-
Morales et al. 2001; Housset et al. 2013; Martínez-Morales et al. 2004). Downregulation 
of OTX2 affects these functions and results in neural retina degeneration and vision loss. 
Ultimately, there is evidence suggesting OTX2 expression in RPE to be both necessary and 
sufficient to prevent photoreceptor degeneration onset in some cases (Housset et al. 2013).  
PAX6 expression is distributed over the entire optic vesicle and early optic cup. It is, 
however, downregulated upon developing RPE at the late optic cup stage (Martínez-
Morales et al. 2004). When PAX6 expression is impaired, differentiation of RPE is delayed 
or reduced. It has also been shown that PAX6 acts together with MITF, by binding and 
activating it, to promote RPE-specification, adapting its effect depending on tissue-specific 
context (Bharti et al. 2012). We know now that there is a tight interplay to control 
fundamental factors’ expression levels, such as MITF, OTX2 and PAX6, during optic cup 
formation. Without MITF, for instance, phenotypes as severe as anophtalmia can occur 
(Martínez-Morales et al. 2004; Fuhrmann 2010; Fuhrmann et al. 2014). Mutations/loss of 
OTX2 in humans have been linked to ocular malformation and degenerations of RPE, 
photoreceptors, bipolar and müller cells (Housset et al. 2013). PAX6 plays a crucial role in 
eye induction, as we have learned by the eyeless phenotype observed in animal models 
depleted of it. Conversely, ectopic expression of PAX6 has been shown to induce eye 
formation in Drosophila’s antennae and legs (Halder et al. 1995). 
Other than intrinsic factors, external signals can shift the balance and influence 
regionalization of the patterning eye. For instance, Transforming growth factor beta 
(TGFβ) family members from the extraocular mesenchyme favor cells of the optic vesicle 
to become RPE, whereas FGF signals from the lens placode suppress RPE and reinforce 
neural retina identity (Fuhrmann et al. 2014; Martínez-Morales et al. 2004) (Figure 1. 7). 
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Figure 1. 7 - Representation of the signaling pathways regulating RPE patterning: Sonic Hedgehog Signaling (shh), 
Bone Morphogenic Protein (BMP), Retinoic Acid (RA), Wnt/βcatenin, TCF/Lef TFs (Fuhrmann 2010). 
 
Finally, cell proliferation is terminated postnatally and the RPE matures acquiring an 
apical-basal polarity and becoming a monolayer sheet epithelium. Unlike other epithelia, 
the RPE maintains tissue homeostasis through long-term survival, with little evidence of 
cell turnover and no evidence for de novo cell production (Fuhrmann et al. 2014). A 
cumulative understanding of developmental processes driving specification and 
differentiation of RPE is providing more insight into the mechanisms that underlie 
plasticity of the RPE. Yet, a comprehensive explanation covering all molecular networks 
that drive these processes is still being built. Ultimately, the RPE has a limited self-renewal 
and repair ability, which is thought to be tightly conditioned by its extracellular 
environment. 
Since birth, density of RPE cells decreases over time, due to continued growth of the 
eye during the juvenile period, but also due to cell loss related with aging. To maintain the 
barrier epithelium, cells undergo hypertrophy without loss of contact with neighboring 
cells. The RPE has a remarkable intrinsic capacity to cope with damage, being able to 
restore itself (by hypertrophy) even after 60-80% cell loss. Still, upon retinal damage or 
disease, cell loss may cause an over burden of the remainder RPE, which ultimately leads 
to photoreceptor degeneration (Longbottom et al. 2009).  
 
1.3.3	The	promise	of	hPSc-RPE’s	therapeutic	potential	
Autologous RPE replacement surgery has been performed with success, in proof-of-
principle procedures, with some improvement of AMD patients’ visual responses. On a 
first approach, surgical techniques consisting on macular translocation or on substitution 
of macular RPE, using small patches of healthy RPE from the peripheral regions of the eye 
of the same patient, were attempted, with moderate success. However, due to the high 
number of patients with AMD and to the complexity and complications of these surgical 
approaches, tissue transplantation is now considered as a better alternative (Carr et al. 
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2013). Different sources of RPE have been proposed as starting material for transplant, for 
instance fetal or neonatal RPE, as well as spontaneously generated or engineered RPE cell 
lines. Alas, maintaining a supply of fresh neonatal or fetal RPE is difficult and 
controversial, whereas RPE cell lines are known to have a limited propagation capacity and 
lose essential characteristics, ultimately dedifferentiating (Carr et al. 2013). 
Based on collectively built knowledge regarding eye development and RPE 
specification, it is now possible to differentiate RPE from human Pluripotent Stem cells 
(Figure 1. 8). 
 
Figure 1. 8 - RPE can be obtained through differentiation of hES cells or of reprogrammed hiPS cells (Carr et al. 2013). 
 
Since hiPS cells can be derived from somatic cells of a patient, they can more promptly 
be used for cell replacement therapies (for the same donor patient) as cells and host would 
carry the same histocompatibility antigens. When it comes to studying the visual system in 
particular, it is a challenge to obtain samples from patients’ eyes, without causing vision 
impairment, thus induced pluripotent stem cell technology is, in this case, invaluable. 
Nevertheless, iPS cells’ weakness is that they carry the same genetic landscape which may 
have originated the patient’s disorder in the first place. For basic research purposes, patient-
specific iPS cells are an ideal source to investigate genetic mechanisms of disease in vitro 
as well as study disease risk factors or perform drug screening. 
Still, if on the one hand, it is possible to obtain “individual-type RPE” by differentiating 
patient-specific iPS cells, on the other hand, by starting from hES cells it is possible to 
obtain healthy “standard” RPE. In fact, while hES cells are directly recovered from the 
blastocyst, iPS cells require the additional reprogramming necessary to become 
pluripotent, since they are derived from patients’ somatic cells. Ultimately, the use of hES 
cells may be considered more standardized than hiPS cells, in the sense that it requires less 
manipulation, thus allowing a more readily production of similar hPSc-RPE lines. Starting 
from one original hES cell line - with everlasting potential - and using the same protocol 
to differentiate them, it would be, in theory, possible to establish a standard, unremitting 
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RPE line. Additionally, studies aiming at engineering histocompatible embryonic stem 
cells are proceeding with the ultimate goal of surpassing the disadvantages of iPS cells: 
high cost for each patient and prolonged cell culture for reprogramming and differentiation, 
validation and regulatory approval (Riolobos et al. 2013).  
Importantly, a thorough characterization of newly-obtained human Pluripotent Stem 
cell-derived RPE (hPSc-RPE) is prerequisite, whether these cells are used for laboratory-
based cell biology research or for clinical settings, in cell-replacement therapies. hPSc-
RPE are usually compared to RPE primary cultures (fetal and adult) and to standard RPE 
cell lines, namely to assure specific RPE markers expression and functional similarities. 
Transcriptional profiling indicates that hPSc-RPE is more similar to fetal than adult RPE, 
expressing many essential RPE markers, such as RPE65, Retinaldehyde-binding protein 1 
(CRALBP), Bestrophin (Best) and Zonula Occludens 1 (ZO-1), some of which are lost in 
RPE cell lines. Furthermore, hPSc-RPE is able to polarize, exhibiting comparable 
transepithelial electrical resistance (TEER or TER) values to those of RPE obtained from 
primary cultures. hPSc-RPE are also able to secrete such essential growth factors as VEGF 
and PEDF in a polarized fashion and, most notably, they are capable of phagocytosing 
POS. Additionally, hESc-RPE and hiPSc-RPE usually present similar expression profiles 
compared to one another, as well as typical RPE functions (Carr et al. 2013; David E. 
Buchholz 2009; A. J. Carr et al. 2009). 
In the end, whether derived from embryonic or induced pluripotent stem cells, hPSc-
RPE cells have been obtained successfully and used for transplantation studies in animal 
models. These experiments were shown prolific: hPSc-RPE displayed phagocytic ability 
in vivo and most importantly, visual performance of transplanted animals was improved 
(Carr et al. 2013; Forest et al. 2015; Kamao et al. 2014). 
Following animal testing, clinical trials directed towards the treatment of macular 
degeneration patients by cell replacement therapies are proceeding (Figure 1. 9). 
 
Figure 1. 9 - Representation showing stem cell research for RPE replacement therapies (Astrid Limb n.d.). 
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Fundamentally two types of cell-replacement therapies have been tested: injection of 
single-cell suspension and insertion of an implant containing an RPE monolayer (Carr et 
al. 2013; Forest et al. 2015). 
Recent reports on phase I/II clinical trials using hESc-RPE attest no significant adverse 
effects, including no abnormal cell proliferation or tumor formation, whether in suspension 
or monolayer implant (Schwartz et al. 2012; Carr et al. 2013). Furthermore, patients were 
monitored for improvement in visual acuity, with encouraging results, when comparing 
treated eyes with non-treated controls (Schwartz et al. 2015).  
Still, because hES cells are derived from embryos, ethical questions and concerns 
related to allogeneic transplantation may arise. On the other hand, the use of iPS cells as 
starting material could surpass these disquiets, but entail other types of worries. 
Specifically, the first trial using iPSc-derived RPE revealed several mutations in the cells 
derived from one of the two patients included in the study, i.e. in the process of 
reprogramming the patients’ somatic cells into hiPSc or during their differentiation towards 
RPE, the cells acquired random mutations, which precluded the continuance of the trial. 
For this reason, even though no evidence was found to indicate these mutations were 
problematic, these iPSc-RPE were not used, and the study was stopped, for precaution 
(Mandai et al. 2017). Still, despite being interrupted, this trial has since restarted, not 
without greatly contributing for the discussion on standardization of risk/benefit limits, 
defined to evaluate these particular therapies. 
 
1.3.4	Using	hPSc-RPE	to	model	disease	
While using hPSc-RPE for cell replacement is in the progress of being implemented, it 
is relevant to note that these therapies are very complex to apply in a broad way. There is, 
however, another approach to face the problem of AMD treatment: use this new readily 
accessible hPSc-RPE cells to study and model the molecular mechanisms of this disease. 
This methodology allows the development of efficient and more accessible remedies to 
prevent or to stop disease progression, in time. 
While research using animal models of disease greatly contributes to our understanding 
of the cellular processes that drive these diseases, some argue there are serious limitations 
of these models. For instance, the most commonly used animal model (the mouse) does 
not have a fovea/macula. Furthermore, the surface area of the mouse retina is seventy times 
smaller than that of the human eye, precluding extrapolation of key findings, in some 
instances (Volland et al. 2015; Roska & Sahel 2018).  
On the other hand, simpler RPE models, such as RPE primary cultures, allow 
researchers to easily manipulate human RPE. As mentioned, human RPE obtained from 
primary cultures, are relatively difficult to attain, when compared to hPSc-RPE. Not only 
hPSc-RPE is becoming widely used for in vitro studies concerning the molecular 
mechanisms underlying AMD, but it was also demonstrated that hiPSc-RPE derived from 
AMD patients recapitulate cardinal features of the disease. In fact, hiPSc-RPE models 
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display drusen biogenesis, with extracellular matrix (ECM) changes and importantly, the 
composition of the deposits found underneath these cells was shown to be different 
between controls and AMD patients-derived cells (Galloway et al. 2017). This study not 
only validates the use of iPS cell technology for the study of AMD, but also verifies the 
general reliability of stem cell-derived models of RPE for the study of macular 
degeneration. Eventually, our understanding of such a multifactorial disease as AMD 
greatly benefits from all the information that different models of disease may provide. 
Together with the limitless proliferative capacity inherent of stem cells, the ability to 
reproduce cardinal features of disease ascertains the true potential and the ultimate promise 
of hPSc-RPE: find the molecular mechanisms of disease, test drugs and develop new 
therapies to tackle AMD and other retinal degenerative disorders. 
 
1.4	Aging	and	Lysosome	Dysfunction	
While most chronic and age-related diseases are undisputedly multifactorial, it is 
becoming increasingly evident that many such diseases share common mechanisms due to 
the dysregulation of cellular homeostasis. Lysosomes have emerged in the past few years 
as critical players in the complex cellular network that comprises endo-lysosomal and 
autophagic pathways as well as metabolic sensing. Mounting evidence indicates that this 
network is prone to age and disease-related dysregulation.  
Declining lysosomal function is postulated to cause and/or facilitate a number of 
chronic age-related disorders (Carmona-Gutierrez et al. 2016). In fact, dysfunction of the 
lysosomal network was shown to be associated with adult-onset forms of familial 
neurodegenerative diseases such as Alzheimer´s disease (AD) and Parkinson´s disease 
(PD), cancer, atherosclerosis, as well as a decline in lifespan (Wolfe et al. 2013; Zheng 
2012; Bourdenx & Dehay 2016; Dehay et al. 2013). Specifically, in the visual system, 
dysfunction of the lysosomal network is a critical component in the pathogenesis of AMD, 
the most common blinding disease in the western world (Sinha et al. 2016). Lysosomal 
dysfunction in the RPE cells is thought to be at the center of a pathogenic hub contributing 
to proteotoxicity, mitochondrial dysfunction, redox imbalance and inflammation in AMD 
(Golestaneh et al. 2017; Ferrington et al. 2016). 
The critical role of lysosomal pathobiology as causative of chronic, late-onset diseases 
affecting post-mitotic tissues represents a paradigm-shift from more traditional views 
(Appelqvist et al. 2013). 
 
1.4.1	Main	trafficking	pathways	to	the	lysosome	
Inside the cell, trafficking routes closely interact and intertwine in a controlled and 
accurate fashion. In particular, there are mechanisms in place that allow for distinction of 
one specific organelle from another (Behnia & Munro 2005). The way a protein recognizes 
and associates to the correct organelle is by binding to specific lipids, such as 
phosphoinositides, or to activated forms of monomeric GTPases of the Rab and Arf 
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families (Schink et al. 2016; Segev 2011). Unique combinations of lipids and GTPases are 
distributed on a subset of intercellular membranes, hence providing each organelle with 
their identity and allowing for precise binding of proteins. Phosphoinositides are short-
lived molecules and GTPases alternate between membrane-associated activated GTP-
bound and cytosolic inactivated GDP-bound states, working as molecular switches. For 
this reason, whilst integral membrane proteins are subjected to complicated trafficking 
steps until they reach their destination, lipids can be synthesized or GTPases can be 
activated rapidly, only at the required site of action (Munro 2002). These are the tools with 
which the cell is able to segregate organelles in a defined way, while also allowing for 
interactions between them and maintaining a certain degree of plasticity within intracellular 
pathways (Behnia & Munro 2005). 
There are three main pathways related to cargo processing inside the cells, namely 
endocytosis, phagocytosis and autophagy. Perturbations in the trafficking and processing 
of (un)digestible cargo through these pathways is of utmost importance to upkeep retinal 
health, particularly in the case of AMD (Gross & Bales 2015). Ultimately, all these 
different cargo-trafficking routes have in common their final destination: the lysosome. 
Lysosomes are the organelles responsible for maintaining the balance between production 
of new and degradation of old/damaged cellular components. For this reason, they are 
instrumental when it comes to prolonged retinal health and are definitely involved in the 
development of age-related dysfunction, particularly in the case of AMD. 
 
Endocytosis	
The endocytic pathway initiates with the incorporation of extracellular material by the 
cell, and comprises different trafficking events occurring inside the cell, until the endpoint, 
when cargo is targeted for degradation. Briefly, material is included into vesicles, at close 
proximity with the plasma membrane and interacts with other structures, by moving and 
fusing with other organelles and acquiring/exchanging specific molecular markers in a 
timely manner (Elkin et al. 2016).  
During the first steps of the endocytic pathway, cargo is internalized in early endosomes 
(EE), through specific mechanisms, namely macropinocytosis, clathrin-mediated 
endocytosis, caveolin-mediated endocytosis and clathrin- and caveolin-independent 
endocytosis (Settembre, Fraldi, et al. 2013; Keeling et al. 2018). EE are typically identified 
by the presence of phosphoinositide-3-phosohate (Pi(3)P) and also a set of Rab GTPases, 
namely endocytic markers Rab4 and Rab5 and recycling endosome marker Rab11. These 
are responsible for sorting and targeting these EE to their destinations (Behnia & Munro 
2005; Keeling et al. 2018; Ketel et al. 2016; Klumperman & Raposo 2014). From there, 
EE may enter retrograde trafficking either to have their content returned to the plasma 
membrane or to the trans-Golgi network, for re-use. Alternatively, EE can form 
intraluminal vesicles of multivesicular bodies (MVBs) and/or undergo maturation into late 
endosomes (LE) (Elkin et al. 2016). Maturation of EE into LE is typically described as the 
regulated exchange between EE marker Rab5 and LE’s Rab7 and also Pi(3)P conversion 
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to Pi(3,5)P2, as well as a gradual decrease of the vesicle’s intraluminal pH (Huotari & 
Helenius 2011). Endosome pH is regulated by the large multimeric proton pump, vacuolar 
ATPase (vATPase), which associates with the endosomal membrane and drives protons 
into the lumen. While EE have a mildly acidic pH of 5.9-6.8, LE and lysosomes are highly 
acidic, with a pH of 3.8-5.0 (Keeling et al. 2018; Kissing et al. 2017) (Figure 1. 10). 
 
Figure 1. 10 - Schematic representation of the endocytic organelle identity (Elkin et al. 2016). 
 
From the point of view of cargo processing, along the endosome maturation steps, 
hydrolytic enzymes are recruited to LE and lysosomes, and become active as the pH 
decreases. Regarding spatial localization within the cell, EE are usually located at the cell 
periphery and, as they mature, they are trafficked to the perinuclear area where degradative 
lysosomes reside (Cabukusta & Neefjes 2018). 
 
Phagocytosis	
Phagocytosis allows for internalization of particles of ≥1µm diameter (whilst endocytic 
cargo ranges between 200-500nm in diameter). Similarly to endocytosis, it occurs via a 
temporal sequence of events, which include recognition, binding to receptors, intracellular 
signaling, internalization and digestion (Kevany et al. 2010). It is primarily through 
phagocytosis that RPE cells incorporate POS, however this process has also been studied 
in detail in other professional phagocytes, such as macrophages or dendritic cells (Pauwels 
et al. 2017). Briefly, once internalized, phagosomes mature through a number of fusion 
events with EE, LE and lysosomes (Esteve-Rudd et al. 2014; Pauwels et al. 2017). In 
parallel to what was previously described for the endocytic pathway, phagosomes may also 
acquire Rab4, Rab10 or Rab11 and be recycled back to the plasma membrane, or go 
through the Rab5 to Rab7 conversion, as the phagosome matures (Kevany et al. 2010; 
Molino et al. 2016). Because RPE cells are polarized, POS are typically internalized at the 
apical side and transported toward the basal membrane for degradation (Figure 1. 11).  
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Figure 1. 11 - Schematic representation of the phagocytosis by RPE (Ferrington et al. 2016). 
 
Finally, these structures become what is designated as phagolysosome, characterized 
by progressive acidification of the lumen and increased production of reactive oxygen 
species and proteolysis(Kevany et al. 2010; Keeling et al. 2018), not unlike typical 
endolysosomes. Taking into consideration that RPE cells are post-mitotic, it has been 
estimated that each RPE cell phagocytoses hundreds of thousands of POS discs over a 
human lifetime (Kevany et al. 2010; Keeling et al. 2018). Thus, RPE is considered one of 
the most active phagocytic cells in the human body, responsible for the efficient turnover 
of phagocytosed material on a daily basis, otherwise they suffer the damaging effects of 
undigested material build-up. In many eye pathologies this physiological function of the 
RPE is impaired (Ferrington et al. 2016). 
 
Autophagy	
Finally, the third main pathway through which cargo is degraded inside the cell is 
termed autophagy. Autophagy may work in a non-selective way, in response to nutrient or 
amino acid starvation, or it can be selective, to eliminate misfolded or aggregated proteins, 
oxidized lipids or damaged organelles (Galluzzi et al. 2017). In any case, it consists on a 
self-digestive mechanism (hence the term autophagy), in the sense that intracellular 
constituents are degraded so that their building blocks can be recycled. This is a crucial 
process, whether considering a stress situation, low energy stores or the effects of aging, 
particularly in post-mitotic cells, such as the RPE (Settembre, Fraldi, et al. 2013; Keeling 
et al. 2018; Frost et al. 2014). 
Different types of autophagy have been described, namely microautophagy, chaperone-
mediated autophagy and macroautophagy (Galluzzi et al. 2017). Microautophagy consists 
on direct engulfment of cytosolic proteins by the lysosome or by the endosomal membrane 
with consequent targeting for degradation in the lysosome; in chaperone-mediated 
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autophagy cytosolic proteins containing the KFERQ motif are preferentially captured by 
the lysosome through chaperone- and receptor- mediated internalization, directly via 
lysosome-associated membrane protein 2A (LAMP2A); macroautophagy can be selective, 
again through identification of the KFERQ motif, and requires the formation of double 
membrane-bound vesicles termed autophagosomes, which sequester cytoplasmic material, 
followed by fusion with EE, LE and finally, lysosomes (Keeling et al. 2018; Settembre, 
Fraldi, et al. 2013; Galluzzi et al. 2017).  
Autophagy is tightly regulated by numerous autophagy-related proteins (Atg) and it is 
typically described as a sequence of initiation, nucleation, elongation and closure of 
autophagosomes, culminating with recycling of content or degradation in 
auto(phago)lysosomes (Frost et al. 2014) (Figure 1. 12). 
 
Figure 1. 12 - Schematic representation of the main molecular players involved in autophagy and respective stages 
(Frost et al. 2014). 
 
It is relevant to mention that the proteasome too is responsible for degrading misfolded 
cytoplasmic proteins that have been ubiquitinated (Ferrington et al. 2016). However, 
whenever these proteins accumulate and aggregate, they are targeted by macroautophagy, 
through binding of autophagy receptors (Zhan et al. 2016). Because it plays such a 
remarkable role in the cell, including entire organelle sequestration, macroautophagy is the 
best characterized autophagic process so far and many times it is described simply as 
autophagy (Galluzzi et al. 2017). 
The mammalian target of rapamycin complex 1 (mTORC1) plays the role of principal 
regulator of autophagy, metabolism and cell growth, through sensing and signaling 
mechanisms. Because this complex exerts its activity at the lysosomal surface, a tight co-
regulation between cell growth or biosynthesis and cell catabolism has been suggested 
(Settembre, Fraldi, et al. 2013). Amino acids, glucose, growth factors, hormones, oxygen 
and stress have been shown to activate mTORC1 and trigger responses based on mRNA 
and protein regulation, lipid biosynthesis and ATP production (Settembre et al. 2013b; 
Settembre & Ballabio 2014; Ballabio 2016). Remarkably, when nutrients are available in 
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the cell, mTORC1 is activated and inhibits autophagy, through direct phosphorylation and 
thus repression of autophagy-initiating ULK1 complex, which comprises ULK1-ATG13-
FIP200 (Settembre, De Cegli, et al. 2013). Conversely, inhibition of mTORC1 during 
nutrient depletion or low energy status leads to activation of this complex, consequently 
promoting autophagy initiation and triggering a cascade of events culminating in the 
degradation and recycling of cargo (Settembre, Fraldi, et al. 2013).  
Autophagy has been proposed as a retinal protection mechanism against light-induced 
degeneration, particularly with a non-canonical form of autophagy being described to 
maintain the visual cycle (Kim et al. 2013; Ferguson & Green 2014; Frost et al. 2015). 
Specialized phagocytic cells have been reported to use a hybrid pathway, which combines 
the phagocytic and autophagic pathways, known as LAP: LC3 Associated Phagocytosis 
(Frost et al. 2014; Ferguson & Green 2014; Sanjuan et al. 2007; Galluzzi et al. 2017). LC3 
recruitment to the phagosomal membrane, in this context, is Atg5-dependent and Ulk1 
independent. Researchers looking at this process reported that the RPE circadian cycle of 
phagocytosis coincides with increase of LC3 lipidation, but not with autophagy initiation 
complex containing Ulk1 (Kim et al. 2013). Nevertheless, it is important to keep in mind 
that the majority of phagosomes do not associate with LC3, making LAP a secondary 
mechanism, possibly to compensate for an overload of the phagocytic pathway. LC3 
association nonetheless has been shown to induce fusion of phagosomes to lysosomes, 
leading to rapid acidification and efficient degradation (Sanjuan et al. 2007). LAP is still 
not a consensual mechanism, but the reasoning behind these studies support the existence 
of overlap between autophagy and the phagocytic pathway. 
Throughout these three main pathways, endosomes/phagosomes/autophagosomes at 
different stages of maturation co-exist and interact, according to their affinity or repulsion, 
driven by the cell’s biological needs. For this reason, depending on their spatial subcellular 
localization or on the type of cargo they carry, hybrid organelles may form. These pathways 
play crucial roles within the cell, regulating entry and exit of molecules, finally converging 
at the lysosome (Figure 1. 13). 
 
Figure 1. 13 - Representation of endocytic, phagocytic and autophagy pathways, all converging at the lysosome. 
Adapted from (Dehay et al. 2013). 
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1.4.2	Point	of	Convergence:	The	Lysosome	
Lysosomes are found in all animal cell types, with the exception of erythrocytes, and 
represent the cell’s principal catabolic organelle. They compose up to 5% of the volume 
content of animal cells and consist on vesicles, delimited by a single bilayer membrane, 
which can be heterogeneous in size and morphology, appearing as electron-dense or as 
multilamellar membrane structures, under an electron microscope (Klumperman & Raposo 
2014; Settembre, Fraldi, et al. 2013). 
The lysosomal membrane is decorated with proteins responsible for the transport of 
substances in and out of the lumen, for the maintenance of an acidic pH and also for the 
fusion of the lysosome with other structures (Saftig & Klumperman 2009). Among these, 
the Lysosomal-associated membrane proteins 1 and 2 (LAMP-1 and LAMP-2) together 
account for ~50% of the lysosomal membrane protein content (Wartosch et al. 2015). 
Enzymes within the lysosomal membrane are responsible for the degradation of a wide 
range of intracellular macromolecules, organelles, surface receptors and pathogens, among 
others (Luzio et al. 2007). 
A mature lysosome is limited by a cholesterol-poor membrane, containing an inner 
glycocalyx-coating, in order to prevent the lysosomal membrane from being digested by 
luminal hydrolases and also to keep the highly acidic environment from contacting the rest 
of the cell (Settembre, Fraldi, et al. 2013). Specific lysosomal membrane proteins anchored 
at the membrane perform fundamental functions, serving as structural backbone, receptors 
or channels. Furthermore, the acidic environment is maintained by the proton-pumping V-
type ATPase, also moored at the membrane, which pumps protons from the cytoplasm into 
the lysosome (Figure 1. 14). 
 
Figure 1. 14 – Main functions of Lysosomes, required for homeostasis maintenance (Appelqvist et al. 2013). 
 
The V-ATPase also interacts with important protein complexes, such as the lysosomal 
nutrient sensing (LYNUS) machinery, in order to sense lysosomal nutrient content and 
signal information to the nucleus (Settembre, Fraldi, et al. 2013). Briefly, degradation 
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occurring at the lysosomal lumen is detected on the cytosolic face through amino-acid 
release and consequent activation of mTORC1 at the lysosomal surface. As such, the 
activity of specific proteins is directly affected by the lysosome and, conversely, lysosomal 
function is regulated by the proteins and protein complexes which interact at the lysosomal 
surface (Ballabio 2016). 
A critical aspect which determines degradative function of a lysosome is its luminal pH 
(Kissing et al. 2015). In fact, the amount of available protons reflects the net charges of 
biological surfaces, impacting protein structure and function. Thus, acidification is a key 
feature which allows for protein sorting, receptor-ligand dissociation and recycling, post-
translational modifications, and also membrane fusion and fission (Kissing et al. 2017). 
Additionally, although acidification and spatial distribution are typically thought of as 
coincidental events in endosome maturation steps, a causal effect has been demonstrated 
(Korolchuk & Rubinsztein 2011; Cabukusta & Neefjes 2018). In fact, when spatial 
localization of endocytic vesicles is altered, so is their intraluminal pH and, consequently 
perinuclear lysosomes are generally more acidic, while peripheral lysosomes are less acidic 
(Johnson et al. 2016). All of these aspects are thus required for efficient cargo processing 
within degradative pathways. In order to upkeep a low pH, the V-ATPase pumps protons 
into the endocytic vesicles, generating an electrochemical potential difference across the 
membrane. To that effect, the V-ATPase relies on a rotary mechanism composed by two 
sectors, acting together: sector V1 is responsible for ATP hydrolysis and generation of the 
rotational force which drives proton transport through sector V0, which manages the 
transport of protons through the membrane into the lumen (Maxson & Grinstein 2014). 
Because the lumen of the organelle becomes positively charged, there is concomitant 
import of anions and/or export of cations, in order to neutralize the generated voltage. 
Chloride channels found in endosomes, phagosomes and lysosomes participate in this 
process, by regulating Cl- intake, while transient receptor potential cation channel, 
mucolipin (TRPML) regulates cation export (Kissing et al. 2017). Another way to control 
organelle pH is by managing V-ATPase location and assembly of its two sectors, 
depending on isoform expression, tissue specificity or metabolic status, for instance. 
Lastly, lysosomes and phagosomes have been reported to exhibit proton leakage, with 
consequent increase of luminal pH, conveying acidification control with yet another layer 
of complexity (Kissing et al. 2017; Mindell 2012). 
The acidic environment provides the lysosome with degradative ability by enabling the 
activity of several hydrolases, including proteases, lipases, nucleases, sulfatases, 
glycosidases and phosphatases, whose endeavor is optimal at pH 4.5-5 (Kissing et al. 
2017). This vast collection of enzymes allows the processing of numerous biological 
substrates, such as sphingolipids, glycogen, glycosaminoglycans and proteins (Settembre, 
Fraldi, et al. 2013). Lysosomal hydrolases are trafficked from the Golgi into lysosomes (or 
targeted for secretion), mainly through mannose-6-phosphate receptors (M6PR)-mediated 
regulation. In fact, lysosomes can be distinguished from late endosomes by the absence 
M6PR (Brown et al. 1986; Bright et al. 1997). The lysosome itself is transported and fused 
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with other organelles, with Rab GTPases and SNAREs acting as mediators (Luzio et al. 
2007). Particularly, several players involved in the fusion between (auto)phagosomes and 
endolysosomes also participate in their biogenesis (Settembre, Fraldi, et al. 2013; Wartosch 
et al. 2015). Cathepsins are the principal lysosomal proteolytic enzymes, and therefore, 
their activity is generally considered as a readout of lysosomal degradative ability. They 
are typically characterized as members of the lysosomal cysteine proteases family, even 
though there are also members of the serine protease (cathepsins A and G) and aspartic 
protease (cathepsins D and E) families (Laurent-Matha et al. 2006). 
 
1.4.3	Lysosome	biogenesis	and	regulation	
Lysosome biogenesis is regulated mainly by the members of the Microphthalmia family 
of transcription factors. Together, Transcription Factor EB (TFEB), TFE3, TFEC and 
Microphthalmia-associated Transcription Factor (MITF) constitute the MiT/TFE family. 
Interestingly, the “microphthalmia” designation stands from the deficient eye development 
in MITF mutants, which also present abnormal pigmentation both in RPE and melanocytes 
(Fuhrmann 2010). This family has been shown crucial for nutrient sensing and maintenance 
of homeostasis, namely through regulation of lysosomal function and energy metabolism. 
Activity of this family of TFs has been shown important for different cell types, namely 
RPE, melanocytes, dendritic cells, osteoclasts, etc (Martina et al. 2015; Slade & 
Pulinilkunnil 2017; Napolitano & Ballabio 2016). Crucial functions related to cell survival, 
immunity, proliferation, tissue specification, pigmentation, all are regulated in some degree 
by this MiT family (Steingrímsson et al. 2004). It is not a coincidence that many of these 
functions rely on lysosomal or lysosome-related organelles’ typical features. 
The hypothesis by which lysosomal function is transcriptionally regulated was first 
tested by Ballabio’s group (M Sardiello et al. 2009). Through the analysis of the promotor 
region of several lysosomal genes, one motif stood out for being able to recognize members 
of the MiT/TFE family. This motif was designated by Coordinated Lysosomal Expression 
and Regulation (CLEAR) element, and shown to drive the expression of lysosomal 
hydrolases and autophagy-related proteins (Keeling et al. 2018; Napolitano & Ballabio 
2016; Platt et al. 2012). 
Members of the MiT family have similar structures and are able to homodimerize or 
heterodimerize, a critical step for binding to DNA and consequently activate expression of 
target genes (Martina et al. 2015). TFEB, MITF and TFE3 also share a conserved activation 
domain, which is absent in TFEC (Zhao et al. 1993). Because these TFs regulate a similar 
set of genes and because they themselves are regulated in a similar way, studies concerning 
one member of the family generally can apply to all other members. Particularly TFEB has 
been described to regulate lysosomal genes that usually contain clusters of multiple 
CLEAR sequences: overexpression of TFEB causes increase in lysosomal gene expression, 
as well as added activity of hydrolytic enzymes, for instance Cathepsin D, and the opposite 
effect is observed upon its silencing (M Sardiello et al. 2009). Additionally, TFEB also 
induces lysosomal exocytosis and autophagy (Settembre, Fraldi, et al. 2013) (Figure 1. 15). 
  24 
 
Figure 1. 15 - TFEB, and other MiT family members, control fundamental processes of cellular clearance. namely 
lysosomal biogenesis, autophagy and lysosomal exocytosis (Settembre, Fraldi, et al. 2013). 
 
MiT/TFE transcription factors alternate between an inactive cytosolic form, when 
phosphorylated by mTORC1 or ERK2 (also known as MAPK1) and an active form, which 
upon de-phosphorilation translocates to the nucleus and drives gene expression (M 
Sardiello et al. 2009; Napolitano & Ballabio 2016). De-phosphorilation of TFEB occurs 
through mTORC1 inhibition and also activation of the phosphatase calcineurin. For 
example, during exercise, calcium release in muscle cells induces Calcineurin, which de-
phosphorilates TFEB, causing it to translocate to the nucleus and drive mitochondrial 
biogenesis and also glucose uptake. AMP-activated protein kinase (AMPK), on the other 
hand, responds to reduced ATP levels, by inhibiting  mTORC1 and by directly activating 
autophagy players ULK1 and BECN1(Galluzzi et al. 2017). 
The physiological role of TFEB is highly context-specific, for instance while in the 
liver it plays a striking effect on lipid metabolism, in muscle tissue it has a strong influence 
on mitochondria biogenesis. For this reason, when studying the different processes driven 
by TFEB regulation, its role in cellular adaptation to challenges stands out: adaptation to 
starvation, adaptation to physical exercise, to infection, etc, with the lysosome at the center 
of these key processes. TFEB and TFE3 have also been reported in circadian rhythm 
regulation, with involvement in the rhythmic induction of lysosomal and autophagic genes, 
suggesting there is a direct link between light/day onset and nutrient management (Luo et 
al. 2016). Additionally, a recent study demonstrated mTORC1 activation subsequent to 
POS shedding-morning burst, and also after in vitro feeding of POS to RPE cells (Yu et al. 
2018). 
 
1.4.4	The	dynamic	nature	of	lysosomes	
For a long time, lysosomes have been described as the degradative compartment of the 
cell and the endpoint of the endocytic and the autophagic pathways (de Duve 2005). More 
recently, lysosomes have been shown to be much more heterogeneous and dynamic than 
previously described, and our knowledge of functional interactions between all these 
pathways has significantly expanded (Settembre, Fraldi, et al. 2013; Luzio et al. 2017). 
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Lysosomes receive newly synthesized proteins from the trans-Golgi network and also 
cargo targeted for degradation, which is delivered by direct fusion of the lysosome with 
late endosomes, phagosomes or autophagosomes (Figure 1. 16). 
 
 
Figure 1. 16 - Lysosomes are very dynamic, continuously fusing with other organelles, to form hybrids, and reforming 
back into lysosomes, after cargo processing (Wartosch et al. 2015). 
 
Lysosomes are thus in the center of the metabolic/catabolic balance of the cell. 
Nowadays, lysosomes are thought to have a crucial role in sensing nutrient availability and 
composition. Specifically, they are involved in signaling to the nucleus, mediating cellular 
responses to starvation and thus regulating energy metabolism, programmed cell death, 
plasma membrane repair, development, differentiation, immune response, among others 
(Settembre, Fraldi, et al. 2013; Luzio et al. 2017; Carmona-Gutierrez et al. 2016; Choy et 
al. 2018). 
Some specific cell types evolved more permanent adaptation strategies, in order to 
provide specialized functions, in what are called collectively lysosome-related organelles 
(LROs) or secretory lysosomes. LROs are organelles that share many features with 
lysosomes, however LRO secretion has been shown to convey unique functions to specific 
cell types, such as bone resorption by osteoclasts, pigment transfer by melanocytes, 
degranulation of cytotoxic T lymphocytes, and hydrolase release by spermatozoa, during 
fertilization (Settembre, Fraldi, et al. 2013). 
LROs and (conventional) lysosomes are thought to have similar origins and to use the 
same molecular machinery to move towards the plasma membrane and fuse. In fact, 
evidence suggests that virtually in all cell types lysosomes are able to undergo regulated 
exocytosis, in response to stimuli, such as an increase in intracellular calcium concentration 
(Reddy et al. 2001; Rodríguez et al. 1997; Andrews 2000; Luzio et al. 2014). This lysosome 
exocytosis mechanism was shown to be important in a variety of cellular processes, namely 
plasma membrane repair, microbial infection and ECM degradation (Appelqvist et al. 
2013; Samie & Xu 2014). Importantly, lysosomal exocytosis, whether in the context of 
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LROs’ or in stimulated conventional lysosomes, is thought to be regulated by TFEB 
(Medina et al. 2011). 
The term “lysosome” occasionally acquires a broad denotation, when considering its 
different characteristics. As our understanding of the molecular mechanisms surrounding 
this organelle advances, new concepts emerge, in order to relay the full complexity of this 
compartment. Specifically, transient/kiss-and-run and complete fusion events between 
lysosomes and late endosomes or MVBs have been described as necessary for the delivery 
of macromolecules to acidic and hydrolase-active compartments inside the cell. From these 
fusion events, new hybrid organelles emerge, known as endolysosomes (or autolysosomes 
or phagolysosomes), which have a mixture of properties between late endosomes and 
lysosomes. After cargo processing, vesicles bud off from endolysosomal tubules and 
mature into dense lysosomes, completing the endocytic and autophagic cycles of 
degradation, by fission events and reformation of lysosomes (Platt et al. 2012; Bright et al. 
2016). In this context, lysosomes can be regarded as storage compartments for acidic 
hydrolases that become active only upon fusion with endolysosomes, and return to an 
inactive state after this lysosome reformation, within what are designated terminal storage 
lysosomes (Figure 1. 17).  
 
Figure 1. 17 - The lysosome cycles as it fuses to form hybrid catabolically active endolysosome and reforms back to a 
mature, terminal storage lysosome (Bright et al. 2016). 
 
Likewise, luminal pH has been suggested to be highly acidic for endolysosomes, as it 
is required for hydrolytic events, while terminal storage lysosomes are proposed as a less 
acidic reservoir, which does not accumulate acidotropic probes (Bright et al. 2016). These 
relevant studies on lysosome biology are dissecting these intersections and shedding light 
on the true dynamic nature of the lysosome. 
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1.4.5	Lysosomal	Dysfunction	
At a molecular level, in lysosomal dysfunction settings, whether standing from genetic 
Lysosomal Storage Disorder (LSD) or from other contributory stressors such as aging, cells 
present excessive levels of undegraded macromolecules or catabolic products. Plus, 
increased numbers of endo/autolysosome are typically found in these cases. This 
accumulation arises from defects in intracellular clearance mechanisms (Li et al. 2016; 
Samie & Xu 2014). Undegraded material accumulated due to mutated lysosomal 
components will itself inhibit the activity of other lysosomal enzymes, leading to secondary 
substrate accumulation (Platt et al. 2012). Furthermore, TFEB signaling pathway was 
shown to be activated in several LSDs, suggesting this pathway to be abnormally 
stimulated, possibly as a coping mechanism (M Sardiello et al. 2009). Progressive 
accumulation of undegraded molecules triggers a cascade of events which impacts not only 
the above mentioned pathways, but also other organelles, such as mitochondria, the 
Endoplasmic Reticulum, Golgi, peroxisome and overall homeostasis (Platt et al. 2012). For 
this reason, there is a decrease of the autophagic flux and persistence of autophagosomes 
both without and with lysosomal markers (autolysosomes). Additionally, microautophagy 
and chaperone-mediated autophagy are also impaired in the lysosomal dysfunction context, 
as is lysosomal reformation, suggesting both fusion and fission problems (Platt et al. 2012; 
Valapala et al. 2014). 
Altogether, genetic diseases characterized by lysosomal proteins’ dysfunction and 
consequent accumulation of undigested cargo are collectively known as Lysosome Storage 
Disorders or LSDs (Platt et al. 2012). LSDs have an estimated incidence of 1 in every 5000 
live births and comprise over 50 different disorders. Most LSDs stand from genetic 
mutations affecting hydrolytic enzymes, albeit some forms also result from defects in 
lysosomal membrane proteins or non-enzymatic soluble lysosomal proteins (Saftig & 
Klumperman 2009; Wartosch et al. 2015). LSDs usually present as infancy 
neurodegenerations, although adult-onset also occurs. A study in the UK revealed that 
lysosomal disorders are the most common cause of neurodegeneration diagnoses in 
children, accounting for 45% of cases (Verity et al. 2010; Platt et al. 2012). Central Nervous 
System (CNS) involvement in LSDs is fairly common, and associated neurodegeneration 
can occur in multiple brain regions. Neurons seem particularly susceptible to endo-
lysosomal defects since mutations in lysosomal enzymes give rise to multiple 
neurodegenerative genetic diseases, in spite of the ubiquitous function of lysosomes. 
LSDs are considered a group of rare diseases, however the same features related to 
impairment of cargo digestion and consequent effects namely for the endocytic and 
autophagy pathways, are thought to also underlie conditions such as Parkinson’s disease 
(PD), Alzheimer’s disease (AD) and Huntington’s disease, among other neurodegenerative 
disorders (Keeling et al. 2018; Dehay et al. 2013; Carmona-Gutierrez et al. 2016). The 
mechanisms that drive mistrafficking and buildup of different substrates, in these cases (a-
synuclein in PD, amyloidb in AD or Huntingtin protein in the case of Huntington’s), are 
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different in many aspects, but all culminate in lysosomal overburden and autophagy 
impairment (Keeling et al. 2018; Wartosch et al. 2015). 
In general, disease manifestation may depend on the type of metabolite that becomes 
accumulated, on the type of response triggered (for instance local inflammation or 
apoptosis) and also on the susceptibility that different cell types present to lysosomal stress 
(Platt et al. 2012). Naturally, post-mitotic cells, such as neurons and the RPE, are 
vulnerable to lysosomal malfunction, yet other cell types may also be severely affected. 
For instance Type 1 Gaucher Disease is a relatively common LSD, caused by b-
glucocerebrosidase deficiency, which manifests in macrophages (Platt et al. 2012). 
In some forms of hereditary spastic paraplegias, in Chédiak-Higashi syndrome and also 
in the case of mucolipidosis, there is impairment of lysosome reformation from 
autolysosomes (Durchfort et al. 2012; Treusch et al. 2004; Chang et al. 2014). Studies 
where lysosome reformation was hampered using sucrose buildup in both late endosomes 
and endolysosomes showed they were able to fuse with lysosomes, depleting the cell of 
dense core (terminal storage) lysosomes. This implies there was no significant biogenesis 
in this case, but instead lysosomes reformed from endolysosomes, when sucrose digestion 
was resolved by uptake of exogenous invertase (Bright et al. 1997). A similar reformation 
defect was demonstrated by different approaches, including inhibition of PI3-kinase, 
PIKfyve and also of cathepsin activity (Olson et al. 1980; Kim et al. 2014; Bright et al. 
1997; Yu et al. 2010; Choy et al. 2018). Niemann-Pick Type C (NPC) disease is an LSD 
which is characterized by mis-trafficking of cholesterol, and its accumulation at LE and 
lysosomes, among other lipids. Particularly in this case, lysosome reformation was shown 
to be hampered due to NPC1 or NPC2 protein deficiency, with cells presenting problems 
in LE/lysosomal fusion and fission, respectively (Goldman & Krise 2010). Interestingly, 
NPC1 and NPC2 are lysosomal proteins (membranar and soluble, respectively), with 
important roles related to ion-trapping mechanisms, in fact playing a role in amine 
accumulation and vacuolization of lysosomes. Accumulation of lysomotropic amines, for 
instance chloroquine, has been shown to stimulate LE/lysosome fusion events, as well as 
lysosome exocytosis, in an NPC1 dependent way (Goldman & Krise 2010; De Duve et al. 
1974; Kaufmann & Krise 2008).  
Even though some studies suggest a duality between lysosome biogenesis and 
reformation from pre-existing lysosomes, these concepts are tightly connected. However, 
the mechanisms that fail in lysosomal dysfunction settings are still unknown. In 
homeostatic conditions, upon degradation of cargo within the lysosome, the cell undergoes 
lysosome reformation mediated by mTOR reactivation. In this case, mTOR reactivation is 
thought to be triggered by amino acids leaving the lysosome to be recycled (Shang et al. 
2017; Settembre, Fraldi, et al. 2013; Yu et al. 2018). Conversely, pharmacological 
inhibition of lysosomal proteases and general lysosomal impairment in LSDs settings, 
impair mTOR reactivation, thus impeding lysosomal reformation (Yu et al. 2010). On the 
other hand, upregulation of MiT family members, namely TFEB and TFE3, is crucial to 
clear accumulation of substrates resulting from defects in the lysosomal-autophagic 
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pathway in several models of disease (Ballabio 2016). In particular, TFEB overexpression 
was shown to reduce the buildup of substrates and ameliorate the damages in LSDs 
(Spampanato et al. 2013), in models of obesity (Settembre, De Cegli, et al. 2013) and in 
neurodegenerative disorders: Parkinson’s (Decressac et al. 2013), Alzheimer’s (Polito et 
al. 2014; Xiao et al. 2015) and Hungtington’s (Tsunemi et al. 2012; M Sardiello et al. 
2009), among others. What causes impairment in mTOR reactivation, whilst precluding 
sufficient activation of lysosomal biogenesis by MiT members remains the missing link. 
Nevertheless, it is not unreasonable to consider that a shift in the equilibrium of these 
processes reaches a chronic non-recoverable imbalance. 
 
1.4.6	Lysosomes	in	Retinal	Degeneration	
In the eye, the RPE is responsible for maintaining photoreceptor health and to recycle 
the visual pigment, by daily digestion of POS. Each RPE cell contacts closely with 24-45 
rod or cone photoreceptors and phagocytoses an estimated 10% of their volume every day 
(Keeling et al. 2018; Young 1971).  
This lysosomal burden has been proposed as a key mechanism underlying AMD, 
Stargardt disease and Choroideremia (CHM) (Keeling et al. 2018; Guha et al. 2013; 
Anderson et al. 2017; Wavre-Shapton et al. 2013), among others. A common feature 
underlying these diseases is lysosomal dysfunction, typically characterized by increased 
lysosomal pH and accumulation of unprocessed cargo (Keeling et al. 2018; Sinha et al. 
2016; Guha, Coffey, et al. 2014) (Figure 1. 18).  
 
Figure 1. 18 - Normal/healthy RPE versus AMD settings: lysosomal pH is increased, and cargo accumulates both intra 
and extracellularly (Guha, Coffey, et al. 2014). 
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Additionally, pharmacological agents such as chloroquine have been shown to cause 
retinopathy, due to lysosomal impairment (Mahon et al. 2004; Guha, Coffey, et al. 2014). 
These retinopathies are generally characterized by accumulation of undigested cargo, 
namely POS, as well as autophagy substrates, identified by typical markers such as LC3 
and SQSTM1/p62. These components, together with oxidized lipids, are thought to 
originate lipofuscin granules. Lipofuscin occurs naturally and accumulates gradually with 
aging, but is exacerbated in disease settings. Such is the case of Stargadt disease, some 
LSDs, for instance Niemann-Pick C and neuronal ceroid lipofuscinosis, and also AMD 
(Anderson et al. 2017). Besides lipofuscin, appearance of complex granules such as 
melanolipofuscin and melanolysosomes have been proposed as trademarks of RPE damage 
and/or aging. Consistent with that model, researchers have found that while melanin 
content decreases with aging, lipofuscin and complex granules increase, together 
occupying up to 30% of RPE cytoplasmic area in aged eyes (Feeney-Burns et al. 1984). 
Lipofuscin’s molecular composition has not been fully characterized, however N-
retinylidene-N-retinylethanolamine (A2E) is found in lipofuscin granules and has been 
extensively studied (Anderson et al. 2017). A2E was shown to be a cationic amphiphilic 
derivate of N-retinylidene phosphatidylethanolamine which builds up in RPE and 
interferes with phagolysosomal digestion of POS, by disturbing cholesterol metabolism, 
inhibiting the V-ATPase and irreversibly inhibiting protease activity up to 50% (Anderson 
et al. 2017; Kevany et al. 2010; Keeling et al. 2018). A2E can also cause damage to 
mitochondrial membranes and to DNA. Furthermore, it is photo-oxidized, generating free-
radical species which modify lipids to form high molecular weight components that remain 
stable in the lysosome (Keeling et al. 2018; de Jong 2006). 
Ultimately, lysosomal dysfunction is considered a central factor contributing to retinal 
degeneration. Accumulated cargo is thought to be in part retained by the RPE and in part 
exocytosed. Consequently, these aggregates are found both in the RPE and also in drusen 
deposits, underneath (Keeling et al. 2018; Guha, Coffey, et al. 2014). It has been proposed 
that in aged RPE, intracellular unwanted material can be released via exosomes (Wang et 
al. 2009). Still, it is possible that RPE lysosomes can fuse directly with the plasma 
membrane and release their contents to the extracellular milieu. In this case, lysosome 
exocytosis would function as an emergency safety valve for intracellular clearance. Indeed, 
the role of lysosome exocytosis in the maintenance of plasma membrane integrity has been 
extensively studied in tissues susceptible to mechanical or ischemic stress, such as skeletal 
and cardiac muscle and in epithelia (Appelqvist et al. 2013; Toops & Lakkaraju 2013). 
Additionally, abnormal lysosomal secretion in cardiac cells can promote changes in ECM 
turnover leading to inflammatory and apoptotic responses that contribute to the onset and 
progression of cardiovascular diseases. In cancer cells, on the other hand, the secretion of 
lysosomal hydrolytic enzymes was shown to promote ECM degradation, stimulating 
angiogenesis, tumor growth and invasion (Appelqvist et al. 2013; Machado et al. 2015).  
Although lysosome exocytosis is an essential cellular process, the molecular machinery 
involved in the regulation of the different steps of this pathway is still not fully 
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characterized. Studies have shown that lysosomes can translocate from the perinuclear 
region to the cell periphery along microtubule tracks, independently of the intracellular 
calcium concentration, by a mechanism similar to that of lysosome-related organelles (Pu 
et al. 2015). In polarized cells, such as the RPE, lysosomes have been shown to fuse 
predominantly with the basolateral membrane in a process regulated by the actin 
cytoskeleton and membrane cholesterol (Xu et al. 2012). 
 
1.5	Final	Remarks	
Vision impairment significantly alters quality of life of affected individuals and 
constitutes a large healthcare burden to society. In the developed countries, over 50% of 
blind patients suffer from retinal disorders caused by age-related, diabetic or genetic 
diseases. Current treatments focus mainly on symptom management, even though there are 
still large gaps in our knowledge of the eye homeostasis and its control mechanisms. 
Therapies aimed at the regeneration and repair of retinal cells, namely RPE, are of great 
interest, given the significant impact on patients’ lives (Congdon 2004; Leach & Clegg 
2015). 
There are many advantages when it comes to studying the eye and developing therapies 
to improve vision. These are related to the fact that the eye is a relatively small organ, 
readily accessible for monitoring improvements or deficits non-invasively; moreover, it is 
separated from systemic circulation by the blood-retinal barrier and has potential immune 
privilege. Finally, it is convenient, for research purposes, to be able to compare progress in 
a treated eye, to its paired control (Bharti et al. 2010; Leach & Clegg 2015). 
Nowadays, the concepts related to RPE differentiation from Pluripotent Stem cells are 
becoming familiar. Yet, part of the reason why there are few therapies targeting initial 
events of AMD is the scarcity of reliable human RPE in vitro models available before the 
advent of hPSc differentiation. Moreover, by studying differentiation of stem cells, as well 
as eye patterning, it is now possible to develop more complex systems, recapitulating not 
only the RPE monolayer, but other components of the visual unit, such as the Bruch’s 
membrane and choroid (Leach & Clegg 2015; Song & Bharti 2016). 
On the other hand, we know surprisingly little about lysosomes despite 60 years of 
research. The operational definition of a lysosome (pH 4.5-5, containing hydrolytic 
enzymes and specific membrane proteins such as LAMPs) is too simple to reflect the 
reality. By large, the biogenesis, ageing and degradation of lysosomes remain ill 
characterized. Therefore, it is not surprising that lysosome dysfunction is similarly ill 
characterized. Lysosomes are no longer considered merely the end-point of degradation in 
the cell. Instead, they are now regarded as hubs of nutrient sensing and cell signaling 
events, allowing for a tight control of degradation and recycling. Lysosomes can 
accumulate a variety of cargos and release them, depending on the cell’s demand. This 
metabolism control implies harmony between the multiple pathways that reconcile at the 
lysosome, as well as interaction with transcription regulators, in order to keep the cellular 
energy balance. 
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Most common reports on degenerative diseases focus problems associated with the 
elimination of a single mutant protein, giving rise to accumulation of misfolded proteins 
aggregates. Conversely, age-related degenerations often stand from impaired turnover of 
long-lived proteins and organelles. Specifically, in the RPE, the lysosomal network is 
subjected to a heavy burden. 
 
The working hypothesis in the basis of this work is that AMD degenerative process, 
occurring within the RPE, is caused by lysosome dysfunction. As an emergency 
mechanism, it is postulated that the RPE secrete the indigestible material by lysosomal 
exocytosis, which in turns initiates a series of characteristic extracellular events, such as 
drusen formation and inflammation. Eventually, RPE cells die and the associated 
photoreceptors die too, leading to retinal degeneration. In fact, many cardinal features of 
AMD are reminiscent of lysosomal dysfunction, including the intracellular accumulation 
of protein aggregates, gathering of lipofuscin and of extracellular, poorly digested deposits 
(drusen). 
  33 
 
 
 
 
 
 
 
CHAPTER 2 
Materials and Methods 
 
2.1	Cell	Culture	and	maintenance	
All cells were maintained at humidified cabinet at 37ºC and 5% CO2. 
 
2.1.1	human	Embryonic	Stem	cells	(hESc)	
Human embryonic stem cell line H9 (WiCell Research Institute, Madison, WI, 
http://wicell.org) was maintained in mTeSR1 medium or in Essential 8 Flex medium, on 
hESC-qualified matrigel-coated plates (BD Biosciences).  
 
2.1.2	human	RPE	from	Lonza	(Lonza	hRPE)	
hRPE purchased fom Lonza were cultured in Retinal Pigment Epithelial Cell Growth 
Medium (Lonza) and, upon confluence, changed to Dubelcco’s Modified Eagle Medium 
(DMEM) F12 (Biowest), supplemented with 1% FBS (Gibco/Invitrogen) and PenStrep 
(Gibco/Invitrogen). These cells are plated onto laminin-coated surfaces (BioLamina 
rhLaminin-521).  
 
2.1.3	Porcine	RPE	primary	cultures	and	maintenance	(pRPE)	
Porcine eyes were collected, pre-scalding, and eyes were kept on ice; RPE was collected 
and put in culture on the same day. Briefly, external tissue from the eye balls was removed 
and eyes were cleaned in an iodine surgical scrub solution, diluted 1:4 in water. Eyes were 
washed in a PenStrep/PBS solution for 5min. The eyes were opened, inside the tissue 
culture hood, using a scalpel, and kept in multiwell dishes, opening facing up. The eye cups 
were filled with PBS and the neural retinas were removed. PBS was replaced by trypsin 
and the eye cups were incubated for 30min, at 37ºC. RPE was ressuspended in DMEM 
10% FBS, spun at 1000rpm at room temperature, 5min. The pelleted cells were 
ressuspended in fresh medium (containing 10% FBS) and seeded in 6-well plates. Medium 
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(DMEM F12 from Biowest) is changed once a week until cells reach confluency, at which 
point they are changed to reduced-serum medium (1% FBS). Primary cultures can be 
expanded and used for assays, by plating onto multiwell plates, maintained in DMEM F12 
(Biowest), supplemented with fetal bovine serum (FBS) (Gibco/Invitrogen), 100U/mL 
Penicillin and 100µg/mL Streptomycin (PenStrep) (Gibco/Invitrogen). Whenever using 
glass coverslips or transwells, cells were seeded onto laminin-coated surfaces (BioLamina 
rhLaminin-521).  
 
2.1.4	hESc-RPE	differentiation	and	maintenance	
Upon colony maturation, H9 cells were dissociated with Versene and passaged directly 
onto non-growth factor reduced Matrigel, in retinal differentiation medium (RDM): 
DMEM F12 with 1x B27, 1x N2 and 1x NEAA. For day 0, the following factors were 
added to the RDM: 10mM Nicotinamide, 50ng/mL noggin, 10ng/mL Dkk-1, 10ng/mL 
IGF-1. On day 1, medium is changed to remove cell debris, but composition is maintained. 
At day2, media composition is changed, as the following factors are added to the RDM, 
10mM Nic, 10ng/mL noggin, 10ng/mL Dkk-1, 10ng/mL IGF-1 and 5ng/mL bFGF. At day 
4, media is again changed, by adding to the RDM: 100ng/mL activin A, 10ng/mL Dkk-1, 
10ng/mL IGF-1. At day 6, 100ng/mL activin A, 10µM SU5402 are added to the RDM. 
Finally, at days 8, 10 and 12, RDM is supplemented with 100ng/mL activin A, 10µM 
SU5402, 3µM Chir99021. At day 14, immature RPE is obtained, and cells are transferred 
to new wells (previously coated with growth factor reduced Matrigel), at 1x105 cells/cm2 
density – P0. These new and small RPE cells are maintained with X-VIVO 10 medium 
(Lonza), changed twice a week, and left to mature for 30 days. At day 30 cell pigmentation 
is evident and cells are passaged again (P1) to further expand the culture. From this point 
on, cells are plated onto laminin-coated surfaces (BioLamina rhLaminin-521). 
Table I: Retinal Differentiation Media Supplements and Reagents 
Reagent	 Supplier	(Manufacturer)	 Concentration	
N2 Supplement Thermo Fisher 1X  
B27 Supplement Thermo Fisher 1X  
Nicotinamide Sigma 1M	
Recombinant mouse noggin  Fisher (R&D Systems) 10-50ng/mL 
Recombinant human DKK-1  Fisher (R&D Systems) 10ng/mL 
Recombinant human IGF-1 Fisher (R&D Systems) 10ng/mL 
bFGF Peprotech 5ng/mL 
Recombinant h/m/r Activin A  Peprotech 100ng/mL 
SU5402 FGF inhibitor  Santa Cruz Bio. 10µM 
CHIR99021 Stemgent 3µM 
Y27632 Fisher 10µM 
Non-GFR Matrigel Fisher N/A	
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2.1.5	ARPE19	
Human RPE cell line ARPE19 was obtained from American Type Culture Collection 
(ATCC). This cell line was cultured in DMEM/F12, containing 10% FBS and Pen Strep. 
 
2.2	POS	isolation	from	porcine	eyes	
Porcine eyes were collected and eyes were kept on ice. External tissue from the eye 
balls was removed and eyes were washed in a PenStrep/PBS solution for 5min. The eyes 
were opened, using a scalpel, and kept in multiwell dishes, opening facing up. The eye 
cups were filled with PBS and the neural retinas were removed and collected in a falcon 
containing homogenization solution (20% sucrose, 20mM tris acetate pH 7.2, 2mM MgCl2, 
10mM glucose, 5mM taurine). Retina homogenate was filtered through gauze and added 
to a continuous sucrose gradient (25-60%). POS are separated by centrifugation at 25.000 
rpm (76,7g) for 120min, in a Beckman SW-32-Ti swing rotor. A single orange band in 
upper third of gradient, corresponding to POS, was aspirated with a P1000 tip and collected 
into a new falcon. After three washes, POS prep were stored in medium containing 10% 
FBS, 2.5% sucrose, azide 0.04% and PenStrep. Before Phagocytosis assays, POS preps 
were washed three times in PBS. 
 
2.3	Phagocytosis	Assays	
RPE cells seeded onto polycarbonate Transwell® membrane inserts were challenged 
for 4 h at 37˚C with POS in basal medium with 10% FBS (50-200µg/mL), after POS were 
subjected to a 5-min sonication step in an ultrasonic bath. After the pulse, cells were 
washed three times with PBS to remove the unbound POS and chased for 24 h up to one 
week. 
 
2.4	Chloroquine	(CQ)	treatments	
All RPE cells tested were repeatedly subjected to the following treatments, on an 
everyday basis: a period of 4h pulse with medium containing 10% FBS, either without or 
with porcine POS (200µg/mL); this pulse was followed by an overnight treatment of either 
regular medium (reduced serum) or medium containing chloroquine with concentration 
ranging from 1µg/mL to 50µg/mL (corresponding to approximately 2-100µM, 
respectively). One round of this treatment is considered an acute CQ treatment; for three 
consecutive days it is considered a continued CQ treatment; seven consecutive rounds of 
this treatment are considered a chronic CQ treatment. At instances where Rapamycin and 
Bafilomycin were used as controls, they were acutely/continued/chronically added to the 
media, rather than CQ, in parallel wells. 
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2.5	Polarity	assessment	of	RPE	monolayers	
Barrier function was assessed by monitoring TER with an epithelial volt/ohm meter 
using an electrode (STX2; World Precision Instruments, Sarasota, FL). The resistance 
values for individual monolayers at specific times (Ωcm2) was determined from the average 
of three independent measurements, and corrected for background resistance produced by 
the blank filter and culture medium. 
 
2.6	RNA	isolation	and	Reverse	Transcriptase	(RT)-PCR	
Total RNA was extracted using RNAse Mini kit (Qiagen) according to the 
manufacturer’s instructions. One µg of RNA was converted into complementary DNA 
using random primers and SuperScript II reverse transcriptase (Life Technologies).  
 
2.7	Viability	assays	-	Lactate	Dehydrogenase	(LDH)	
Conditioned media were collected after cells were appropriately treated. LDH activity was 
assessed, according to Kit instructions (Thermo Scientific Pierce LDH Cytotoxicity Assay 
Kit # 88953). Briefly, conditioned media were incubated with reaction mixture, for 30min 
at room temperature. Stop solution was added and absorbance was measured at 490 and 
680nm. 
 
2.8	Exosomes	Isolation	
Exosome isolation was performed by sequential centrifugation. Briefly, (exo-free) 
conditioned medium from hESc-RPE was collected and centrifuged at 300g, to remove cell 
debris. Medium was recovered into ultracentrifuge tubes and spun for 20min at 16500g, 
4ºC. Medium was again recovered and filtered (200µm filter) into new ultracentrifuge 
tubes and centrifuged again for 1h10 at 120 000g, 4ºC. Medium was discarded and 
exosomes were ressuspended in PBS and re-centrifuged for 1h10 at 120 000g, 4ºC. PBS 
was discarded and exosomes were recovered in Ripa Buffer and prepared for Western Blot. 
 
2.9	Flow	Cytometry	
Cells were washed with PBS, detached using trypsin and resuspended in FACS buffer 
(1% FBS and 2mM EDTA in PBS). Acquisition was performed in a FACS CANTO II (BD 
Biosciences) flow cytometer, and at least 20 000 cells were analyzed using FlowJo version 
10.1r7 software. 
 
2.10	ß-hexosaminidase	(β-hex)	release	
β-hex release assay was performed as described elsewhere (Rodríguez et al., 
1997; Kima et al., 2000). In brief, hESc-RPE cells were seeded transwells and incubated 
until confluency and formation of polarized epithelium (TER>150Ωcm2) at 37°C, 5%CO2. 
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Cells were treated with 200µg/mL POS for 4h from the apical side, following which 
medium of both chambers was changed to CQ-containing medium, for overnight 
incubation. This was repeated for three days, in the case of the continuous CQ treatment 
and for seven days, in the chronic treatment. Supernatant from the apical and basal chamber 
of the transwells were collected and kept on ice. Cells were also shifted to ice. In parallel, 
cells were lysed with 1% IGEPAL/dH2O and diluted 1:5 in dH2O. β-Hex activity was 
determined by incubating cell supernatant or lysate in a 96-well plate with 6 mM of the 
substrate 4-methyl-umbelliferyl-N-acetyl-β-d-glucosaminide (4-MU-β-D-GlcNAc; 
Glycosynth) resuspended in HBSS with 40 mM sodium citrate and 88 mM Na2PO4, pH 
4.5, for 15 min at 37°C. Fluorescence was measured in a plate-spectrofluorimeter at 
excitation 365 nm/emission 450 nm. Protein content from cell supernatant and lysate was 
determined using the BCA protein assay kit (Thermo Fisher Scientific), as described by 
the manufacturer. HBSS-SLO-CaCl2 and 1% IGEPAL 1%/dH2O were used as controls. 
β-Hex activity is expressed as fluorescence (365 nm/450 nm) per milligram of cell 
protein. The total β-hex activity is the sum of apical and basal β-hex activity in the 
supernatants and 5 × (β-hex activity in the cell lysate). β-Hex released is expressed as the 
percentage of β-hex activity in the supernatant relative to the total β-hex activity. 
 
2.11	Drugs	and	Dyes	
 
Table II: Drugs and Dyes used for Lysosomal dysfunction studies 
Drug/Dye	 Action	 Working	dilution	(Time)	 Supplier	
Bafilomycin	 V-ATPase	inhibitor	 50-200nM	 Sigma	
Rapamycin	 Autophagy	inducer	 100nM	 Sigma	
Chloroquine	 Lysosome	impairment	 1-50µg/mL	=	2-100µM	 Sigma	
DAPI	 Nuclear	staining	 300nM	 Thermo	Fisher	
Phalloidin	 Actin	staining	 5µM		 Thermo	Fisher	
DQ-BSA	 Proteolisys	read-out	 10µg/mL	(overnight)	 Thermo	Fisher	
Magic	Red	 CatB/L	activity	read-out	 1X	(30min)	 ImmunoChemistry	
Bodipy	CatD	 CatD	activity	read-out	 1µM	(30min)	 Invitrogen	
Lysotracker	 Acidic	vesicle	read-out	 50nM	(10min)	 Thermo	Fisher	
 
2.12	Image	Analysis	and	Statistics	
Images were processed using ImageJ. Numerical data are presented as mean ± SD. 
Two-way analysis of variance significance analysis followed by Dunnett’s test was used 
for comparison relative to control with GraphPad Prism software. 
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2.13	Antibodies	used	
 
Table III: List of Antibodies used 
 
 
2.14	Protein	Lysates	and	Western	Blot	
Whole cell lysates were collected in Ripa Buffer, quantified using the BCA kit and 
prepared together with Laemmli Sample Buffer. Total protein concentration of 25 
µg/sample. Samples were denatured at 95°C for 10 min and then loaded in a 12% 
polyacrylamide gel. Proteins were transferred into a nitrocellulose membrane (Bio-Rad, 
USA) using the Trans-Blot® TurboTM Transfer System (Bio-Rad, Hercules, CA, USA), 
through a 7 min transfer. Membranes were then blocked with 5%Bovine Serum 
Albumin/Tris-buffered Saline – Tween 20 (5% BSA/TBS-T) (w/v) for 1 hour at room 
temperature and incubated overnight with the primary antibody diluted in PBS-T. The 
membranes were washed with PBS-T three times for 5 min each and incubated with the 
secondary antibody diluted in PBS-T for 1 hour at room temperature. After washing with 
PBS-T, the membranes were analyzed in the Chemidoc Touch (Bio-Rad, Hercules, CA, 
Antigen Host Species Working dilution (application) Supplier Catalog # 
Bestrophin1 rabbit 1:50 (IF)/1:1000 (WB) Alomone Labs ABC-001 
RPE65 mouse 1:50 (IF)/1:1000 (WB) Abcam ab13826 
PMEL17 mouse 1:1000 (WB)/1:100 (EM) Dako HMB45 M0634 
Rab27a goat 1:500 (WB) Sicgen AB45-200 
CANX goat 1:1000 (WB) Sicgen AB41-200 
CRALBP mouse 1:50 (IF) Abcam ab15051 
ZO-1 goat 1:50 (IF)/1:1000 (WB) Sicgen AB0054-200 
TRP-1 mouse 1:50 (EM) Abcam ab3312 
PEDF rabbit 1:1000 (WB) Milipore ab07-280 
VEGF mouse 1:1000 (WB) GeneTex GTX23109 
Flotillin-1 rabbit 1:1000 (WB) Santa Cruz sc-25506 
CD63 goat 1:1000 (WB) Sicgen AB47-200 
1D4 mouse 1:100 (IF);1:2000 (EM) Abcam ab5417 
RET-P1 mouse 1:100 (IF);1:200 (EM) Thermo Fisher MA5-11741 
TFEB rabbit 1:50 (IF) Werfen 1674240S 
TFE3 rabbit 1:50 (IF) Sigma HPA023881 
MitfA mouse 1:50 (IF) Abcam ab12039 
CatD rabbit 1:1000 (WB) GeneTex GTX62063 
p62 mouse 1:1000 (WB) Santa Cruz sc-28359 
LC3 rabbit 1:1000 (WB) Sigma L8918 
Actin goat 1:1000 (WB) Sicgen AB0145-200 
ApoE goat 1:50 (IF)/1:1000 (WB) Millipore ab947 
Lamp1 mouse 1:50 (IF) Hybridoma bank H4A3a 
  39 
USA) using the PierceTM ECL Western Blotting Substrate (Thermo Fisher Scientific, 
Waltham, MA, USA). 
In the case of VEGF and PEDF, media from 24 wells was collected from the apical and 
basal chambers of a set of transwells and pooled together. Protein was precipitated by 
incubating media in 5x vol. acetone overnight at -20ºC. The next day, media were spun 
10min at 10.000rpm. Pellets were ressuspended in Ripa Buffer and prepared for western 
blot, as described above. 
 
2.15	Immunofluorescence	(IF)	
Cells were seeded on glass coverslips (Menzel-Glaser), at 1x105 cells/cm2 density and 
left to mature for two weeks. Cells were washed with PBS and fixed with 4% 
paraformaldehyde (PFA) (Electron Microscopy Sciences) in PBS for 15min at room 
temperature. Cells were blocked and permeabilized with 1%BSA (Sigma) in PBS, with 
either 0.05% saponin (Sigma) or 0,02% Triton, for 1h at room temperature. Cells were 
incubated with primary antibodies, for 1h at 37ºC or overnight at 4ºC. After washing in 
PBS, cells were incubated with secondary antibodies for 30min at room temperature. 
Samples were mounted using ProLong Gold Antifade Mountant with DAPI (Thermo 
Fisher Scientific)  
 
2.16	Light	Microscopy	
Coverslips were examined using a LSM 710 laser scanning confocal microscope 
(ZEISS) with a Plan-Apochromat 63× 1.4 NA oil-immersion objective; the 405, 488, 543, 
and 633nm laser lines; and spectral detection adjusted for the emission of DAPI 
fluorochromes. Digital images were analyzed by using LSM Image software or ImageJ. 
For live-cell confocal imaging cells were seeded on glass-bottom eight-well (Labteks). 
After treatments, cells were incubated with the appropriate dyes, acording to table, washed 
three times with PBS and imaged. 
 
2.17	Transmission	Electron	Microscopy	(TEM/EM)	
RPE cells were prepared and processed for conventional EM and for cryo-immuno EM. 
 
2.17.1	Fixation	and	Embedding	
For conventional EM of cells cultured on Transwell filters and glass coverslips: cells 
were fixed in 2% paraformaldehyde (PFA)/2% gluteraldehyde (GA) in 0.1M cacodylate 
buffer for 2 hours at room temperature, or overnight at 4°C. Post-fixation was performed 
with 1.5% osmium tetroxide/1.5% potassium ferrycyanite for 1 hour on ice before 
dehydrating with a series of ethanol solutions increasing from 70% to 100%. Cells on glass 
coverslips were further dehydrated with 100% propylene oxide. Transwell filters or 
coverslips were subsequently infiltrated with two 1 hour incubations in 100% Epon resin 
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and embedded in coffin moulds or Epon stubs, respectively, and polymerised overnight at 
70°C. 
For cryo-immuno EM, cells on Transwell filters were fixed in 4% PFA in 0.1M 
phosphate buffer (PB) overnight at 4°C. 0.1% GA was occasionally used in combination 
with PFA for enhanced structure preservation, although use of GA was limited by its 
masking of some epitopes. After removing the fixative, free aldehyde groups were 
quenched with 200mM glycine for 10 minutes before approximately 1mm x 1mm squares 
of filters were cut and infiltrated in 12% gelatine (Rousselot) for 1 hour at 37°C. The 
squares of filter were subsequently embedded in a thin layer of 12% gelatine between two 
glass slides, the gelatine allowed to solidify on ice for several minutes, and the embedded 
squares of filters were cut from the surrounding excess gelatine. Gelatine-embedded filters 
were sucrose-infused with a 2.3M sucrose solution overnight at 4°C for cryo-protection 
(Tokuyasu 1973) The specimens were mounted on pins and flash frozen and stored in 
liquid nitrogen. 
 
2.17.2	Ultrathin	Sectioning	
For conventional EM, resin blocks were trimmed with a single-edged razor blade and 
the block face polished with a glass knife. 70-120nm ultrathin sections were cut on a Leica 
UM7 ultramicrotome using a diamond knife (Diatome), and placed on copper mesh grids 
or formvar-coated slot grids. 
For cryo-immuno EM, trimming and polishing of frozen gelatine-embedded Transwell 
filters was performed using a diamond trimming tool (Diatome) in a liquid nitrogen-cooled 
chamber at -80°C, ultrathin sectioned at 90-120nm at -120°C, and ribbons of sections 
retrieved in a drop of a 1:1 mix of 2% methyl cellulose and 2.3M sucrose and placed on 
formvar-coated copper mesh grids. 
 
2.17.3	Formvar	Coating	of	Copper	Grids	
When single-slot grids were used, or for cryo-immuno EM, grids were coated with a 
thin layer of formvar to support sections. A solution of 1% formvar in chloroform was used 
to coat a clean glass slide, the formvar film floated upon distilled water, grids placed on 
top of the film and the film retrieved from the water using a parafilm-coated glass slide. 
 
2.17.4	Immunogold	labelling	of	ultrathin	cryosections	
Cryosections were labelled and thawed frozen sections were firstly placed section-side 
down in PBS at 37°C for 30 minutes to remove excess gelatine. All subsequent incubations 
were performed at room temperature. To reduce non-specific binding of antibodies, free 
aldehyde groups were quenched and proteins blocked using 200mM glycine and 1% BSA, 
respectively. Grids were incubated on a drop of diluted primary antibody in 1% BSA in 
PBS for 1 hour and washed several times with 0.1% BSA in PBS to remove unbound 
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antibodies. In the case of the primary antibodies being any species other than rabbit, the 
grids were incubated for 20 minutes with a bridging antibody (as protein A-gold). 
 
2.17.5	Imaging	
Specimens were observed with a JEOL 1010 transmission electron microscope and 
imaged with a Gatan Orius SC1000B charge-coupled device camera. 
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CHAPTER 3 
Pluripotent Stem cell-derived 
Retinal Pigment Epithelium 
Development and establishment of a disease model  
 
The main goal of Chapter 3 is to describe the process through which a functional in 
vitro model of human Retinal Pigment Epithelium, derived from Pluripotent Stem cells, 
was established in the lab. The ensuing direction of the work intends to use this newly 
obtained hPSc-RPE cells to address retinopathies’ early events. In this section, the 
protocols used for differentiation are described in detail and the results obtained in each 
case as well as thorough characterization of newly obtained RPE cells are presented. 
 
3.1	RPE	Differentiation	Process	
When human stem cells grow to confluence in the absence of basic fibroblast growth 
factor (bFGF) differentiation is triggered, giving rise to RPE pigmented foci, among other 
cell types. These pigmented cells can be excised and enriched, eventually forming RPE 
monolayers. This spontaneous differentiation of pluripotent stem cells into RPE began to 
be document thoroughly by 2002 when, after culturing monkey embryonic stem (ES) cells 
with a stromal cell line for 3 weeks, 8% of ES cell colonies were reported to contain 
polygonal pigmented cells, positive for Pax6 (Kawasaki et al. 2002). These cells were later 
characterized and shown to express typical RPE markers, as well as phagocytic capability 
(Haruta et al. 2004). Other authors invigorated this notion by demonstrating that ES cells 
alone can spontaneously differentiate into RPE-like cells, when cultured in the absence of 
FGF, for 4-6 weeks (Klimanskaya et al. 2004). The obtained cells were characterized and 
shown to more closely relate to human fetal RPE than to RPE cell lines, by gene expression 
profiling; moreover, these cells were capable of phagocytosing rod outer segments and 
even repair phagocytic function in the retinas of Royal College of Surgeons (RCS) rats, 
demonstrating their therapeutic ability in a widely used model of inherited retinal 
degeneration, in vivo (Vugler et al. 2008). Later in 2009, RPE was derived from induced 
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Plutipotent Stem cells (iPS cells) with similar characteristics, when compared to ESc-
derived (David E. Buchholz 2009). These studies were crucial to determine that MERTK 
expression in these RPE cells was essential for outer segment phagocytosis (A.-J. Carr et 
al. 2009) and that RCS rats transplanted with human iPS cells-derived RPE have improved 
visual function (A. J. Carr et al. 2009), although studies have found the transplanted cells 
did not survive for long periods of time (Lu et al. 2009). 
Even though the spontaneous differentiation method can yield high purity RPE cultures, 
it is lengthy and inefficient. Improvements to this technique have been developed, guided 
by our knowledge of the developmental biology of the eye. By relying on the effect of 
added exogenous factors to promote the neuro-ecotodermal lineage, followed by 
specification of RPE fate, it is now possible to efficiently obtain functional RPE from hPSc 
in as little as two weeks (Buchholz et al. 2013; Leach et al. 2015). 
This process of directing differentiation towards RPE lineage has been perfected over 
the years. In 2008 and 2009, researchers started by using serum-free floating conditions in 
order to obtain neural precursors, preferably to mesodermal or endodermal lineages – this 
system was designated as serum-free embryoid body-like conditions, or SFEB (Hirami et 
al. 2009; Osakada et al. 2009; Osakada et al. 2008). Neural induction was further enhanced 
by adding Dkk1 and Lefty A to inhibit endogenous Wnt and Nodal signals, respectively. 
Cells were grown in suspension for approximately 20 days, and plated onto plates coated 
with poly-D-lysine, laminin or fibronectin (Hirami et al. 2009; Osakada et al. 2009). Other 
groups were also successful in obtaining RPE from collagen I (Kamao et al. 2014), laminin 
(Idelson et al. 2009), matrigel (Krohne et al. 2012) and fibronectin (Zhu et al. 2011)-coated 
plates. 
Some researchers surpass the suspension culture step altogether and guide adherent 
pluripotent cells towards RPE fate, by changing medium conditions in a stepwise fashion 
(Brandl et al. 2014; Maruotti et al. 2013; Buchholz et al. 2013). In the end, most protocols 
converge in the idea that RPE specification is attained by sequentially adding neural 
differentiation factors followed by RPE promoting signals. One group in particular has 
reported over 97% efficiency (based on PMEL17 expression) of RPE differentiation, after 
only 14 days (Buchholz et al. 2013; Leach et al. 2015). They start by inducing neural retinal 
progenitors from ESc and iPSc using Noggin, Insulin Growth Factor 1 (IGF1), Dkk1 and 
bFGF; additional RPE-specification factors are also used, such as Nicotinamide (NIC), 
Activin A, Vasoactive Intestinal Peptide (VIP), SU5402 and CHIR99021(Buchholz et al. 
2013; Leach et al. 2015). 
The work presented herein was developed under the already validated hypothesis by 
which it is possible to derive hRPE cells from hPluripotent Stem cells (A. J. Carr et al. 
2009; Singh, Shen, et al. 2013; Osakada et al. 2009; Maruotti et al. 2013; Buchholz et al. 
2013; Eiraku & Sasai 2012; Zhu et al. 2013). 
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3.2	From	Stem	cells	to	RPE	–	Differentiation	Protocol	Implementation	
In the course of this work, several differentiation protocols were put in place, in an 
effort to obtain RPE derived from Pluripotent Stem cells. 
The scientific approach primarily applied to obtain a model of RPE was the follow-up 
of previous work, where pluripotent stem cells were reprogrammed from mouse embryonic 
fibroblasts (MEFs) (Pires 2014). Briefly, MEFs from a Choroideremia (CHM) mouse 
model were reprogrammed, either using the Yamanaka transcription factor cocktail to 
obtain iPS cells (Takahashi & Yamanaka 2006) or testing different combinations of eye-
field transcription factors to directly reprogram MEFs into RPE, thus surpassing the 
pluripotent state. These particular cells had been engineered as a conditional knock-out of 
CHM (Pires et al. 2012; Pires 2014). During the course of the work presented herein, 
experiments were implemented in an effort to differentiate these previously obtained cells 
into functional mouse RPE, with the final goal of studying this model of retinal 
degeneration. Ultimately these attempts were not successful, as will be discussed in the 
following section. 
Alternative approaches were undertaken, this time using human Embryonic Stem cells 
as base material, in order to obtain wild type human RPE. Differentiation protocols that 
had been used before for mouse iPS cells differentiation, were revisited, now for hES cells. 
For instance, starting from floating aggregates, protocols developed by Osakada and Zhu 
(Osakada et al. 2009; Zhu et al. 2013) were used; and, for adherent cell culture, protocols 
developed by Brandl, Maruotti and Buchholz were endeavored (Brandl et al. 2014; 
Maruotti et al. 2013; Buchholz et al. 2013). Among these different methodologies, 
application of the protocol developed by Buchholz et al. stood out with encouraging results, 
successfully giving rise to RPE-like cells. 
Finally, all these previous experiments contributed to an enhanced stem cell- and RPE 
cell- handling know-how, with fruitful attainment of pure and fully mature human RPE 
cultures. 
 
3.2.1	mouse	RPE	differentiation	
As previously mentioned, differentiation protocols were first applied to mouse 
embryonic fibroblast cells which had been subjected to reprogramming. These earlier 
experiments were based on forced expression of TF-cocktails to induce changes in cell 
identity and ultimately originate RPE. A significant limitation of this strategy is the 
inability to guarantee reproducibility in the reprogramming process between experiments. 
To minimize this difficulty, a reporter system was developed, which was driven by 
Tyrosinase expression (Lenti-Tyr-GFP). Several sets of TFs were systematically tested, in 
particular MITF, OTX2, and PAX6 combinations, due to their relevance in RPE 
specification (Martínez-Morales et al. 2004). Hence, MEFs were first transduced with this 
lentiviral reporter system, driven by Tyrosinase expression. Subsequently, blasticidin-
selected cells were further transduced with fresh combinations of TF-carrying lentiviral 
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vectors. Preliminary results (data not shown) were encouraging, with cells becoming 
pigmented and changing morphology after transduction (Pires et al. 2012). 
Differentiation protocols applied were based on the premise that RPE originates from 
neural tissue, i. e. cells were firstly directed towards a neural fate and then to RPE, by 
adding chemical cues in the culture medium. With that in mind, cells were firstly exposed 
to neuro induction medium (Pires 2014). As expected, cells appeared to change 
morphology and Tyrosinase-driven GFP expression became evident. As cells grew to 
confluence, aggregates started growing upwards until they were released and begun 
floating in the cell culture medium, as live cell aggregates. Images of such cells are shown 
in Figure 3. 1. 
 
Figure 3. 1 - Cell morphology during early steps of differentiation, assessed by light microscopy. A: Differentiating 
cells grew to confluence, taken at 40x magnification. B: These cells express GFP fluorescence, driven by the Tyrosinase 
promoter, taken at 100x magnification. C: Live cell aggregates were released and floated in the culture medium, taken 
at 100x magnification. 
 
As the differentiation proceeded, floating aggregated cells self-organized to an extent, 
seemingly to the whole embryoid bodies described by Gonzalez Cordero (Gonzalez-
Cordero et al. 2013). Reorganization of cells inside these structures also resembled that 
described by these authors as a recapitulation of the optic vesicle and, later on, optic cup 
patterning. It was possible to observe the formation of protrusions in the extremities of the 
spheres, with GFP expression beginning to localize to the periphery, rather than the middle 
of the structure – Figure 3. 2. 
 
Figure 3. 2 - Differentiating cells self-organized, presenting protrusions in the extremities, assessed by light microscopy 
(A), taken at 40x magnification. Expression of GFP localized mainly to the extremities (B and C), taken at 100x 
magnification and zoomed (C) in for better visualization. 
 
As time progressed, cell distribution and regional density in the aggregates changed. In 
some cases, aggregates resembled those described by Gonzalez Cordero (Gonzalez-
Cordero et al. 2013) as optic cup precursors or whole embryoid bodies and in other cases, 
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the lumen of such aggregates appeared less dense alike neuroepithelium cysts described by 
Zhu (Zhu et al. 2013) (Figure 3. 3). 
 
Figure 3. 3 - Differentiating cells produced optic cup-like configurations, assessed by light microscopy. A and B: Optic 
cup-like structures, similar to those described by (Gonzalez-Cordero et al. 2013) (taken at 40x and 100x magnification, 
respectively). C: Peripheral GFP expression (100x magnification). D: Neuroepithelium-like cysts, similar to those 
depicted by (Zhu et al. 2013) (40x magnification). 
 
RPE differentiation protocols generally converge in a second step, corresponding to 
adherent culture conditions, using a medium supplemented with RPE specification factors.  
After 30-45 days of adherent culture conditions, cells presented RPE-like morphology: 
polygonal shape, disposed as a monolayer of juxtaposed cells. However, cell populations 
were not homogeneous, with some clones presenting dissimilar features. In fact, even when 
considering a single clone, cell shape was not consistent throughout the well, with regions 
consistent of fusiform cells, amongst polygonal-shaped cells. A representation is shown in 
Figure 3. 4. 
 
Figure 3. 4 - mouse cells gained RPE-like morphology, nevertheless with heterogeneous populations, 40x and 100x 
magnification, respectively. 
 
When considering cell morphology, results were encouraging and in some cases, cells 
were starting to develop pigmentation. In some wells, there were lumps or protuberances, 
as if cells were forming domes, which has been reported as a characteristic feature of 
polarized maturing RPE, when cultured in non-porous supports (Maruotti et al. 2013; 
Singh, Shen, et al. 2013; Jin et al. 2012; Zhu et al. 2013). 
Cells were transferred to transwells, to further stimulate a fully polarized and mature 
RPE. Shortly after seeding, cells regained an RPE-like morphology, with packed 
polygonal-shaped juxtaposed cells. In some cases, cells appeared to have become 
pigmented, as can be observed in Figure 3. 5. 
  48 
 
Figure 3. 5 - mouse cells display RPE-like morphology and pigmentation, when cultured in transwells. Illustrative light 
microscopy image, taken at 40x magnification. 
 
In order to assess polarization, TER was measured. Usually, RPE is considered to be 
efficiently polarized when cells reach a TER value over 150Ωcm2 (Song & Bharti 2016; 
Bharti et al. 2006; Brandl et al. 2014; Zhu et al. 2013). TER values were inconsistent and 
ultimately inconclusive. There was no increase of TER with time and measurements were 
significantly under what would be expected for polarized RPE, with values < 30 Ωcm2. 
Additionally, expression of relevant RPE-specific markers was negative (data not shown). 
Ultimately, cells were not properly differentiated into polarized and mature RPE and these 
protocols were discontinued. 
 
3.2.2	human	RPE	differentiation	process	
H9 human Embryonic Stem (hES) cells constitute a standard commercially available 
cell line, commonly used for differentiation protocols as well as other applications. In 
particular, these cells have been used before to obtain RPE (Zhu et al. 2013; Leach et al. 
2015; Buchholz et al. 2013), and thus were selected as the starting material. H9 cells are 
depicted in Figure 3. 6. 
 
Figure 3. 6 - Undifferentiated H9 embryonic stem cell colony. hES cells typically grow as compact, multicellular 
colonies, with distinct borders, as depicted. High nucleus-to-cytoplasm ratio and prominent nucleoli are also 
characteristic of these cells. Phase contrast illustrative light microscopy image, taken at 100x magnification. 
 
Empirically determined aspects such as initial cell confluency and the maturation state 
of stem cell colonies are of utmost importance for the differentiation process to run 
according to a timeline. Visual interpretation of the differentiation progress is key, as the 
protocol can be adjusted in terms of time. For these reasons, the protocols described in the 
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papers do not always reference initial cell confluency or plating densities. Each researcher 
must adjust the method, according to pluripotent stem cell line, for instance, as they can 
have specific characteristics/timing demands. 
The following sections depict the results obtained from the two most promising 
differentiation approaches used throughout the course of this work. 
 
Spontaneous	differentiation	method	
Spontaneous differentiation requires long waiting periods and relies on technical skill, 
in order to manually pick out the pigmented foci that arise, to enrich the final RPE culture. 
The spontaneous differentiation method is fairly simple, as depicted in Figure 3. 7. 
 
Figure 3. 7 - Schematic representation of the spontaneous differentiation method timeline. Stem cells are plated at high 
confluency, in X-VIVO10 medium, and allowed to differentiate for >50 days until pigmented foci become evident. 
 
Several different media have been used as basal medium, for being compatible with 
stem cell unprompted differentiation into RPE (Pennington et al. 2015). X-VIVO 10 is one 
of such media and, because it was reported to yield highly pure RPE cultures (Leach et al. 
2015), it was selected as the basal medium for these experiments. hES cells were plated at 
high confluency and left to spontaneously differentiate, for >50 days, until pigmented foci 
started to appear; those pigmented foci are to be picked out to continuously enrich the 
culture, in order to yield homogeneous RPE. Spontaneously differentiated RPE is depicted 
in Figure 3. 8. 
 
Figure 3. 8 - RPE typical morphology and pigmentation. A: RPE-like cells, at differentiation day 45. Cells are 
heterogeneous with pigmented and non-pigmented patches. Phase contrast light microscopy illustrative image, taken 
at 100x magnification. B: Pigmented foci are visible to the naked eye, typically after 3-4 months, as pigmented cells 
are organized in ridges and circles of darker color; photograph of a well from a multiwell plate. 
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After 120 days of differentiation, pigmented and polygonal-shaped cells were picked 
out, and went through an enrichment phase. Scraping off undifferentiated colonies or 
selecting and picking out pigmented cells to re-plate require proficient handling skills and 
deep knowledge of these cells behavior. Ultimately, not all the cells that were selected were 
pre-RPE. Additionally, the cells were plated at lower confluency than would be ideal, 
causing this fragile presumed-to-be pre-RPE to transdifferentiate. In the end, this protocol 
was discontinued, as it was possible to obtain high yield of RPE cultures and in a shorter 
time-frame, using the directed differentiation method. 
Nevertheless, and despite their lower efficiency, spontaneous differentiation protocols 
continue to be used by several research groups, as they are effective and yield high purity 
RPE cultures. 
 
Directed	differentiation	method	
After first attempts to differentiate RPE, the protocol shown to be most promising was 
the one developed by Buchholz and colleagues at the Clegg Lab, University of California, 
Santa Barbara (Buchholz et al. 2013). Buchholz’s protocol requires several different factors 
to be added sequentially to the basal medium. Further contributions to the protocol made it 
more expensive, but significantly improved differentiation efficiency and efficacy (Leach 
et al. 2015) (Figure 3. 9). 
 
Figure 3. 9 - Schematic representation of the directed differentiation method timeline. Cells are given different 
differentiation factors every other day, in a specific order, to induce differentiation to RPE. 
 
As described in the papers, not all factors are absolutely required, for instance 
Nicotinamide and SU5402 are not essential, but were shown to improve differentiation 
(Leach et al. 2015). Likewise, on first attempts to reproduce the protocol, not all the factors 
were used, as not all were available in the lab. Pre-RPE colonies were obtained, with small 
groups of cells showing a polygonal shape. However, the wells were not completely 
homogeneous and not all cells were pigmented (data not shown). 
After encouraging preliminary results, the directed differentiation protocol was 
adjusted, based on the conclusions drawn from both articles (Buchholz et al. 2013; Leach 
et al. 2015). In the end, the factors used to induce differentiation were Nicotinamide, 
Noggin, Dkk-1, IGF-1, bFGF, Activin A, SU5402 and Chir99021, sequentially added, as 
depicted in Figure 3. 9. 
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Following the initial period of protocol adjustments, the guided differentiation process 
was successful and efficiently gave rise to mature RPE, with full wells containing pure 
populations (Figure 3. 10). 
 
Figure 3. 10 - hES cells differentiation stages, until defining an RPE fate. Images were taken at differentiation days 6, 
8 and 12, respectively. Morphological changes are observed, as the differentiation process develops, giving rise to a 
monolayer of homogeneous polygonal cells. Phase contrast light microscopy illustrative images, taken at 100x 
magnification. 
 
During the first days, cells start to spread out from the compact stem cell colonies and 
become “spiky”, as neural projections start to come off the edges. Later on, when the 
bottom of the wells becomes full (days 4-6), cells adhere to each other, become more 
polygonal and even-out their cell size, relative to one another. At the end of the 14-days 
period, the wells are consistent, with a monolayer of small uniform cells, which can then 
be passaged to new plates (Passage 0), in order to expand and further mature. 
Approximately 1 month after P0, typical features of maturing RPE are readily visible, such 
as dome formation and pigmentation (Figure 3. 11). 
 
Figure 3. 11 - Typical features of mature RPE: dome formation (A and B), pigmentation and polygonal shape (C). 
Phase contrast light microscopy illustrative images (A and B), taken at 100x magnification, at day 35. The bright field 
image (C) was taken at day 135 and zoomed in for better visualization of fully mature RPE. 
 
Dome formation occurs due to polarized fluid secretion towards the basolateral side, 
and is characteristic of newly differentiated RPE plated on impermeable plastic plates 
(Leach et al. 2015; Maruotti et al. 2013; Zhu et al. 2013). This effect works as a visual 
indicator of polarized cells and together with distinct hexagonal shape and readily visible 
pigmentation imply mature and functional RPE. At this point, cells are ready to be passaged 
again, to be expanded or used for experiments. 
Prior to further investigations, however, a comprehensive characterization of these cells 
is required, in other to assure correct RPE establishment. 
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3.3	hESc-RPE	characterization	
Human Pluripotent Stem Cell derived-RPE cells (hPSC-RPE) have been shown to share 
many characteristics with native human RPE, including morphological similarities, gene 
expression, protein expression electrophysiologic properties and fluid transport 
(Klimanskaya et al. 2004; A.-J. Carr et al. 2009; Idelson et al. 2009; Leach et al. 2015; 
Vugler et al. 2008; Singh, Phillips, et al. 2013; Meyer et al. 2009; Zhu et al. 2013; Kamao 
et al. 2014). Typical features may vary depending on the differentiation or culture method 
and even maturation stage of seemingly analogous hPSC-RPE. Nevertheless, comparative 
studies suggest hPSC-RPE resemble human fetal RPE more closely than adult RPE 
(Klimanskaya et al. 2004; Lu et al. 2009), with the exception of one study (Kamao et al. 
2014). In an effort to standardize RPE characterization, a systematic approach has been 
suggested, in which a panel of characteristics would be evaluated and considered as a 
minimum requirement to validate RPE fate. This panel includes gene and protein analysis, 
a phagocytosis assay, TER evaluation, growth factor secretion and retinoid metabolism 
assays (David E. Buchholz 2009). 
To thoroughly characterize the newly-produced hESc-RPE, different types of assays 
were preformed, to assess specific RPE features and compare these newly established cells 
to other commonly used RPE cell lines. 
 
3.3.1	RPE	Morphology	and	Polarization	
RPE cells organize as a polarized epithelium, in a single monolayer, by establishing 
close connections with their neighboring cells. This is visible by light microscopy, with the 
cells presenting characteristic polygonal shape (Figure 3. 12). 
 
Figure 3. 12 - hESc-RPE organizes as a monolayer of pigmented polygonal-shaped cells, as evidenced by A: bright 
field confocal image and correspondent B: Phalloidin fluorescence staining. Scale bar 10µm. 
 
The use of Phalloidin allows the clear visualization of the defined polygonal shape. On 
the other hand, the bright field image allows for the assessment of typical pigmentation, 
also characteristic of these cells. The pigment covers the cells, allowing the distinction of 
the nuclear area, devoid of it. 
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Formation of tight junctions is necessary in order to guarantee the epithelium properties 
regarding barrier function. Polarized epithelia forms, as cells grow to confluence, and this 
is verifiable by regarding their structure and distribution with great detail. Electron 
Microscopy (EM) images allow a very thorough analysis of these cells. In particular, they 
permit observations referring to monolayer organization and polarized structure. In 
particular, it is possible to confirm that 1) cells do organize side-to-side, as a monolayer, 
rather than superimposed, and 2) cells arrange their intracellular components in a polarized 
manner: basal nucleus (N), apical processes (AP) and basal infoldings (BI); also visible 
within the cell are mitochondria and melanosomes. Melanosomes are readily identified as 
very dark electron dense structures, widely distributed throughout the cells (Figure 3. 13). 
 
Figure 3. 13 - hESc-RPE monolayer observed by Transmission Electron Microscopy. Image shows an RPE cell (dashed 
line) plated onto a filter, flanked by two other RPE cells. Notice the apical processes (AP) and basal infoldings (BI), 
typical of polarized RPE; also visible are the nucleus (N), melanosomes and mitochondria. 
 
When comparing the newly established hESc-RPE to other RPEs, their morphological 
similarities become evident. Specifically, hESc-RPE were compared side by side with RPE 
lines derived from primary cultures, namely porcine RPE (pRPE) and a commercially 
available human RPE line, from now on designated as Lonza hRPE (Figure 3. 14). 
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Figure 3. 14 - hESc-RPE cells (A) have similar morphology to Lonza hRPE (B) and also to pRPE (C), as evidenced by the 
monolayer appearance of polygonal shaped cells. Phase contrast images taken using a wide field light microscope, taken at 
100x magnification. 
 
A closer look, by EM, allows us to exhaustively compare the hESc-RPE to pRPE. As 
such, it is possible to confirm similar cell size and polarization features (such as apical 
processes and basal infoldings), as well as the presence of mitochondria and pigment-
loaded melanosomes. pRPE melanosomes are much bigger and generally darker than 
hESc-RPEs’ (Figure 3. 15). 
 
Figure 3. 15 - Transmission Electron Microscopy images of hESc-RPE and pRPE. hESc-RPE cells (A) have similar 
morphology to pRPE (B): prolonged apical processes, basal infoldings, melanosomes, similar size and intracellular 
organization. 
 
As mentioned, when plated at high confluency, RPE cells connect to each other via 
tight junctions, which dynamically interact with numerous other proteins to regulate 
permeability, polar orientation of membrane proteins and trafficking within the cell. 
Epithelial cell polarity is usually measured by assessing the TER. While RPE cell lines, 
such as ARPE19, typically have low (<50 Ωcm2) TER, other types of RPE, such as primary 
porcine RPE (pRPE), human fetal RPE (hfRPE) or hESc-RPE have been shown to develop 
tight monolayers, with TER above 200 Ωcm2 (Rizzolo 2014; Lehmann et al. 2014; Sonoda 
et al. 2009). 
TER is routinely measured, to guarantee a certain standardization of assays; i. e. 
because barrier function is characteristic of mature RPE, TER indicates if cells are mature 
and thus ready for experiments, when they reach a certain threshold, above 150 Ωcm2. As 
part of the characterization of the newly obtained hESc-RPE, TER was measured regularly 
(Figure 3. 16). 
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Figure 3. 16 - hESc-RPE become polarized, approximately after two weeks, with a Transepithelial Electrical Resistance 
value above 500Ω, which translates to a Unit Area Resistance reaching 200Ω.cm2. n>40. 
 
As the cultures reach confluency and form a monolayer, there is an increase of TER. 
This increase is consistent throughout the experiments and highly dependent on the initial 
cell confluency. 
 
3.3.2	RPE	Gene	Expression	and	Molecular	Markers	
In order to assess gene expression, undifferentiated hES cells were collected, as well as 
hESc-RPE, during the differentiation process (day 9) and fully matured at day 136 of 
differentiation (Figure 3. 17 A). Additionally, protein levels of relevant RPE markers were 
evaluated by western blot and compared to Lonza hRPE, pRPE and commonly used human 
RPE cell line ARPE19 (Figure 3. 17 B).  
 
Figure 3. 17 - hESc-RPE express markers characteristic of mature RPE. A: PCR relative expression of relevant RPE 
markers was compared between undifferenciated hESc and differentiated hESc-RPE. HPRT was used as loading 
control B: protein levels of RPE markers were evaluated by western blot, by comparison between the RPE lines: porcine 
RPE, hESc-RPE, Lonza hRPE and ARPE19; CANX was used as loading control. 
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Contrary to undifferentiated stem cells, mature RPE expresses specific functional 
markers, such as Rlbp1 and Best1. Otx2 is expressed by undifferentiated H9 cells, but is 
even more expressed in differentiated RPE. Oct4 on the other hand is expressed in H9 cells 
and in hESc-RPE, but expression appears to be downregulated as the RPE matures, comes 
up again in differentiated hESc-RPE, though at relatively lower levels (Figure 3. 17 A). 
This evaluation is merely preliminary, and should be confirmed by further testing. 
Protein levels of relevant markers of mature RPE were further confirmed by western 
blot. To this end, human ESc-RPE cells lysates were run side-to-side with pRPE, hRPE 
from Lonza and the human RPE cell line ARPE19 and analyzed for expression of typical 
RPE markers (Figure 3. 17 B). hESc-RPE were shown to express RPE65 and Best1, as did 
the other RPE lines evaluated. RPE65 is a retinoid isomerohydrolase responsible for the 
conversion of all-trans to 11-cis retinal, during the visual cycle. Best1, on the other hand, 
is a calcium-activated anion channel. Expression of these markers is typical of mature RPE 
and suggests these cells to be readily functional. 
PMEL17 composes melanosome internal matrix fibers, playing an essential role for 
melanin deposition. As expected, its expression is higher in hESc-RPE than other cell lines, 
corroborating the observation that these cells are actively undergoing melanogenesis. 
While usually pRPE is heavily pigmented, the absence of a distinct band could mean that 
the cells used here were in fact less pigmented or that PMEL fibers are masked by melanin 
(Figure 3. 17 B). 
Regarding Rab27a, it is highly expressed in hESc-RPE, with lower levels being 
detected for hRPE from Lonza and ARPE19. Rab27a is not RPE specific, but it is involved 
in vesicular transport, namely trafficking of melanosomes and exosome release and 
therefore it was expected to be present. 
Immunofluorescence (IF) stainings were produced, using antibodies specific for mature 
RPE markers (Figure 3. 18).  
 
Figure 3. 18 - IF images show hESc-RPE express characteristic RPE markers, evaluated by light microscopy, such as 
Best1, CRALBP, ZO-1 and RPE65. Taken at 100x magnification. 
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hESc-RPE presented relevant markers, as detected by IF. In particular, there is 
expression of Zonula Occludens (ZO-1) which attests for the monolayer tightness, and of 
components involved in the visual cycle, such as cellular retinaldehyde-binding protein 
(CRALBP) and RPE-65. Furthermore, expression of Best-1 was also assessed by IF and 
its presence suggests that the RPE is functionally able to regulate essential processes, such 
as maintenance of cellular volume and Ca2+ signaling. 
 
3.3.3	Functional	characterization	of	hESc-RPE	
As discussed in section 1.1.2, the RPE is responsible for a broad range of functions, 
critical to ensure vision. In order to assure hES cells differentiated properly, it is necessary 
to confirm these hESc-RPE cells are capable of essential functions, characteristic (though 
not exclusive) of the RPE. To this effect, these cells were evaluated regarding their ability 
to pigment, to secrete important growth factors (namely VEGF and PEDF) and 
exososomes, and finally, their ability to phagocytose POS. 
 
Melanogenesis	
Melanosomes are specialized organelles which contain melanin, providing color and 
photoprotection to pigmented structures. Specifically, in the RPE, melanosomes are 
thought to be retained within the cell, to capture scattered stray light and protect from 
oxidative attack (Raposo & Marks 2007; Lopes, Wasmeier, et al. 2007).  
During melanosome maturation, protein fibers of amyloid nature are formed, to a great 
extent by polymerization of Pmel17. Later on, the enzymes involved in melanin synthesis 
(such as Tyrosinase and Tyrp1) are carried to premelanosomes, to provide for the actual 
pigment (Delevoye et al. 2011; Raposo & Marks 2007). To assess melanogenesis in hESc-
RPE, the cells were prepared for cryo-immuno EM and gold-labeled for representative 
markers (Figure 3. 19). 
 
Figure 3. 19 - immuno-EM staining showing specific labeling of melanosomes, analyzed by TEM. A: PMEL17-labeled 
premelanosome and B: TRP1-labeled late melanosome. 10nm gold. 
 
Melanosomes mature through four defined stages, based on their morphology, as 
observed by EM. During this process, an immature non-pigmented premelanosome begins 
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to form (stage I) and progressively acquires matrix fibers (completed by stage II), as well 
as an ellipsoid conformation. Starting from stage II, melanin is synthesized and deposited 
onto the protein fibrils, thickening and blackening stage III melanosomes, until all internal 
structure is concealed in a homogeneous stage IV mature melanosome (Figure 3. 20). 
 
Figure 3. 20 - Schematic representation of the four stages of melanosome maturation, from stage I premelanosome to 
heavily pigmented stage IV. Adapted from (Bissig et al. 2016). 
 
Melanogenesis occurs during a short window of embryogenesis, in mammals. In 
humans, melanin granules are observed up to 30 days of fetal development and by the 14th 
week, melanosomes at all stages of maturation are present (Rózanowska 2011). Within a 
few weeks melanogenesis stops and the RPE cells keep roughly the same melanin content 
throughout life. Commonly used cell culture protocols for human RPE usually lead to the 
loss of pigment granules through their repeated dilution in daughter cells. This is true for 
established cell lines and primary cultures of adult donor RPE. However, in some RPE 
lines, such as fetal RPE and pluripotent stem cell-derived RPE, melanogenesis is observed. 
In fact, hESc-RPE obtained through the course of the present work do continuously 
produce melanosomes (Figure 3. 21). 
 
Figure 3. 21 - Melanosomes are fully matured in porcine RPE, but at different stages of maturation in hESc-RPE, 
assessed by TEM. A: porcine RPE with heavily pigmented melanosomes; B: hESc-RPE’s melanosomes at different 
stages of melanogenesis. 
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Because postnatal RPE cultures do not readily produce melanosomes, melanogenesis 
has been studied to a greater extent in skin melanocytes, but not in the RPE. hESc-RPE 
have now emerged as a key tool to study molecular mechanisms of RPE pigmentation, both 
in healthy conditions and in ocular disorders, which frequently manifest with pigmentation 
anomalies, as previously discussed. 
 
Secretion	
Another important aspect, which indicates the RPE is mature and polarized, is secretion 
of essential factors, such as VEGF and PEDF: polarized RPE secretes PEDF predominantly 
from the apical side, and VEGF primarily through the basolateral side. For this reason, 
polarized secretion of these factors has been suggested as functional criteria to evaluate 
hESc-RPE newly established lines. 
In order to evaluate this feature, medium was collected from upper and bottom 
chambers of transwells containing hESc-RPE and processed according to the description 
in Materials and Methods. A western blot obtained from the precipitation of conditioned 
medium proteins, from apical and basal chambers of the transwells, showing PEDF and 
VEGF content in the respective media (Figure 3. 22). 
 
Figure 3. 22 - hESc-RPE cells secrete VEGF and PEDF into the medium, in a polarized manner, as assessed by western 
blot. Medium was collected from apical and basal chambers of transwells and precipitated, as described in Materials 
and Methods. 
 
Even though these are preliminary data, and VEGF is hard to visualize in the presented 
image, the result for PEDF suggests cells are in fact secreting this factor in a polarized 
manner. 
Additionally, though not RPE-specific, exosome release was evaluated in hESc-RPE 
cells and shown occur, under standard culture conditions (Figure 3. 23). 
 
Figure 3. 23 - hESc-RPE release exosomes into the medium, detected by western blot. Exosome markers CD63 and 
Flotillin-1 were evaluated in whole cell lysate and correspondent exosome fraction, isolated from the medium, 
according to Materials and Methods. 
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In order to evaluate exosome production by these cells, conditioned medium was 
collected and exosomes were isolated by sequential centrifugations, as described in 
Materials and Methods. These exosomes were run side-to-side with whole cell lysates and 
blotted using anti-CD63 and anti-Flotillin1 antibodies, typical markers of exosomes. 
Results suggest hESc-RPE produce and release exosomes (Figure 3. 23). 
 
Phagocytic	Ability	
Phagocytosis consists on capturing extracellular material, typically utilizing specific 
ligand-receptor interactions. Some of the most fundamental roles of the RPE, necessary to 
our visual process, include phagocytosis of POS and subsequent recycling of visual 
pigment, through the retinoid cycle. 
POS are specialized light sensing organelles contained within photoreceptor cells. They 
are composed by stacked disc membranes, containing rhodopsin, as described in Chapter 
1. Two different rhodopsin antibodies were used to stain POS: RET-P1 and 1D4. These 
two antibodies have been shown to recognize different epitopes of rhodopsin, thus 
identifying distinct stages of phagosomal maturation (Wavre-Shapton et al. 2014). On the 
one hand, RET-P1 recognizes an epitope at the N-terminus (extracellular) intradiscal 
domain of the rhodopsin molecule and labels both rhodopsin monomers and aggregates. 
1D4, on the other hand, recognizes the C-terminal amino acids (cytoplasmic domain) of 
rhodopsin. For this reason, early phagosomes located at the apical region contain both 
epitopes and are thus 1D4- and RET-P1- positive. As the phagosome matures, RET-P1 
staining continues visible, but 1D4 is gradually lost, indicating a progression from double-
labelled to single labelled phagosomes in a time-dependent manner (Wavre-Shapton et al. 
2014). 
To determine whether hESc-RPE were able to phagocytose POS, it was first necessary 
to establish a POS-isolation protocol in the lab. Upon optimization, it was possible to obtain 
pure preparations of porcine POS, using a sucrose gradient, as described in Materials and 
Methods. The obtained POS were analyzed by EM (Figure 3. 24). 
 
Figure 3. 24 - Isolated porcine POS consist on multi-membrane discs, as evaluated by TEM. The sucrose gradient 
method produces pure preparations of POS membranes. 
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EM images depict pure preparations of POS, without other organelle contamination 
(Figure 3. 24). 
hESc-RPE cells were fed with porcine-POS, and IF staining anti-rhodopsin (1D4) was 
performed, in order to establish whether these cells indeed phagocytose (Figure 3. 25). 
 
Figure 3. 25 - hESc-RPE are able to phagocytose porcine POS, as evidenced by IF rhodopsin staining (1D4). Phaloidin 
fluorescence evidences the cell limits. 
 
hESc-RPE were also observed by EM (both conventional EM and cryo-immuno EM, 
as described in Materials and Methods), after being fed with porcine POS (Figure 3. 26). 
 
Figure 3. 26 - Conventional EM images show hESc-RPE are able to phagocytose porcine POS. A: apical processes 
extend to touch POS membranes and cells are able to engulf and create intracellular compartments containing POS 
membranes, as depicted. B: further magnification of the section highlighted in image A. 
 
It is possible to identify phagosomes containing POS membranes, which typically get 
degraded after an overnight chase. Gold-labeling using different rhodopsin antibodies 
confirmed that these vesicles are indeed consistent with POS-containing phagosomes 
(Figure 3. 27). 
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Figure 3. 27 - cryo-immuno EM images show hESc-RPE are able to phagocytose porcine POS, using rhodopsin 
antibodies (white arrows). A: 1D4 staining and B: RET-P1 staining, both specifically labeling POS-containing 
phagosomes inside the RPE cell. Black arrow indicates RPE apical processes. 10nm gold. 
 
While 1D4 staining is found at the apical region of the cell, near the apical processes, 
RET-P1 staining is generally found more to the interior of the RPE cell. Specific labeling 
of these structures by rhodopsin antibodies confirms their phagosomal origin. Therefore, 
hESc-RPE were shown to uptake POS and to store them within (Figure 3. 27). Phagosome 
processing by RPE cells is characterized by progressive maturation and ultimate 
degradation of this cargo at the lysosome, as discussed in Chapter 1. 
 
3.4	hESc-RPE	Processing	of	Phagocytic	Cargo	
hESc-RPE cells were fed with porcine POS, to load the lysosomes with digestible 
cargo, and then analyzed regarding different aspects. Initially, POS presence was directly 
measured, using anti-Rhodopsin antibodies, as previously. 
 
3.4.1	hESc-RPE	Phagocytic	ability	
Degradation kinetics may be variable depending on the situation, namely considering 
in vivo situation versus in vitro and also from cell line to cell line. Therefore, first, in order 
to assess the normal time frame of POS degradation by the newly established model of 
hESc-RPE, cells were fed with a single pulse of POS (at 200µg/mL) for a 4h period, 
followed by chronological chase periods, as described in the schematic representation of 
Figure 3. 28. 
 
Figure 3. 28 - Schematic representation of the experimental layout. hESc-RPE were pulsed with a single POS feeding 
and chased at time 0 after pulse, overnight, 3 days and 1 week. 
 
At each of the time points, cells were fixed for IF, and stained using rhodopsin RET-P1 
antibody, in order to follow POS degradation through time (Figure 3. 29). 
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Figure 3. 29 - Time course of POS processing by hESc-RPE, assessed by light microscopy. Before POS feeding RET-
P1 staining is missing, suggesting specific labeling of rhodopsin. hESc-RPE were able to uptake POS, as evidenced by 
staining at time 0, and were successful in digesting them, as shown by little rhodopsin staining after overnight chase 
and at day 3, and none at all after 1 week. Scale bar 10µm. 
 
These experiments regarding POS uptake and normal digestion allowed for a setup of 
the experimental time frame: hESc-RPE are able to uptake POS, as can be observed by the 
IF images obtained for time 0 (Figure 3. 29). RET-P1 staining at early time points consists 
of dispersed small dots, consistent with several early phagosomes, at the cell periphery. An 
overnight chase is sufficient to allow most of the POS to be degraded, with few RET-P1 
positive vesicles being detected at this time. Notably, after the third day of chase, RET-P1 
staining seems to become fainter and no staining was detected after 1 week (Figure 3. 29). 
 
3.4.2	Lonza	hRPE	and	pRPE	Phagocytic	ability	
The same experiment was performed using Lonza hRPE: a single 4h POS (200µg/mL) 
pulse was chased from time 0 after POS washout up until one week. While in hESc-RPE, 
POS digestion was only followed through rhodopsin staining, in Lonza hRPE another 
readout was observed: POS-induced autofluorescence. Therefore, POS digestion was 
followed by observing POS-derived autofluorescence and RET-P1 staining (Figure 3. 30). 
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Figure 3. 30 - RET-P1 IF staining and POS-derived autofluorescence in Lonza hRPE, detected by light microscopy. 
Cells were able to uptake POS, as evidenced by rhodopsin RET-P1 staining from time 0 and up to 3 days after pulse. 
After one week, the staining is fainter, suggesting degradation. Autofluorescence starts to appear 24h after POS pulse 
and remains after 1 week. Scale bar 10µm. 
 
It is important to mention that autofluorescence is observed whether or not cells are 
stained, meaning that it is not bleed through from another channel, but instead derived from 
POS. 
Not unlike hESc-RPE, Lonza hRPE cells are able to uptake and process rhodopsin, as 
evidenced by RET-P1 IF staining and by POS-derived autofluorescence. Prior to POS 
feeding there is no rhodopsin staining and few auto fluorescent dots. After POS feeding, 
RET-P1 staining is detected immediately at time 0, and remains until one week, although 
it starts to become fainter. Conversely, autofluorescence starts to develop later, it is only 
visible 24h after feeding and remains even after digestion of the majority of rhodopsin at 
one week.  
Finally, single POS pulse (200µg/mL) and chase was also tested in porcine RPE, 
considering rhodopsin staining with RET-P1 antibody and autofluorescence (Figure 3. 31). 
 
Figure 3. 31 - RET-P1 IF staining and POS-derived autofluorescence in pRPE, detected by light microscopy. Cells 
were able to uptake POS, as evidenced by RET-P1 rhodopsin staining from time 0 and 24h after pulse. pRPE presents 
autofluorescent dots even before POS feeding. Autofluorescence increases 24h after POS pulse and remains 24h post-
pulse. Scale bar 10µm. 
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Porcine RPE cells were able to uptake POS, as evidenced by the staining at time 0 after 
washout, and continue phagosome processing for over 24h, shown by the abundant 
presence of RET-P1 positive aggregates at this time point. Regarding autofluorescence, 
pRPE cells already contained autofluorescent particles, before POS feeding (Figure 3. 31). 
The number of autofluorescent specks increases after POS feeding, in some cases in close 
proximity to RET-P1 staining, although not necessarily co-localizing. 
 
3.4.3	POS-derived	Autofluorescence	
In order to further confirm this autofluorescence is in fact POS-derived and establish a 
correlation with increase of POS, two different concentrations of POS preparation were 
used: 50µg/mL and 200µg/mL. POS-derived autofluorescence was detected by flow 
cytometry analysis, in this case of Lonza hRPE (Figure 3. 32). 
 
Figure 3. 32 - POS-derived autofluorescence in Lonza hRPE detected by flow cytometry, in unstained cells. 
Autofluorescence appears after 24h, in a dose-dependent manner. The number of autofluorescent cells increases with 
time, for the higher concentration of POS. n= 20.000 cells acquired for each condition and experiment represented; 
Results are expressed as mean ± s.d.; the numbers over the bars indicate repeats of the same condition. 
 
At time 0 post-pulse, autofluorescence is at the same levels as in control unfed cells. 
This is consistent with the microscope images (Figure 3. 30) and therefore, since Lonza 
hRPE were found not to be autofluorescent before POS feeding, this is considered a 
baseline. As the phagocytic cargo is processed, autofluorescent cells appear, again coherent 
with microscopy findings (Figure 3. 30). Comparing “No POS” situation with POS at 
50µg/mL, a modest difference is detected, with higher numbers of autofluorescent cells in 
the POS 50 situation than in control (No POS) situation, at the same time point (Figure 3. 
32). Regarding POS at 200µg/mL, a regular increase of autofluorescent cells is verified at 
each time point. In spite of the seemingly modest differences (less than 10%), when 
analyzing these data, it is important to keep in mind the method of detection: while 
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microscopy images allow the detailed visualization of particles within cells, flow cytometry 
detects whole cell fluorescence; i.e. establishing the threshold of detection relies on 
sufficient autofluorescent particles per cell which confer this property to the cell. For this 
reason, flow cytometry is regarded as a less sensitive technique than microscopy. Still, 
considering reproducibility between assays and a high number of cells per experiment, a 
direct correlation can be found between POS processing by RPE cells and the appearance 
of autofluorescent particles/cells. 
In accordance with the previous experiments, RPE cells fed with different 
concentrations of POS produce different amounts of autofluorescent particles. POS-
derived autofluorescence in parallel with RET-P1 IF staining within the same cells, both in 
Lonza hRPE and in pRPE, using POS at 50µg/mL or 200µg/mL, is represented in Figure 
3. 33. 
 
Figure 3. 33 - Lonza hRPE and pRPE develop POS-derived autofluorescence in a dose dependent manner, as indicated 
by RET-P1 IF staining, after single pulse and overnight chase; assessed by light microscopy.  Both rhodopsin staining 
and autofluorescence increase in a dose-dependent manner. Scale bar 10µm. 
 
First of all, by comparing Lonza hRPE to porcine RPE, it is possible to observe that 
pRPE cells already contained POS, labeled by RET-P1 antibody, as well as specks of 
autofluorescence, before feeding (No POS situation) (Figure 3. 33). Lonza hRPE is a fetal 
RPE cell line, and for this reason, should be fairly naïve in terms of photoreceptor 
phagocytosis. On the contrary, pRPE is derived from adult porcine eyes, which means that 
the RPE has been digesting POS on a daily basis throughout the pig’s whole life. This could 
be one explanation for the remaining rhodopsin staining in the porcine cells, although the 
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staining is faint, consistent with partial degradation of POS by these cells. For the same 
reason, autofluorescence is evident in pRPE while absent in Lonza hRPE: pRPE are adult 
cells, with a lifetime accumulation of mis-processed material and possibly with presence 
of autofluorescent lipofuscin and complex granules (Figure 3. 33). 
A 4h POS pulse (either using 50µg/mL or 200µg/mL POS) followed by overnight chase 
resulted in evident increase of both RET-P1 staining and autofluorescence, in both cell 
types. The concentration of POS cells were fed with directly impacts the area of RET-P1 
staining and also of autofluorescence (Figure 3. 33). 
Finally, although RET-P1 staining co-localizes with autofluorescence, many times 
autofluorescence seems to come from the inside of RET-P1 stained vesicles. On the other 
hand, despite RET-P1 IF staining almost always co-localize with autofluorescence, 
autofluorescence does not always co-localize with RET-P1 IF staining (Figure 3. 33). 
Importantly, for these experiments, autofluorescence was detected using the 405 nm 
channel whereas RET-P1 IF staining was acquired in the 488 nm channel. So, efforts were 
made to prevent bleed-through from one channel to the other. RET-P1 labeling has been 
described to be lost upon fusion of the phagosome with the lysosome (Wavre-Shapton et 
al. 2014), and autofluorescence may in fact be derived from POS processing within the 
lysosome. This would be consistent with the absence of autofluorescence in unfed Lonza 
hRPE and also with the appearance of RET-P1 around autofluorescent particles, which 
may represent phagolysosomes actively digesting POS. 
In an effort to quantify this POS-derived autofluorescence and establish dose-
dependency, Lonza hRPE and pRPE were again incubated with increasing concentrations 
of POS, from 50µg/mL to 600 or 400µg/mL, respectively, and analyzed by flow cytometry 
(Figure 3. 34). 
 
Figure 3. 34 - Lonza hRPE and pRPE develop POS-derived autofluorescence, dependent on initial POS concentration 
(50-600 and 50-400 µg/mL, respectively), after single pulse overnight chase, assessed by flow cytometry. n= 20.000 
cells acquired for each condition represented; Results are expressed as mean ± s.d.; the numbers over the bars indicate 
repeats of the same condition. 
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Consistent with previous findings, there is an increase of the autofluorescent cell 
numbers, in direct proportion to initial POS concentration, for Lonza hRPE. As for pRPE, 
there is also an increase, dependent on POS concentration, but this increase seems to 
plateau/decrease at the highest concentration (400 µg/mL) (Figure 3. 34). There is some 
variability between assays, as represented by the error bars. Similar to Figure 3. 32, there 
is a modest but consistent increase of the autofluorescent cell numbers and it is interesting 
to find the increase is more significant in porcine than in human cells (Figure 3. 34). It is 
not possible to draw conclusions from the baseline differences in both cases, as these can 
be attributed to intrinsic differences, but also to settings adjustment for each experiment. 
Still, comparing to the control situation in each case, POS-derived autofluorescence 
increases more in pRPE than in Lonza hRPE (Figure 3. 34). It could be that pRPE are able 
to uptake higher amounts of POS (for instance more rapidly). It can also mean that pRPE 
take more time to process autofluorescent granules derived from POS degradation. As for 
the apparent reduction in autofluorescent pRPE cell numbers from 200 to 400 µg/mL, it 
would be necessary to repeat the experiment, in order to obtain statistical significance. 
However, it is reasonable to consider the existence of a limit of the RPE’s phagocytic 
ability, at which point there wouldn’t be further increase. 
 
3.5	Model	of	POS-induced	Lysosomal	Dysfunction	
The timeframe of phagocytosis of POS, by in vivo RPE cells has been documented by 
other researchers. Based on such reports, early phagosomes are typically detected at the 
apical region and stained with both 1D4 and RET-P1 rhodopsin antibodies, from time 0 
after POS feeding pulse and until 2 hours after washout; 4 to 6 hours after pulse, both 
phagosomes and phagolysosomes containing POS at different stages of degradation can be 
found; between 12 and 24 hours post-pulse POS are found within lysosomes at the 
perinuclear region (Wavre-Shapton et al. 2014). Additionally, other reports state that LC3 
positive phagosomes are present 12 hours up until 48 hours after pulse (Keeling et al. 2018). 
RPE cells are able to phagocytose porcine POS also in vitro. The three RPE lines tested 
(hESc-RPE, Lonza hRPE and pRPE) were shown able to internalize POS and process them 
(Figure 3. 29 Figure 3. 30 and Figure 3. 31, respectively). Whilst studies concerning POS 
renewal in animal models suggest a circadian burst of POS digestion by the RPE (Young 
1971; Strauss 2005a; Wavre-Shapton et al. 2014), the experiments presented previously 
suggest that RPE cells take more than 24h to process POS, with rhodopsin staining present 
one week after initial pulse. Furthermore, porcine RPE primary culture cells also exhibit 
remaining rhodopsin staining, after being in culture for over two weeks, as depicted in 
Figure 3. 33. This suggests that either RPE cells take more time to fully digest POS than 
previously thought, or that RPE cultured in vitro is not as efficient at processing POS. This 
means the delay could in fact be an artifact caused by culture conditions, comparing to the 
in situ situation. 
On the one hand, the circadian rhythm control of the MiT transcription factors together 
with POS-derived activation of mTORC1 (Luo et al. 2016; Yu et al. 2018) would agree 
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with a daily cycle of POS degradation. On the other hand, a morning boost of lysosomal 
function doesn’t necessarily mean that all rhodopsin is processed and some might remain 
in the RPE. In theory, as the RPE ages and lysosomal function decays, more rhodopsin 
would accumulate each day, undegraded, disturbing RPE function in the long-run. 
Curiously, hESc-RPE were able to process rhodopsin faster than Lonza hRPE and pRPE. 
Specifically, hESc-RPE rhodopsin staining is almost negligible after 24h, while in Lonza 
hRPE it starts to become fainter after 1 week and in pRPE remains even after excising the 
RPE from the pigs’ eyes and leaving them in culture, without additional POS feeding. 
These “degradation efficiency” differences may be related to intrinsic characteristics of the 
cells and culture conditions (medium composition, etc), but they could also result from the 
fact that porcine cells are adult RPE, which were already subjected to a lifetime of POS 
digestive burden. On the other hand, not all porcine RPE cultures present RET-P1 IF 
staining before POS feeding, as evidenced by Figure 3. 31, which argues for variability 
among pools of cells in primary cultures. 
Regarding POS-derived autofluorescence, microscope images and flow cytometry 
analysis of autofluorescent cells suggest a correlation between POS feeding and 
manifestation of autofluorescent structures, in a dose and time-dependent manner (Figure 
3. 33 and Figure 3. 34). Opposed to rhodopsin IF staining, which is readily visible at time 
0, autofluorescence appears only hours after POS feeding (Figure 3. 33). This is consistent 
with autofluorescence occurring as the result of POS processing by lysosomal digestion. In 
fact, analysis of rhodopsin staining and autofluorescence in the same cells suggests that 
autofluorescence emmerges from RET-P1-surrounded vesicles, i.e. phagosomes/ 
phagolysosomes labeled for rhodopsin exhibit autofluorescent material in their center. POS 
preparations contain lipids and proteins other than rhodopsin, which can also account for 
the autofluorescent granules. 
Autofluorescence detection in hESc-RPE has proven difficult to observe, possibly 
because these cells are heavily pigmented. Pigmentation in this case may be masking the 
subtle effect of autofluorescence resultant from POS accumulation, as assessed in the other 
RPE lines. One way to circumvent this would be to avoid pigmentation in hESc-RPE, for 
instance by using Tyrosinase inhibitors. Still, a consistent increase of POS 
autofluorescence was detected, whether in Lonza hRPE or pRPE, following POS pulse. 
This suggests autofluorescence as a byproduct of POS processing, but further 
characterization of the autofluorescent granules is necessary, to confirm their origin. 
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CHAPTER 4 
Chloroquine-induced hESc-RPE 
Model of Lysosomal Dysfunction 
 
Chapter 4 focuses on the establishment and characterization of a lysosomal dysfunction 
model, as a way of reproducing RPE degenerative features, particularly in the case of 
AMD. This model of disease was attained by treating human Stem Cell-derived Retinal 
Pigment Epithelium cells, previously characterized, using Chloroquine as the lysosome 
dysfunction-inducing agent. 
 
4.1	Significance	of	Lysosomal	pH	
Regulation of lysosomal pH has been extensively studied and its importance for 
different cellular functions definitely proven (Kissing et al. 2015; Hughes & Gottschling 
2012; Miao et al. 2015; Davidson & Vander Heiden 2017; Appelqvist et al. 2013). In fact, 
lysosomal re-acidification strategies have been proposed to contribute to solving a number 
of chronic pathologies (Bourdenx et al. 2016; Folts et al. 2016; Trudeau et al. 2016; Lööv 
et al. 2015). On the other hand, it is important to keep in mind that overly acidic pH may 
also have detrimental effects. This has been proposed to be the case of chronic 
inflammatory disorders, such as Systemic Lupus Erythematosus (SLE) and Rheumatoid 
Arthritis (RA) (Al-Bari 2015). Still, the mechanisms involved in lysosome pH maintenance 
and the consequences of a pH imbalance on overall lysosomal function and cellular 
homeostasis are poorly characterized. Keeping in mind specific cellular functions, a tight 
pH regulation, dependent on cell type and on cellular needs/states is essential. 
Inhibitors of the V-ATPase, such as Bafilomycin A1 (Baf) or Concanamycin A 
(ConcA), are commonly used to block lysosomal degradative function. They work as 
specific and strong inhibitors of the V-ATPase V0 subunit, virtually stopping the pump’s 
activity (Huss & Wieczorek 2009). An analogous effect can be obtained using weak base 
lysosomotropic agents, such as Chloroquine (CQ) or NH4Cl, and also ionophores, such as 
Monensin  or Nigericin (Florey et al. 2015; Guha, Coffey, et al. 2014; Huotari & Helenius 
2011). Specifically, weak bases diffuse into the lysosome and become trapped upon 
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protonation, accumulating and thereby dissipating the pH, whereas ionophores pump ions, 
in this case against the H+ gradient, dispersing it (De Duve et al. 1974; Guha et al. 2013).  
CQ is widely used as a therapeutic agent, for instance for malaria prevention, cancer 
treatments and to manage auto-immune disorders (Kissing et al. 2017; Wozniacka et al. 
2002). In these cases, CQ’s beneficial effects are thought to come from the increase of 
lysosomal pH and respective downstream effects on antigen processing and Toll-like 
receptor signaling. Particularly, CQ is thought to facilitate a decrease of auto-antigenic 
peptide loading and also to downgrade Cathepsins B and D activity, thus reducing MHC 
class II processing (Al-Bari 2015). However, despite its therapeutic potential, CQ was 
found to induce retinopathy as a side-effect of prolonged administration (Tanga et al. 2011; 
Bergstrom & Garcia-Valenzuela 2009; Korah & Kuriakose 2008; Biccas Neto & Mesquita 
2009; Fung et al. 2007; Kellner et al. 2008). Currently, other CQ-based pharmaceutical 
formulations are prescribed, namely hydroxychloroquine (HCQ). HCQ is thought to work 
in a similar manner as CQ, but with reduced toxicity (Al-Bari 2015; Sundelin & Terman 
2002). 
 
4.1.1	Understanding	Chloroquine-induced	Retinopathy		
From a research perspective it is interesting to note that CQ-induced retinopathy shares 
clinical features with other retinal degeneration disorders, particularly AMD. These 
features include: retinal thinning (Bergstrom & Garcia-Valenzuela 2009; Korah & 
Kuriakose 2008; Kellner et al. 2008), multilamellar structures within the RPE (Tanga et al. 
2011), RPE atrophy (Biccas Neto & Mesquita 2009; Fung et al. 2007), photoreceptor loss 
(Bergstrom & Garcia-Valenzuela 2009; Kellner et al. 2008; Korah & Kuriakose 2008) and 
lipofuscin-derived autofluorescence (Kellner et al. 2008). Moreover, studies using animal 
models corroborate this parallel between CQ-induced retinopathy and AMD. In fact, 
prolonged administration of CQ (from one week up to four months) causes mice, rats and 
cats to develop deposits in the Bruch’s membrane and photoreceptor loss (Peters et al. 
2006; Ivanina et al. 1983; Lezmi et al. 2013). Furthermore, rhesus monkeys develop CQ-
induced retinopathy, with macular degeneration, similar to human patients (Rosenthal et 
al. 1978). 
The mechanism by which CQ exerts its effect is not completely understood. The highest 
concentrations of CQ ensue in melanin-containing cells and reportedly the RPE from the 
macula region concentrates a peak of melanin density (Rimpelä et al. 2017). Thus it is 
within reason to consider RPE degeneration as a primary event, leading to secondary loss 
of neural retina and consequent visual impairment (Rimpelä et al. 2016). Findings from 
RPE cell models seem to agree on the increased toxicity caused by pigment-affinity and 
consequent accumulation of CQ (Guha, Coffey, et al. 2014; Mannerström et al. 2002). 
Typically, studies of primary RPE cultures and RPE cell lines treated with CQ report 
intracellular vacuolization (Chen et al. 2011; Kaufmann & Krise 2008), increased pH 
(Coffey et al. 2014; Lu et al. 2017; Guha et al. 2013), autophagy substrates accumulation 
(p62/ and LC3 II) (Wu et al. 2017; Song et al. 2016; Sanjuan et al. 2007; Coffey et al. 2014; 
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Lu et al. 2017; Szatmári-Tóth et al. 2016; Zhan et al. 2016), inhibited phagocytic and 
endocytic degradative function (Song et al. 2016; Liu et al. 2008; Guha, Coffey, et al. 2014; 
Chen et al. 2011; Guha et al. 2012), increased autofluorescence (Lei et al. 2017; Guha et 
al. 2013; Guha et al. 2012), lysosomal exocytosis and increase in membrane permeability 
(Beckel et al. 2018; Korthagen et al. 2015). Additionally, few studies regarding RPE CQ-
exposure report increase of Cathepsin activity, followed by the expected decrease, upon 
dosage escalation (Toimela et al. 1995).  
 
4.1.2	Modeling	CQ-induced	Lysosomal	Dysfunction	
Cellular responses may vary dramatically with different drug concentrations, exposure 
times and also with the cells’ own features and states. In this chapter experiments 
undertaken considering relative low dosages of CQ are reported, and at three extensive 
time points, comparing to most in vitro studies (Mahon et al. 2004; Sundelin & Terman 
2002; Yu et al. 2018; Wu et al. 2017; Lu et al. 2017; Liu et al. 2008; Guha et al. 2012; 
Szatmári-Tóth et al. 2016; Chen et al. 2011; Zhan et al. 2016; Beckel et al. 2018; Rimpelä 
et al. 2016; Korthagen et al. 2015; Mannerström et al. 2002). 
A strong hypothesis for the mechanism behind early CQ-induced retinopathy events is 
lysosomal dysfunction (Mahon et al. 2004; Coffey et al. 2014). Still, lysosomal dysfunction 
is generally considered as a broad concept, difficult to underpin and modulate. Lysosomes 
provide essential functions from phagocytic turnover of POS to recycling of intracellular 
components and even ECM maintenance. All these tasks require macromolecules to travel 
through the endocytic pathway, trafficking from endosomes to late endosomes, followed 
by transient or complete fusions between late endosomes and lysosomes. These processes 
are generally accompanied by a decrease of pH, necessary for acid hydrolase activity and 
consequent degradation of their substrates. To add complexity to the system, lysosomes 
tightly associate to transcriptional regulation of cellular metabolism, as described in 
Chapter 1. 
The work developed herein aims to clarify critical aspects of RPE cell biology and of 
lysosomal activity, and in particular establish hESc-RPE as a reliable model to study retinal 
degenerative disease. To this effect, cells were subjected to CQ for prolonged periods of 
time and a detailed characterization of this models’ lysosomal functions is presented. In 
particular, this chapter reports how hESc-RPE cells respond to acute (overnight), continued 
(three days) and chronic (one week) CQ insults. 
For the experiments presented herein, Rapamycin (Rap) and Bafilomycin (Baf) were 
used as controls. On the one hand, Rap is an mTORC1 inhibitor, therefore promoting 
autophagy and lysosomal biogenesis; on the other hand, Baf is a V-ATPase inhibitor, thus 
preventing lysosomal degradation. As such, Rap is considered a positive control and Baf 
is the negative control, regarding active lysosomal function. 
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4.2	Chloroquine	titration	-	LDH	viability	assays	
Newly established hESc-RPE lines were first tested for viability, when treated with 
different concentrations of CQ. Porcine RPE (pRPE), obtained from primary cultures, as 
well as the Lonza hRPE were tested in parallel and compared to hESc-RPE. 
Measurement of lactate dehydrogenase (LDH) enzyme released into the media was 
used as a read-out of damaged cells and cytolysis. CQ’s cytotoxicity corresponds to higher 
absorbance readings and, in this case, analysis was always carried out considering values 
relative to the mean of control non-treated (NT) cells. 
The first approach taken consists on assessing viability for an acute overnight treatment, 
as described in the Materials and Methods (Chapter 2). Briefly, cells were fed with porcine 
POS for 4h, in order to load the lysosomes, followed by an overnight incubation with CQ-
containing medium at different concentrations; medium was collected the following day 
and secreted LDH activity was quantified (Figure 4. 1). 
 
Figure 4. 1 - Chloroquine toxicity evaluation for the three RPE lines indicated, upon an overnight drug treatment, 
assessed by LDH activity determination. The three cell lines exhibited different sensitivities to the overall 
concentrations used (1-50 µg/mL). Absorbance values are considered as relative to NT control mean value, for each of 
the cell lines used and thus presented as fold change, relative to NT (1x fold). Results are expressed as mean ± s.d. and 
n≥3 (**p<0.01; ***p<0.001; ****p<0.0001). 
 
The three different RPE lines were incubated with CQ concentrations ranging from 1 
to 10µg/mL, in the case of pRPE, and 1 to 50µg/mL, in the case of human RPE. Lower 
concentrations of CQ induced reduced cytotoxicity (approximately a 2x fold increase of 
LDH release); CQ at 5µg/mL (CQ5) induced a significant increase of LDH release to the 
medium (4x fold increase) in pRPE cells, while in hRPE it did not have a significant 
increase, but instead caused a slight decrease in the case of Lonza hRPE. CQ at 10µg/mL 
(CQ10) led to significant pRPE cell death (6x fold LDH increase), whereas hRPE lines 
were able to withstand it, similarly to CQ5. For both human RPE lines, the threshold was 
higher, resisting up to CQ25, in the case of Lonza hRPE (9x fold), and CQ50, for hESc-
RPE (11x fold). It is relevant to note that even at CQ50, a mean 11x fold increase (Figure 
4. 1) does not mean that all hESc-RPE cells died as a result of the overnight treatment. In 
fact, in some cases cells were able to survive for three days with no apparent changes in 
morphology or adherence (as assessed by observation under light microscopy). 
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Observations on the microscope corroborated the LDH results (data not shown): pRPE 
cells were visibly affected by 10µg/mL of CQ overnight, dissociating the monolayer and 
detaching from the wells. On the other hand, hRPE cells seemed visibly affected as a result 
of the overnight treatment only when CQ was given at 50µg/mL; in particular, they became 
darker and ultimately detached, disrupting the monolayer. In any case, the overall goal of 
this titration was to understand the range of concentrations which would be useful for 
treatment of cells in a more chronic way, i.e. continuing treatment of the cells with CQ for 
several days, using under-lethal concentrations. 
In order to recapitulate a continued insult and maintenance of the dysfunctional 
lysosome, cells were treated repeatedly with daily POS feedings followed by overnight 
incubations with CQ, for a three-day period. After the third overnight incubation of CQ, 
the medium was recovered and analyzed for LDH activity (Figure 4. 2). 
 
Figure 4. 2 - hESc-RPE, Lonza-hRPE and pRPE viability, following 3 days of CQ treatment, assessed by LDH activity 
determination. CQ was considered to have cytotoxic effects for porcine cells at 5 and 10µg/mL. Absorbance values are 
considered as relative to NT control mean value, and thus representing fold change, relative to NT (1x fold). Results 
are expressed as mean ± s.d. and n≥3 (****p<0.0001). 
 
All three cell lines displayed similar LDH absorbance levels relative to control (NT) 
cells, for the lower concentrations of CQ (CQ1, CQ2.5) at the third day of CQ stimulus 
(Figure 4. 2). When CQ5 and CQ10 were used, a similar result was obtained for both human 
RPE lines: LDH levels stabilized to match controls; however, these concentrations were 
too high for pRPE, with significant cell death at day 3 (4x fold) (Figure 4. 2). 
The main objective of this experiment was to assess if the cytotoxicity would become 
more severe after continued incubations. For this reason, it is worth mentioning that the 
medium was collected on a daily basis, meaning that the results displayed represent LDH 
released during the third day of treatment only and not the accumulated LDH over a three-
day period. 
 
In an effort to recapitulate the effects of chronic lysosome dysfunction, cells were 
subjected to a week-long treatment of CQ. A cumulative burden of CQ is expected to 
increase cytotoxicity over time. On the other hand, it is important to verify whether cells 
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are able to adapt to the first days of insult, i.e. if there is selection of the cell population, 
resistant to the hostile environment. In any case, experimental conditions were pondered 
based on viability studies, as described before. Briefly, cells were subjected to an everyday 
feeding of POS, for 4h, followed by replacement of the culture medium to that containing 
the different concentrations of CQ. Again, medium was collected every day, for seven 
consecutive days, and LDH secretion was evaluated for each day (not cumulatively), for 
all of the RPE lines used. Results are shown separately for each RPE line, for better 
visualization (Figure 4. 3, Figure 4. 4 and Figure 4. 5). 
The results obtained for LDH release by hESc-RPE cells treated with CQ, repeatedly, 
for a week, are presented in Figure 4. 3. 
 
Figure 4. 3 - hESc-RPE viability, after being submitted to a week-long CQ treatment, assessed by LDH activity 
determination. During days 1 and 2, there was modest increase of LDH release to the medium (2x fold) for the whole 
range of CQ concentrations used. Absorbance values are considered as relative to NT control mean value, and thus 
presented as fold change, relative to NT (1x fold), for each day. Results are expressed as mean ± s.d. and n≥3 (*p<0.05; 
**p<0.01; ***p<0.001). 
 
hESc-RPE was able to withstand CQ for the whole one-week period, without showing 
evidence of cytotoxicity with the tested concentrations. There was an increase (2x fold) of 
LDH release in the first two days of the experiment, with no observable changes to cell 
morphology or adherence. These LDH secretion values returned to matching NT controls, 
with minimal oscillations thereafter (Figure 4. 3). 
A tentative pattern seems to emerge, where the first day of insult results in a modest 
increase of LDH release, followed by a period of stabilization and return to control values, 
more obvious when looking at 10µg/mL (CQ10). This can be interpreted as a two-phased 
response to CQ: on the first two days, the LDH in the medium may increase due to death 
of more sensitive or damaged cells; the majority of cells, however, survives this first 
selective phase and thus LDH release is kept at control levels for the remaining days; this 
was confirmed by light microscopy observations, which revealed cells did not lose their 
monolayer configuration. If the experiment were to be prolonged for more time, one could 
speculate that the chronic stressor would ultimately cause the cells to succumb (there is a 
slight increase of LDH release at day 7, although too modest to consider relevant 
cytotoxicity). However, the purpose of the experiment was precisely to cause a chronic 
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non-lethal environment, thus CQ concentrations were kept at relatively low levels and these 
experiments were not followed further. 
Ultimately, LDH release by hESc-RPE is not significantly altered throughout the week-
long CQ treatment, meaning cells are able to survive and manage the insult.  
LDH release after a week-long CQ treatment of Lonza hRPE (Figure 4. 4). 
 
Figure 4. 4 - Lonza hRPE viability, after being submitted to a week-long CQ treatment, assessed by LDH activity 
determination. There was a modest increase of LDH in the medium for cells treated with lower CQ concentrations (1.7x 
fold for CQ1, 1.9x fold for CQ2.5). Absorbance values are considered as relative to NT control mean value, and thus 
presented as fold change, relative to NT (1x fold). A significant difference was found between the NT cells, at day 7 
(**); nevertheless, the medium collected each day was compared to its respective NT condition, for the statistical 
analysis. Results are expressed as mean ± s.d. and n≥3 (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
 
LDH release, in the case of Lonza hRPE, is not expressively altered throughout the 
range of CQ concentrations and for the whole experiment. There were slight oscillations in 
the absorbance values obtained, but always less than a 2x fold change (Figure 4. 4). For 
this reason, these concentrations of CQ were considered not to exert acute toxic effects on 
Lonza hRPE cells. Again, after the first days, LDH levels returned to control (NT) levels, 
or even lower (0.6x fold) (Figure 4. 4). 
Finally, medium from pRPE submitted to the same CQ regimen was also collected and 
LDH secretion was evaluated during the parallel experiment (Figure 4. 5). 
 
Figure 4. 5 - pRPE viability, upon week-long CQ treatment, assessed by LDH activity determination. Cytotoxicity was 
verified for higher concentrations of CQ (4x to 6x fold increase of LDH). Absorbance values are considered as relative 
to NT control mean value, and thus presented as fold change, relative to NT (1x fold), for each day. Results are 
expressed as mean ± s.d. and n≥3 (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
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pRPE cells are more sensitive to CQ, comparing to both human cell lines (Figure 4. 3, 
Figure 4. 4 and Figure 4. 5). Hence, porcine cells exposed to higher concentrations of 
5µg/mL (CQ5) or 10µg/mL (CQ10) died during the experiment. This is readily visible by 
the increase of LDH found in the medium: CQ5 caused the cells to release 4x fold more 
LDH than control cells (NT) on the first day, while CQ10 caused a 6x fold increase. While 
for CQ5 LDH release remained relatively high until day 4 and decayed thereafter, for CQ 
10 LDH values continuously declined from the first day, until the end of the experiment 
(Figure 4. 5). This decline of LDH values can be attributed to cell death: as the experiment 
continues, and cells under higher CQ burden perish, there are less and less cells in the well 
and therefore fewer LDH secretion each day. This is consistent with observations by light 
microscopy (data not shown), which revealed cells detaching from the wells with 
disruption of the monolayer, interpreted as evidence of damage and death, when using 
higher concentrations of CQ. 
Considering lower concentrations (CQ1 and CQ2.5), there is a first increase in LDH 
release to the medium, comparing to NT controls, whereas LDH levels remained steady 
(similarly to hRPE). This relatively minor increase (2x fold) in LDH release was not 
accompanied by evident cell death, and for this reason these relatively soft fluctuations 
were attributed to more sensitive/ already damaged cells. Again, alike in hRPE cells, the 
first LDH increases gave rise to a stabilization to control levels (Figure 4. 5). 
Ideally, measurement of LDH secreted to the medium would be accompanied by 
measurement of intracellular LDH, in order to assess the proportion and extrapolate the 
values to “dead cells” versus “living cells” remaining in the well. However, this would 
require the use of a significantly higher amount of cells, to be collected on a daily basis. 
Nevertheless, based on these preliminary experiments, the aim of the experiment was 
achieved and it was possible to assess the range of under-lethal concentrations to be used 
in the following sections. 
 
4.2.1	Chloroquine-induced	Pigmentation	Modifications	
A curious finding of these CQ early experiments was the pigmentation change that cells 
underwent. Specifically, as time progressed, pigmentation became evident to the naked 
eye, and in accordance to CQ concentration: the higher the concentration, the darker the 
well. This effect was not always detected in Lonza hRPE nor in pRPE, but readily visible 
in hESc-RPE (Figure 4. 6). 
A feature of the newly established hESc-RPE is the fact that these cells continue to 
produce pigment, developing an obvious dark tone, after a month of maturation. Here, 
however, cells were left to mature for only two weeks before the tests, which means cells 
were pigmented, but not very dark, at the beginning of the experiment. hESc-RPE cells 
treated with the highest concentrations of CQ (25µg/mL and 50µg/mL) experienced 
pigmentation changes more promptly and displayed a darker shade (Figure 4. 6). 
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Figure 4. 6 - hESc-RPE exhibit pigmentation changes, when treated with CQ for 1 week (A) or 3 days (B). Cells exhibit 
apparent color intensification, proportional to the CQ concentrations, as indicated on the multiwell plate, and duration 
of treatment. Photograph depicts observation of a multiwell plate, by the naked eye. 
 
Although pigmentation was not objectively measured and quantified, this visual effect 
does not necessarily mean that cells are producing more pigment. In fact, another 
explanation for this result could be the aggregation/accumulation of pigment, causing it to 
become more readily visible. Furthermore, this color change is also observed when cells 
are treated with Baf (data not shown), indicating a direct correlation between pigmentation 
and lysosomal pH. This relationship has already been studied by other researchers, in 
different contexts, substantiating the relevance of such effects namely in hESc-derived RPE 
(Juuti-Uusitalo et al. 2017). 
These findings were not further explored at this time, despite the apparent correlation 
between retinal degenerative disorders and pigmentation anomalies in the RPE. 
Particularly, pigmentation is thought to have a protective role and the risk of AMD 
development and progression correlates inversely with macular pigment optical density 
(Arunkumar et al. 2018). On the other hand, the MiT family of TFs actively regulates 
pigmentation, with MITF being at the heart of many RPE specification and pigmentation 
studies (Steingrímsson et al. 2004; Bharti et al. 2012; Fuhrmann et al. 2014). Consequently, 
it is not surprising that there is a correlation between lysosomal dysfunction and pigment 
changes in the RPE and, despite this being outside the scope of the present work, it opens 
interesting avenues for future work. 
Considering previous results regarding detection of autofluorescence, either by 
microscopy or flow cytometry (Figure 3.33 and Figure 3.34), together with the 
pigmentation-related data (Figure 4.6), some reflections are due. Specifically, in hESc-
RPE, autofluorescence was found to be inherently high, compared to Lonza hRPE or pRPE. 
This feature was attributed precisely to pigmentation because, contrary to the others, when 
hESc-RPE are dissociated and collected as a cell pellet, it is dark to the naked eye (not 
shown). For this reason, when cells were analyzed by flow cytometry, detection threshold 
did not allow visualization of CQ- or POS-derived autofluorescence (Figure 4. 7). 
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Figure 4. 7 - (Auto)fluorescence detection in hESc-RPE, by flow cytometry. A: autofluorescence histogram overlap 
between non-treated hESc-RPE, POS-fed hESc-RPE, CQ10- and CQ25-treated cells; autofluorescence detection ≤1% 
of cells per condition. B: Bodipy CatD fluorescence histogram showing non-treated hESc-RPE unstained, non-treated 
hESc-RPE stained with Bodipy CatD and POS-fed hESc-RPE stained with Bodipy CatD; fluorescence detection ≥99% 
of cells per conditions. n=20.000 cells acquired for each condition represented. 
 
CQ autofluorescence or POS autofluorescence alone were not present at detectable 
levels. In particular, only 1% of cells were found autofluorescent over the detection limit 
(Figure 4. 7 A). In comparison, acquisition of fluorescent dyes (presented in the following 
sections) was easily detected. In fact, Bodipy CatD fluorescence, in the same 488nm 
channel, is represented by a completely different peak in the respective histogram (Figure 
4. 7 B). Based on these preliminary results, a possible interfering effect of either CQ or 
POS on background fluorescence was disregarded in following experiments. In fact, 
Bodipy CatD fluorescence was much more intense and over 99% of cells were brightly 
labeled (Figure 4. 7). When considering the remaining dyes (DQ-BSA, Magic Red or 
Lysotracker), fluorescence was detected in both the 568nm and 647nm channels, showing 
similar profiles (data not shown). In the end, the data were analyzed in the 647nm, to avoid 
bleed through from visible light spectrum. Therefore, although CQ or POS 
autofluorescence may interfere with the results, it is expected that the error found is similar 
for all samples analyzed and small, relatively to the bright fluorescence detected when 
using these dyes. 
Finally, an experimental layout was established by setting a timeline and a range of 
non-lethal concentrations, and by considering experimental limitations. Cellular responses 
to an acute, continued and chronic lysosomal dysfunction was recapitulated and the overall 
features of this disturbance were thoroughly characterized, and are discussed in the 
following sections. 
 
4.3	Chloroquine-induced	MiT	TFs	Nuclear	Translocation	
The MiT family of TFs are major players in control of lysosomal function. These TFs 
are responsible for the regulation of lysosomal hydrolases necessary for substrate 
degradation, of membrane proteins which mediate lysosome fusion, and of components of 
the V-ATPase complex, responsible for lysosomal acidification. In particular, TFEB 
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regulates response to starvation, by targeting autophagy-related genes and regulating 
autophagosome formation and its fusion with the lysosome, as discussed in Chapter 1. 
As described previously, the mammalian target of rapamycin (mTOR), which is part of 
mTOR complex 1 (mTORC1), interacts with TFEB at the lysosomal membrane. This 
interaction occurs when the cell is in homeostatic conditions and leads to phosphorylation 
of TFEB and thus to its cytosolic retention. On the other hand, upon starvation or other 
types of cellular stress, TFEB is no longer phosphorylated and is able to translocate to the 
nucleus and activate autophagy and lysosomal genes. 
Based on these premises, the subcellular localization of TFEB, TFE3 and MITF was 
assessed by immunofluorescence (IF), both in homeostatic conditions and upon challenge 
with CQ. 
In a preliminary experiment, TFEB subcellular localization was evaluated, upon 
overnight treatment of hESc-RPE with 5µg/mL of CQ. The result of this experiment 
demonstrated a clear effect regarding nuclear translocation (Figure 4. 8). 
 
Figure 4. 8 - Acute CQ treatment of hESc-RPE induced TFEB translocation to the nucleus, as evidenced by co-
localization with DAPI nuclear staining, assessed by IF. Scale bar: 10µm. 
 
As depicted, in homeostatic conditions TFEB localizes mostly to the cytoplasm of the 
cell, almost avoiding nuclear localization (Control). On the other hand, under the effect of 
CQ (Overnight CQ5) it translocates to the nucleus, co-localizing notably with DAPI. In 
order to further evaluate this effect, TFEB translocation to the nucleus was quantified, by 
assessing the integrated intensity inside the nuclear area defined by DAPI (Figure 4. 9). 
 
Figure 4. 9 - Acute CQ treatment induced TFEB translocation to the nucleus in hESc-RPE, as determined by selecting 
the nuclear area of random cells (stained with DAPI) and analyzing intensity of TFEB staining within that area, within 
three representative IF images. ****p<0.0001, n=57 and n=58, respectively. 
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A significant difference between non-treated and CQ-treated cells was found; 
specifically, the difference between integrated intensity means was determined as 
approximately 1.5x-fold increase, relative to non-treated cells. For this quantification, a set 
of three representative images was selected for each condition and a total of n=57, n=58 
cells were considered, respectively (Figure 4. 9). 
In subsequent experiments, evaluation of the subcellular localization of TFEB, TFE3 
and MITF was undertaken, in parallel in hESc-RPE incubated with either regular medium 
or medium containing 5µg/mL CQ, overnight (Figure 4. 10). 
 
Figure 4. 10 - TFEB, TFE3 and MITF translocate and concentrate at the nucleus, upon acute CQ treatment, as evidenced 
by co-localization with DAPI, assessed by IF. Scale bar 10µm. 
 
Although TFEB staining of hESc-RPE is generally faint, it is possible to observe that 
it becomes more distinct at the nuclear area, upon CQ treatment. This difference is more 
noticeable in TFE3 staining, which is dispersed in control cells and concentrated at the 
nuclear region in CQ-treated cells. As for MITF staining, it is found in the nuclear region 
both in control and in CQ-treated cells, but again, becomes more concentrated in the 
nuclear area (Figure 4. 10). 
After 3 days of CQ treatment of hESc-RPE cells, TFEB, TFE3 and MITF subcellular 
localization was evaluated again, by IF. Medium was changed every day: control cells with 
fresh regular medium, CQ-treated with medium containing 5µg/mL CQ (Figure 4. 11). 
 
Figure 4. 11 - TFEB, TFE3 and MITF translocate to the nucleus upon treatment with 5µg/mL CQ, for three consecutive 
days, as evidenced by co-localization with DAPI, assessed by IF. Scale bar 10µm. 
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After three consecutive days of treatment, it is possible to notice an intensification of 
the staining at the nuclear area, for TFEB and TFE3. As for MITF, the difference between 
non-treated and CQ-treated cells is less evident (Figure 4. 11). 
The consecutive treatments continued, as formerly described, and intracellular 
localization of the three TFs was evaluated after seven days of treatment (Figure 4. 12). 
 
Figure 4. 12 - TFEB, TFE3 and MITF subcellular localization is severely changed upon treatment with 5µg/mL CQ, 
for seven consecutive days (1 week), as evidenced by co-localization with DAPI, assessed by IF. Scale bar 10µm. 
 
Strikingly, after one week of 5µg/mL CQ treatment, TFEB, TFE3 and MITF stainings 
are spread throughout the whole cell (cytoplasm and nuclei). Only the cell membrane is 
left unstained, emphasizing the typical RPE monolayer polygonal shape Figure 4. 12. 
Interestingly, regarding the control cells and comparing overnight (Figure 4. 10) to the 
third day (Figure 4. 11), translocation of the three TFs to the nucleus seems to be induced 
merely by the change of regular fresh medium, without CQ. One week of media change 
every day, in the control situation (Figure 4. 12), also induces nuclear translocation of the 
TFs, when compared to the overnight-treated control cells (Figure 4. 10), but apparently 
not more than the three-day control cells (Figure 4. 11). A recent study identified that 
HEPES, a buffering compound commonly used in cell culture media, induces lysosomal 
biogenesis (Tol et al. 2018). For this reason, it is important to reflect carefully on the 
conclusions drawn from these results and to consider potential confounding effects. On the 
other hand, it is not surprising to find MITF in the nuclear area (even in cells that were not 
treated with CQ) because this TF is involved in pigmentation. MITF regulates expression 
of Tyrosinase and TRP1, for instance, which are required for pigmentation. As described 
in Chapter 3, hESc-RPE are continuously pigmenting, possibly even more so when 
subjected to CQ treatment (Figure 4. 6). 
Regardless, the addition of CQ to the media seems to increase the nuclear area intensity 
of the stainings, comparing to the control for the same time points, in the overnight and the 
third day situations. After one week, the staining pattern is completely altered, occupying 
the whole cell (Figure 4. 12). A chronic CQ insult possibly causes upregulation of these 
TFs, suggesting a cellular stress-response. Additionally, the fact that these TFs localize 
both to the cytoplasm and to the nucleus suggests inactivation of mTOR, pointing to defects 
in lysosome reformation, as discussed in Chapter 1. 
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Together, these IF results suggest there is potential induction of lysosomal biogenesis, 
more pronounced at the third day of insult than in the overnight treatment, followed by 
lysosomal dysfunction induced by chronic CQ burden. 
 
4.4	CQ-induced	Impairment	of	Phagocytic	Cargo	Digestion	
When treated with CQ, cells are expected to have impairment of their degradative 
ability. This damage is anticipated to become more severe for extended periods of drug 
regimen. The degradative function of lysosomes was evaluated in the same conditions of 
CQ treatment as in the previous experiments. Specifically, in order to verify lysosomal 
dysfunction and consequent degradative deficiency, POS digestion was followed again, for 
the different time points, in hESc-RPE cells treated with CQ. 
Unless otherwise indicated, POS feedings were ensued using 200µg/mL working 
concentration. This concentration was chosen based on the ability of hESc-RPE to digest 
them within the timeframe evaluated in previous experiments (Chapter 3). POS degradation 
was directly measured, using anti-Rhodopsin antibodies, as previously. 
Control cells (without CQ) present RET-P1 positive particles, similar to those found in 
previous experiments, and almost no 1D4 staining, consistent with the fact that 1D4 epitope 
is lost during early phagosome maturation, as assessed by IF staining of rhodopsin, after 
overnight incubation of hESc-RPE with CQ. CQ-treated cells also present RET-P1 staining 
and, interestingly, seem to exhibit more 1D4 staining than control cells, indicating presence 
of early phagosomes even after overnight chase (Figure 4. 13). 
 
Figure 4. 13 - POS accumulation, when hESc-RPE are treated with CQ overnight and depending on drug concentration 
(1-5µg/mL). Rhodopsin IF staining, using anti-RET-P1 and 1D4 antibodies and DAPI for nuclei labeling. Scale bar 
10µm. 
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Accumulation of POS by hESc-RPE cells is aggravated when cells are subjected to 
higher CQ concentrations, namely when treated with 10 and 25µg/mL CQ overnight 
(Figure 4. 14). 
 
Figure 4. 14 - POS accumulation becomes more evident upon treatment with higher CQ concentrations. Rhodopsin IF 
staining, using anti-RET-P1 and 1D4 rhodopsin antibodies and DAPI for nuclei labeling, after treatment with CQ at 10 
and 25µg/mL. Scale bar 10µm. 
 
At higher CQ concentrations, not only 1D4 epitope remains readily visible after 
overnight chase, but also RET-P1 accumulation is easily detected (Figure 4. 14). 
Interestingly, the pattern of rhodopsin staining (using both antibodies) seems different. In 
particular, RET-P1 stains donut-shaped enlarged compartments, resembling those found in 
Lonza hRPE (Figure 3.33); alike previously discusses, this could be indicative of an active 
degradative compartment consisting of an autofluorescent granule within RET-P1-labeled 
vesicle. In fact, autofluorescence bleed-through to the DAPI channel is visible, in this 
particular case (Figure 4. 14). Regarding 1D4 rhodopsin staining, it is focused within 
perinuclear early phagosomes. Still, in experiments with higher concentrations of CQ there 
is generally increase in background autofluorescence, precluding a more detailed analysis 
(Figure 4. 14). 
Furthermore, images acquired in these conditions were evaluated for rhodopsin staining 
intensity (Figure 4. 15). 
 
Figure 4. 15 - Quantification of POS accumulation, with increasing CQ concentrations, upon hESc-RPE acute 
treatment. Fluorescence was quantified for each condition, with each dot representing a different IF image’s mean 
fluorescent integrated intensity as fold increase, compared to control (NT) cells using anti-RET-P1 and anti-1D4 
antibodies. Results are expressed as mean ± s.d. from independent images, n³2 (* p<0.05, **p<0.01; ****p<0.0001). 
  86 
By analyzing image quantification, it becomes obvious that RET-P1 epitope is retained 
after overnight chase, in cells treated with high CQ concentrations 10 and 25µg/mL, as 
previously shown in representative images (Figure 4. 14). Regarding 1D4 epitope, it is also 
retained in the cells, when treated with CQ. In some images of cells treated with lower CQ 
dosages (2.5 or 5µg/mL), the staining’s mean integrated intensity is higher than in control 
cells. However, different image fields and images obtained from different experiments 
using these same concentrations present similar intensity to that of control cells. For this 
reason, statistical significance was only found when looking at higher CQ concentrations, 
10 and 25µg/mL (Figure 4. 15). 
Next, hESc-RPE were treated with CQ in a continued manner, and analyzed again for 
their ability to process phagocytic cargo. In order to continuously load the lysosome, cells 
were fed POS on a daily basis, for 4h, followed by overnight incubation in CQ-containing 
medium, during 3 consecutive days. Representative IF images of RET-P1 and 1D4 
stainings are presented in Figure 4. 16. 
 
Figure 4. 16 - hESc-RPE treated with CQ for three consecutive days accumulate more rhodopsin than control cells. 
hESc-RPE rhodopsin IF staining, using anti-RET-P1 and 1D4 antibodies and DAPI for nuclei labeling, after continued 
CQ treatment. Scale bar 10µm. 
 
After three days of POS feeding and overnight incubation with regular medium (control 
situation), hESc-RPE accumulate more RET-P1-positive vesicles than control cells which 
were fed only once (Figure 4. 14). 1D4 epitope continues to be readily processed by control 
cells and, therefore its staining is inconspicuous. Upon CQ treatment, RET-P1 positive 
vesicles become more evident and 1D4 staining remains visible in the cells (Figure 4. 16). 
Quantification of representative images was performed and is depicted in Figure 4. 17. 
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Figure 4. 17 - Quantification of POS accumulation, with increasing CQ concentrations, upon hESc-RPE continued 
treatment with CQ at 1-10 µg/mL. Each dot represents a different IF image’s mean fluorescent integrated intensity as 
fold increase, compared to control (NT) cells using anti-RET-P1 and 1D4 antibodies. Results are expressed as mean ± 
s.d. from independent images n³3 (* p<0.05, **p<0.01). 
 
Accumulation of rhodopsin in CQ-treated cells occurs in a concentration-dependent 
manner, as assessed by RET-P1 staining. However, 1D4 staining is not altered upon 
treatment. One explanation could be that at low concentrations, CQ does not interfere with 
early phagosomes (1D4), but only affects phagolysosome processing, as RET-P1 labels 
early to late phagosomes (Figure 4. 17). 
hESc-RPE were also subjected to a week-long treatment of CQ, similarly to previous 
experiments. Rhodopsin staining with RET-P1 and 1D4 antibodies  were performed 
(Figure 4. 18). 
 
Figure 4. 18 - POS accumulate as the result of chronic treatment with CQ (1-5µg/mL) for seven consecutive days, when 
comparing to control. hESc-RPE rhodopsin IF staining, using anti-RET-P1 and 1D4 antibodies and DAPI for nuclei 
labeling. Scale bar 10µm. 
  88 
Cells fed with POS and treated with CQ for one week render accumulation of 
rhodopsin-positive vesicles, whether stained with RET-P1 or 1D4 antibodies. Comparing 
Figure 4. 16 to Figure 4. 18, there seem to be fewer phagosomes in the cells, after a week 
of treatment, but those that are present are larger in size and have brighter intensity. 
Regarding 1D4 staining, it is almost unnoticeable in control cells, but readily visible in CQ-
treated cells, indicating impairment of early phagosome processing. 
Quantification of images obtained using the same conditions is shown in Figure 4. 19. 
 
Figure 4. 19 - POS accumulate, in hESc-RPE cells, upon chronic treatment with CQ 5µg/mL. Each dot represents a 
different IF image’s mean fluorescent integrated intensity as fold increase, compared to control (NT) cells, using anti-
RET-P1 and 1D4 antibodies. Results are expressed as mean ± s.d. from independent images n³3 (* p<0.05, 
***p<0.001). 
 
One week of CQ treatment leads to accumulation of RET-P1 and 1D4-labeled 
structures in hESc-RPE cells. In the case of RET-P1 staining, it also accumulates in control 
cells (Figure 4. 18), suggesting not all rhodopsin is processed over a 24h period, which is 
consistent with Figure 3.30. However, when comparing intensity of the staining, it is at 
similar levels to those of CQ-treated cells, for concentrations 1 and 2.5µg/mL. At 5µg/mL 
of CQ, however, RET-P1 staining is more intense than that found in control cells, for the 
same time point. Regarding 1D4 staining, results indicate that there is significantly more 
labeled rhodopsin, when cells are treated with CQ at 1µg/mL and at 5µg/mL. This means 
CQ hinders processing of early phagosomes, which remain in the cell for longer, comparing 
to control (NT) cells (Figure 4. 19). 
Altogether, evidence obtained here suggests that rhodopsin-containing phagosomes 
remain within the hESc-RPE cells, rather than being promptly digested. This is true for 
control cells, which were not treated with CQ, indicating that POS are not completely 
digested overnight, accumulating as the result of repeated feedings. It could be the case 
that 200µg/mL of POS is a high concentration, by itself sufficient to elicit a certain degree 
of lysosomal dysfunction, which could worsen over time. When cells are subjected to CQ 
treatment, POS processing is further impaired. High doses of CQ (10 and 25µg/mL) cause 
rhodopsin to accumulate significantly, even in the case of an acute treatment. Although 
there are indications that continued CQ burden may induce lysosome biogenesis (section 
4.3), it is not sufficient to clear rhodopsin-positive structures. This is substantiated by RET-
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P1 staining increase, dependent on CQ concentration, at the third day of treatment (Figure 
4. 16). Finally, after one week of chronic CQ burden, rhodopsin-labeled vesicles are still 
observed in the cells and accumulate significantly, compared to the control cells at the same 
time point. At this point, there is accumulation not only or RET-P1-positive vesicles, but 
also of 1D4-positive ones (Figure 4. 18). This suggests disturbance in early phagosome 
processing, which points to a more severe dysfunction. 
 
4.5	CQ-induced	Impairment	of	Degradative	Ability	
In order to convincingly assess the degradative ability of hESc-RPE cells when 
subjected to CQ burden, cells were given DQ Red BSA™ (DQ-BSA). This tool consists 
on a derivate of bovine serum albumin (BSA), labeled with a Bodipy™ dye, which is 
strongly self-quenched, but becomes dequenched upon breakdown by proteases. For this 
reason, detection of fluorescence, originating from digestion of the BSA conjugates, is 
commonly used to easily monitor intracellular proteolytic activity. 
Degradative ability of hESc-RPE cells was assessed by incubating the cells with 
medium with or without POS, for 4h, followed by overnight incubation in CQ-containing 
medium, at increasing concentrations, to which DQ-BSA red was added. The next day, 
cells were collected and processed for flow cytometry (Figure 4. 20). 
 
Figure 4. 20 - hESc-RPE cells proteolytic ability is not severely altered upon overnight treatment with CQ, assessed by 
DQ-BSA fluorescence evaluated by flow cytometry. The dashed line separates non-fed from POS-fed cells (+POS). 
Each column represents the Mean Fluorescence Intensity fold change, relative to NT cells. Baf at 50nM was used as a 
negative control. N=20.000 cells acquired for each condition represented. 
 
Cells treated overnight with low doses of CQ alone (1µg/mL and 2.5µg/mL) produce 
more DQ-BSA-fluorescence than control non-treated cells. Relative mean fluorescence 
intensity returned to control levels at higher CQ concentrations (5 and 10µg/mL). When 
cells were fed POS (to the right of the dashed line), a similar effect was recorded: modest 
increase of DQ-BSA fluorescence for lower CQ concentrations and return to control values 
for higher CQ dosages. Baf was used as negative control, as it directly inhibits V-ATPase 
activity and effectively prevents DQ-BSA processing; for this reason, Baf-treated cells’ 
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DQ-BSA fluorescence consists the baseline signal, below control NT cells (0.6x fold), as 
expected. 
Overall differences whether or not cells were fed with POS were not substantial, 
suggesting that POS by themselves do not interfere with the cell’s ability to degrade 
substrates (Figure 4. 20). 
A closer look at the DQ-BSA distribution within the cell, by confocal microscopy, and 
the quantification of integrated fluorescence detected in these images allowed for a deeper 
analysis of this readout (Figure 4. 21). 
 
Figure 4. 21 - hESc-RPE degradative ability is not severely impaired by acute CQ treatment, assessed by DQ-BSA 
fluorescence evaluated by light microscopy. A: DQ-BSA distribution in a vesicular pattern, consistent with lysosomes. 
Scale bar 10µm. B: Quantification of representative images; each dot represents a different image’s mean fluorescent 
integrated intensity, as compared to control (NT) cells. Results are expressed as mean ± s.d. from independent images 
n³9 (*p<0.05). 
 
Typical vesicular-like DQ-BSA fluorescence distribution in the cell was found, upon 
incubation of hESc-RPE cells, whether with or without CQ. A significant difference was 
found between NT and CQ-treated cells: hESc-RPE cells treated with CQ exhibit lower 
fluorescence intensity (Figure 4. 21). 
This, however, is inconsistent with the flow cytometry analysis (Figure 4. 20). Still, in 
the flow cytometer, 20.000 cells were analyzed per conditions, and individually. In 
comparison, dozens of cells were observed together by microscopy, and the images’ mean 
intensities were compared to the control situation. If, on the one hand, confocal images 
allow for the detailed visualization of size and distribution of the DQ-BSA-labeled vesicles 
within cells, flow cytometry should be a more reliable way of quantifying mean 
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fluorescence per cell. Still, CQ-induced differences were, in this case, relatively subtle, and 
the cells were generally able to cope. 
Following the same experimental mindset as before, DQ-BSA fluorescence was also 
evaluated at the third day of CQ continued stimulus. Briefly, hESc-RPE cells were fed with 
POS for 4h and incubated overnight in CQ-containing medium, for three consecutive days. 
In this case of repeated CQ incubations, DQ-BSA red was added to the medium only the 
day before analysis, therefore representing degradative ability at that specific time point. 
DQ-BSA fluorescence on the third day of CQ treatment was evaluated by flow cytometry 
(Figure 4. 22). 
 
Figure 4. 22 - hESc-RPE degradative ability is compromised after continued CQ treatment, assessed by DQ-BSA 
fluorescence evaluated by flow cytometry. The dashed line separates non-fed from POS-fed cells (+POS). Each column 
represents the Mean Fluorescence Intensity fold change, relative to NT cells. Baf at 50nM was used as a control. 
N=20.000 cells acquired for each condition represented. 
 
Not unlike overnight treatment, continued CQ treatment causes an increase of the mean 
DQ-BSA fluorescence intensity, when considering low CQ concentrations (1 and 
2.5µg/mL), followed by decrease of fluorescence for higher CQ concentrations 
(particularly 10µg/mL), relative to NT control cells. 
When cells are fed with POS, the fluorescence increase appears only when using CQ at 
2.5 and 5µg/mL, decreasing drastically in the case of CQ 10µg/mL. In fact, after the third 
day, cells treated with CQ10 have similar fluorescence to that of Baf-treated cells, i.e. 
baseline values. This indicates CQ-induced substantial impairment of DQ-BSA-reported 
degradative ability. 
Again, in order to visualize intracellular distribution of DQ-BSA, representative 
confocal images were acquired and quantified (Figure 4. 23). 
Upon viewing the cells, it becomes obvious that DQ-BSA red fluorescence is 
condensed when cells are exposed to CQ. This manifests through brighter focused 
fluorescence found in fewer vesicles, within a cell, rather than equally distributed 
throughout the cell, as in the control (NT) situation (Figure 4. 23). 
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Figure 4. 23 - Continued CQ treatment impairs degradative ability of hESc-RPE cells, evaluated by light microscopy. 
A: DQ-BSA fluorescence distribution and accumulation upon CQ treatment. Scale bar 10µm. B: DQ-BSA fluorescence 
quantification for each condition, with each dot representing a different image’s mean fluorescent integrated intensity, 
and compared to control (NT) cells. Results are expressed as mean ± s.d. from independent images n³9 (***p<0.001; 
****p<0.0001). 
 
Confocal images illustrate the general decrease of fluorescence, inversely proportional 
to the CQ concentration increase. A significant difference in mean fluorescence intensity 
was obtained for cells treated with 2.5 and 5µg/mL CQ for three days (Figure 4. 23). 
Once more, hESc-RPE were subjected to a week-long treatment of CQ at the different 
concentrations through overnight incubation, for seven consecutive days. DQ-BSA 
fluorescence was evaluated at the seventh day of CQ chronic stimulus by flow cytometry 
(Figure 4. 24). 
 
Figure 4. 24 - Chronic CQ treatment impairs degradative ability of hESc-RPE cells, assessed by DQ-BSA fluorescence 
evaluated by flow cytometry. The dashed line separates non-fed from POS-fed cells (+POS). Each column represents 
the Mean Fluorescence Intensity fold change, relative to NT cells. Baf at 50nM was used as a control. n=20.000 cells 
acquired for each condition. Results are expressed as mean ± s.d. from two independent experiments. All drug 
treatments show significant differences, compared to control p<0.0001. 
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Chronic exposure to CQ disturbs the degradative ability of hESc-RPE cells, as 
evaluated by DQ-BSA fluorescence. In accordance with what was expected, given the POS 
degradation assays, the cells’ ability to process cargo through lysosomal degradation is 
impaired after one week of CQ treatment. As such, all CQ-treated cells show a significantly 
lower mean fluorescence intensity (p<0.0001), as compared to control NT cells. 
Fluorescence levels found in CQ-treated cells were similar to those of negative control cells 
which were treated with Baf (Figure 4. 24). 
Fluorescence microscopy images of hESc-RPE cells treated chronically with CQ are 
represented in Figure 4. 25. 
 
Figure 4. 25 - Chronic CQ treatment severely impairs degradative ability of hESc-RPE, evaluated by light microscopy. 
A: DQ-BSA fluorescence distribution and accumulation upon CQ treatment, shown in representative images. Scale bar 
10µm. B: Fluorescence quantification indicates decrease of proteolytic activity. Each dot represents a different image’s 
mean fluorescent integrated intensity, compared to control (NT) cells. Results are expressed as mean ± s.d. from 
independent images n³3 (**p<0.01; ***p<0.001). 
 
Quantification of the images is consistent with findings from flow cytometry: a 
reduction of DQ-BSA red fluorescence suggests impaired degradative ability of hESc-
RPEs’ lysosomes upon chronic CQ treatment. 
Overnight treatment with CQ did not induce substantial differences in total DQ-BSA 
fluorescence found in the cells (Figure 4. 20, Figure 4. 21). This suggests that uptake is not 
impaired by CQ treatment and that the overnight DQ-BSA pulse allows for a bright 
detection, without significant fluorescence loss over time. Nevertheless, when pondering 
these results, it is important to keep an open mind and contemplate all the experimental 
variables and limitations. 
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It is conceivable that chronic lysosomal dysfunction may disturb cellular functions at a 
deeper level and end up unsettling overall endocytic function. For this reason, the 
possibility of lower detection levels as the result of fewer uptake of the dye should not be 
excluded. Still, considering all evidence from these experiments, taken together with 
previous results regarding POS accumulation, it is reasonable to assume there is in fact a 
cargo degradation impairment rather than intake deficiency. 
As for the negative control, Baf is very efficient, though the concentration used was 
relatively low. In fact, 200nM were shown to effectively block lysosome activity, assessed 
through DQ-BSA fluorescence, Magic RedTM and Lysotracker® signals (data not shown). 
However, in this case, Baf was used at 50nM, and for this reason, complete ablation of the 
signal was not achieved in the acute treatment. When similar experiments were performed, 
using higher concentrations, hESc-RPE cells died, after the third day of Baf 200nM 
incubation. As such, in an effort to maintain similar conditions at the three time points 
chosen, a lower dose was used. 
A potential limitation of using fluorescently-labeled dyes is related to the fact these 
cells are pigmented. Melanin may quench the fluorescence, meaning heavily pigmented 
cells may present weaker signal. As previously discussed, CQ-treated cells and Baf-treated 
cells become darker. This may be the result of MiT TFs regulation, which also manage 
melanosome biogenesis and processing (Bharti et al. 2006; Napolitano & Ballabio 2016). 
To circumvent this aspect, an effort was made to depict cells presenting similar 
pigmentation levels. This, however is a subjective assessment, as pigmentation levels were 
not effectively quantified. Still, and consistent with previous rhodopsin stainings increase 
(rather than pigment-quenching), DQ-BSA findings were found to support lysosomal 
dysfunction settings. 
In an effort to clarify how the hESc-RPE’s proteolytic activity is affected, the function 
of lysosomal Cathepsins was evaluated next. 
 
4.6	CQ	stimulates	Cathepsin	B	and	L	proteolytic	activity	
A straightforward way of detecting Cathepsin activity is to use Magic Red™ reagent, 
which consists on a membrane permeable non-toxic substrate that emits red fluorescence 
upon cleavage by active Cathepsins. The substrate concerned, in this case, comprises two 
Cathepsin target peptide sequences and, when coupled to cresyl violet, it precludes its 
fluorescence. This substrate may be directly added to the cell culture medium and freely 
permeates membranes (plasma membrane and organelles). Upon enzymatic cleavage at 
one or both peptides, mono or non-substituted cresyl violet fluorophores produce 
fluorescence when excited at 550-590nm. Because Cathepsins are active within acidic 
organelles, Magic RedTM is expected to fluoresce at the lysosomes. And since the peptides 
coupled to the fluorophore are tailored, in this case, for Cathepsin B or Cathepsin L 
preferential targeting, fluorescence is expected to reflect these enzymes’ activity directly. 
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Cells were treated with medium either without or with POS, for 4h, followed by 
overnight incubation in medium containing increasing concentrations of CQ, from 1-
10µg/mL. The V-ATPase inhibitor Baf was used as negative control. As before, 
fluorescence was measured by flow cytometry and fluorescence microscopy images were 
obtained, in order to assess cellular distribution pattern of the dyes (Figure 4. 26, Figure 4. 
27). 
 
Figure 4. 26 - Acute CQ treatment causes increase of Cat B and L activity, assessed by Magic RedTM fluorescence 
evaluated by flow cytometry. The dashed line separates non-fed from POS-fed (+POS) cells. Each column represents 
the Mean Fluorescence Intensity fold change, relative to NT cells. Baf at 50nM was used as negative control. n=20.000 
cells acquired for each condition Results are expressed as mean ± s.d. from independent experiments (two for CatB, 
one for CatL). 
 
Both graphs depict a direct correlation between increase of CQ concentration and 
Magic Red™ fluorescence fold increase, relative to control NT cells. Addition of POS 
alone does not have a significant effect on Cathepsins B or L activities. Instead, the 
fluorescence gain seems to be a direct result from CQ treatment. Surprisingly, rather than 
impairing Cathepsin activity, CQ appears to boost it, upon acute overnight treatment. Baf, 
on the contrary, completely extinguished Magic RedTM signal, in both cases, effectively 
serving as negative control (Figure 4. 26). 
Representative images showing CatB substrate-derived fluorescence is shown in Figure 
4. 27. 
hESc-RPE cells display Magic RedTM fluorescence with a vesicular pattern, assumedly 
representing the active lysosomal population. The cellular active lysosomal content is 
increased, upon CQ treatment, observed as more fluorescent vesicles, distributed inside the 
cells. The nuclear area is spared from the dye, suggesting specific localization to the 
endocytic compartments. Alike the flow cytometry results, cells show increased Magic 
RedTM fluorescence, in proportion to CQ concentration rise (Figure 4. 27). 
Image quantification further confirms results obtained by flow cytometry: Cathepsin B 
activity produces fluorescence in proportion to CQ concentration, suggesting increased 
proteolytic activity (Figure 4. 26 and Figure 4. 27).  
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Figure 4. 27 - CatB activity increases upon acute CQ treatment of hESc-RPE cells, evaluated by Magic RedTM 
fluorescence, assessed by light microscopy. A: Representative images showing the dye’s distribution in a vesicular 
pattern, consistent with lysosomes. Scale bar 10µm. B: Quantification of fluorescence mean integrated intensity of 
representative images. Each dot represents a different image’s mean fluorescent integrated intensity, compared to 
control (NT) cells. Results are expressed as mean ± s.d. from independent experiments, n³6 (****p<0.0001). 
 
Following the protocol previously described for continued CQ treatment, cells were fed 
POS and treated with CQ overnight, for three consecutive days. Flow cytometry results 
report Cathepsins B and L activity, measured as Magic RedTM fluorescence (Figure 4. 28). 
 
Figure 4. 28 - Continued CQ treatment induces CatB and CatL activity, assessed by Magic RedTM fluorescence 
evaluated by flow cytometry. The dashed line separates non-fed from POS-fed cells. Each column represents the Mean 
Fluorescence Intensity fold change, relative to NT cells. Baf at 50nM was used as negative control. n=20.000 cells 
acquired for each condition represented. 
 
Continuous CQ-treatment leads to consistent increase of Cathepsins’ B and L activity, 
compared to control non-treated cells. Again, this effect is independent of POS feeding, 
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occurring whether or not the cells were fed. Interestingly, in the case of Cathepsin L, Baf 
treatment does not produce the expected reduction of activity to baseline levels (Figure 4. 
28). The systematic increase of Cathepsin activity resulting from CQ burden is unexpected, 
but could mean these enzymes are pH permissive or that their expression is stimulated. 
Cellular distribution pattern of the Magic RedTM fluorescence was assessed by 
microscopy images and quantified (Figure 4. 29). 
 
Figure 4. 29 - Continued CQ treatment alters cellular distribution of CatB activity in hESc-RPE cells, evaluated by 
Magic RedTM fluorescence microscopy. A: Distribution of the dye, spreading throughout the cell, upon CQ treatment. 
Scale bar 10µm. B: Fluorescence quantification for each condition, with each dot representing a different image’s mean 
fluorescent integrated intensity, and compared to control (NT) cells. Results are expressed as mean ± s.d. from 
independent images n³3 (**p<0.01; ****p<0.0001). 
 
Cathepsin B and L effectively degraded their respective substrates, thus giving rise to 
fluorescence. Cathepsin B-related fluorescence appears in a vesicular pattern, consistent 
with lysosomes and other acidic endocytic vesicles. This fluorescence increases upon CQ 
treatment, in a dose-dependent manner. Image quantification is consistent with flow 
cytometry findings, conveying a consistent intensification, in proportion to the rise in CQ 
concentration (Figure 4. 28 and Figure 4. 29). 
In order to evaluate the chronic effects of CQ burden in hESc-RPE’s Cathepsin activity, 
the same experimental approach used before was put in place: cells were fed POS for 4h, 
followed by overnight incubation with increasing CQ concentrations, for seven consecutive 
days. Following the seventh day’s overnight incubation, cells were given Magic RedTM 
Cathepsin B or L and prepared for flow cytometry analysis (Figure 4. 30). 
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Figure 4. 30 - Chronic CQ burden induces CatB and CatL activity in hESc-RPE cells, assessed by Magic RedTM 
fluorescence evaluated by flow cytometry. The dashed line separates non-fed from POS-fed cells. Each column 
represents the Mean Fluorescence Intensity fold change, relative to NT cells. Baf at 50nM was used as negative control. 
n=20.000 cells acquired for each condition represented. 
 
Similarly to the acute and continuous treatments, chronic CQ burden produces 
increased Magic RedTM fluorescence, compared to control situation, suggesting increased 
activity both of Cathepsin B and L. On the contrary, long-term treatment of these cells with 
Baf returns very low levels of fluorescence, indicating few Cathepsin-active compartments, 
as would be expected (Figure 4. 30). 
Surprisingly, Magic RedTM fluorescence implies an increase of Cathepsins’ B and L 
activities, rather than the expected decrease, upon CQ treatment. This constant surge in 
fluorescence, proportionally to CQ concentration rise is rather puzzling. It may be 
interpreted as a compensatory mechanism, which partially allows the cell to process cargo 
(POS or DQ-BSA), despite CQ. In addition, Cathepsins B and L have been described to be 
active within a relatively high range of pH (Turk et al. 1997). For this reason, it is possible 
that CQ-induced pH increase is not sufficient to inhibit these Cathepsins activity. On the 
other hand, overnight treatment with CQ was shown sufficient to induce TFEB, TFE3 and 
MITF nuclear translocation, which potentiates lysosomal biogenesis, as discussed 
previously. Therefore, there might be a stimulation of Cathepsin B and L expression and 
hence activity. 
Another potential caveat of using Magic RedTM reagents is that the red fluorophore 
accumulates overtime and may accumulate not only in lysosomes, but also in other areas 
of low pH, such as mitochondria (ImmunoChemistryTechnologies 2002). Nevertheless, a 
substantial degree of specificity is expected from this assay, thus Magic RedTM 
fluorescence was considered as an appropriate read-out to measure lysosomal cysteine 
protease activity, though results should always be kept in context. 
 
4.7	CQ-induced	disturbance	of	Cathepsin	D	activity	and	expression	
Cathepsin D (CatD) is the only aspartic-type protease ubiquitously expressed in all the 
cells of the human body, and it is present at high level in the retina and brain (Rakoczy et 
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al. 1997). CatD is a soluble lysosomal enzyme, which is synthesized in the rough 
endoplasmic reticulum as preproCathepsin D. PreproCathepsin D is processed into the 
proCathepsin D form (52 kDa) and targeted to endosomes, phagosomes and lysosomes. 
ProCathepsin is cleaved, when in the acidic lysosomal lumen. This cleavage gives rise to a 
48 kDa intermediate form and further proteolytic processing originates the final mature 
form: the globular structure of CatD, composed of a heavy (34 kDa) and a light (14 kDa) 
chains non-covalently linked(Benes et al. 2008; Laurent-Matha et al. 2006) (Figure 4. 31). 
 
Figure 4. 31 - Representation of the human CatD processing steps, from pre-pro-enzyme up to the mature active form. 
Image from (Laurent-Matha et al. 2006). 
 
CatD is responsible for the degradation of unfolded or oxidized protein aggregates, 
delivered to lysosomes via autophagy or endocytosis. In addition, it is an important player 
in rhodopsin proteolysis (Rakoczy et al. 1997). For this reason, its activity and levels of 
expression were evaluated in the proposed experimental settings. In particular, Pepstatin 
A, Bodipy™ FL reagent was used to evaluate CatD activity. To obtain this reporter, 
pepstatin A was covalently conjugated with Bodipy™ fluorophore. The resulting 
commercially available product is able to selectively bind to the protease at low pH and 
thus stains CatD active lysosomes (Chen et al. 2000). This probe competes with other CatD 
substrates and therefore inhibits this enzyme’s activity. Still, since the tool was used 
immediately before acquiring the signal, rather that exposing the cells to a continued 
treatment, consequently it is considered here as a reliable readout of that moment’s active 
enzyme. 
Additionally, CatD protein levels were evaluated by Western Blot, in the different 
experimental conditions tested, as before. Using this technique, it is possible to compare 
total amount of CatD in the cell lysates obtained in each of the settings and also to study 
the ratio of mature (lower molecular weight) and proCathepsin forms (higher molecular 
weight). 
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hESc-RPE were fed with POS for 4h, after which cells were incubated overnight in CQ-
containing medium, with concentrations ranging from 1 to 10 µg/mL. The next day, 
Bodipy™ FL was added to the medium and cells were prepared for flow cytometry 
analysis, as described in the Materials and Methods section (Figure 4. 32). 
 
Figure 4. 32 - Acute CQ treatment leads to decreased CatD activity in hESc-RPE cells, assessed by Bodipy™ 
fluorescence evaluated by flow cytometry. The dashed line separates non-fed from POS-fed cells. Each column 
represents the Mean Fluorescence Intensity fold change, relative to NT cells. Baf at 50nM was used as negative control. 
n=20.000 cells acquired for each condition. 
 
Active CatD, adjudicated as Bodipy™ fluorescence, is decreased upon CQ treatment. 
In particular, the reduction of active CatD, varies opposed to CQ concentration. Baf was 
used as negative control, decreasing CatD activity to half, relative to control non-treated 
cells, considered as baseline. Feeding the cells with POS does not produce significant 
changes in cat D activity patterns, comparing to the non-fed situation (Figure 4. 32). 
Moreover, CatD protein levels were evaluated resorting to Western Blot, using the same 
conditions as previously described (Figure 4. 33). 
 
Figure 4. 33 - CatD protein profile is altered by CQ acute treatment of hESc-RPE. Western Blot using anti-CatD 
antibody shows immature (52 and 48kDa, upper bands) and mature (34kDa, bottom bands) forms of this Cathepsin. 
Rap and Baf were used as positive and negative controls, respectively. +P: POS-fed cells. Calnexin was used as loading 
control. A representative result is shown from three independent experiments. 
 
The first thing to notice is the strong effect Baf has over this enzyme, effectively 
depleting the cells of proCathepsin and leaving trace amounts of mature CatD. Secondly, 
comparing non-fed with POS-fed cells (+P), the blots are very similar, thus the lysosomal 
cargo itself does not seem to produce an effect. Strikingly, as CQ concentrations increase, 
a band becomes visible at approximately 52 kDa, corresponding to the proCathepsin form. 
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The mature (34kDa) form, on the other hand, seems slightly reduced at CQ5, compared to 
the control (Figure 4. 33). 
In order to assess total CatD, bands were quantified and the respective graph is 
represented in Figure 4. 34. 
 
Figure 4. 34 - CatD total amounts are not altered upon acute CQ treatment of hESc-RPE. Western Blot relative 
quantification of bands represents total CatD, per condition. A: cells treated with CQ alone. B: CQ treatment after POS 
feeding (+P). Rap and Baf were used as positive and negative controls, respectively. Band intensity was normalized 
according to the loading control. Results are expressed as mean ± s.d. from independent experiments, n=3. 
 
By observing the quantification of total CatD, as evaluated by Western Blot, it is 
possible to confirm that Rap induced CatD expression, while Baf effectively inhibited it, 
as predicted. CQ does not produce a significant effect on Cathepsin total amounts, in unfed 
cells. POS-fed cells, however, when treated with CQ, exhibit a slight increase of CatD total 
amounts (Figure 4. 34). Next, the ratio between mature and immature CatD forms was 
pondered and the graph the obtained data is presented in Figure 4. 35. 
 
Figure 4. 35 - The ratio of mature/immature CatD is altered upon acute CQ treatment of hESc-RPE. Ratio between 
mature (34kDa) and immature forms (48 and 52kDa) of CatD was obtained from Western Blot relative quantification. 
A: cells treated with CQ alone. B: CQ treatment after POS feeding (+P). Rap and Baf were used as positive and negative 
controls, respectively. Band intensity was normalized according to the loading control. Results are expressed as mean 
± s.d. from independent experiments, n=3. 
 
A decrease of the mature form, relative to immature forms of CatD, directly correlated 
with an increase of CQ concentration is observed. This is true for cells that were not POS-
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fed. Regarding POS-fed cells, there is relatively more mature catD in the POS-fed control 
(NT+P) and CQ1+P cells, relative to non-treated, unfed cells (NT) (Figure 4. 35).  
Considering the previous graph, this increase in mature CatD form occurs at the expense 
of the immature forms, as total levels remain unchanged (Figure 4. 34). As CQ 
concentration increases, the mature form of Cathepsin is reduced, while immature forms 
increase. As depicted in Figure 4. 33, Baf causes the immature forms to vanish and the 
mature forms to fade away, and for this reason, the ratio seems so elevated. As for Rap, 
considering the total amount increase in this case (Figure 4. 34), the low value for 
mature/immature CatD means there is more immature CatD than mature (Figure 4. 35). 
Therefore, it is possible to conclude: Baf causes a strong reduction of both forms of CatD; 
Rap leads to an increase of the total amount and especially the immature form, indicating 
biogenesis; CQ causes an increase of the immature forms, at the expense of mature CatD. 
Since, in the case of unfed cells there is no increase in the total amount, it means 
proCathepsin is not being processed into the mature form (up to 0.5x fold difference, 
relative to control) (Figure 4. 35); in the case of POS-fed cells, there can also be biogenesis, 
but still there is reduction of functional enzyme (up to 10x fold, relative to POS-fed control) 
(Figure 4. 35). 
For the continued treatment, hESc-RPE were fed with POS and subsequently incubated 
overnight in CQ-containing medium, for three consecutive days. After the third day, 
Bodipy™ FL was added to the medium and cells were prepared for flow cytometry analysis 
(Figure 4. 36). 
 
Figure 4. 36 - Continued CQ treatment does not alter CatD activity in hESc-RPE cells, assessed by Bodipy™ 
fluorescence evaluated by flow cytometry. The dashed line separates non-fed from POS-fed cells. Each column 
represents the Mean Fluorescence Intensity fold change, relative to NT cells. Baf at 50nM was used as negative control. 
n=20.000 cells acquired for each condition. 
 
Again, Baf is able to abolish BodipyTM fluorescence, meaning it blocks CatD activity, 
as expected. CQ does not produce a strong apparent effect on CatD activity, in the case of 
unfed cells. In POS-fed cells there is a 15% reduction in CatD-derived fluorescence, at 
10µg/mL CQ (Figure 4. 36). 
Western Blot permitted the evaluation of relative protein amounts (Figure 4. 37). 
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Figure 4. 37 - Continued CQ treatment does not change CatD protein profile in hESc-RPE cells. Western Blot using 
anti-CatD antibody shows mature (34kDa) and immature (48 and 52kDa) forms of this Cathepsin. Rap and Baf were 
used as positive and negative controls, respectively. +P: POS-fed cells. Calnexin was used as loading control. A 
representative result is shown from at least two independent experiments. 
 
Similarly to the previous experimental setup Figure 4. 33, there seems to be a slight 
reduction of the mature form of CatD in CQ5-treatment, compared to control NT cells. Baf 
effectively reduced both immature and mature forms of CatD and Rap caused a slight 
increase of the immature proCathepsin (more readily visible in the POS-fed situation) 
(Figure 4. 37). Relative quantification of the bands was ensued, and the respective graphic 
representation is presented in Figure 4. 38. 
 
Figure 4. 38 - Continued CQ treatment causes a slight increase of total CatD in hESc-RPE cells. Western Blot relative 
quantification of bands represents total CatD, per condition. A: cells treated with CQ alone. B: CQ treatment after POS 
feeding (+P). Rap and Baf were used as positive and negative controls, respectively. Band intensity was normalized 
according to the loading control. +P: POS-fed cells. Results are expressed as mean ± s.d. from independent experiments, 
n=2. 
 
Quantification of Western Blot bands suggests a general increase of the total CatD 
amount, induced by CQ treatment (except in the POS-fed CQ1 condition) and Rap. Baf 
causes a reduction of total CatD (Figure 4. 38). The ratio between mature and proCathepsin 
forms is presented in Figure 4. 39. 
Taking into account the Western Blot image and quantification of the total CatD (Figure 
4. 37 and Figure 4. 38), it is possible to verify that despite increase of the total CatD, the 
proCathepsin is more abundant than the mature form. 
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Figure 4. 39 - CatD ratio is altered upon CQ continued treatment of hESc-RPE cells. Ratio between mature (34kDa) 
and immature forms (48 and 52kDa) of CatD was obtained from Western Blot relative quantification. A: cells treated 
with CQ alone. B: CQ treatment after POS feeding (+P). Rap and Baf were used as positive and negative controls, 
respectively. Band intensity was normalized according to the loading control. Results are expressed as mean ± s.d. from 
independent experiments, n=2. 
 
This is shown by the relative decrease of the ratio (34 kDa/ 48 and 52 kDa forms), 
compared to control NT cells (Figure 4. 39). In POS-fed cells, this effect is stronger, in 
fact, although there is more total CatD, CQ5-treated cells have lower levels of the mature 
CatD form than Baf-treated cells (Figure 4. 38 and Figure 4. 39). Together these data 
suggest that CQ leads to biogenesis of Cathepsin (total CatD increase), but failed 
processing and maturation into the active form. 
The same treatment was repeated for seven consecutive days, as described in previous 
sections, in an effort to recapitulate the chronic CQ-burden situation. In some of these 
experiments, hESc-RPE were analyzed in parallel to Lonza hRPE cells. After the seventh 
day of POS feeding and overnight CQ treatment, Bodipy™ FL was added to the medium 
and cells were prepared for flow cytometry analysis (Figure 4. 40). 
 
Figure 4. 40 - CatD’s activity is increased by chronic CQ treatment of hESc-RPE cells, assessed by Bodipy™ 
fluorescence evaluated by flow cytometry. The dashed line separates non-fed from POS-fed cells. Each column 
represents the Mean Fluorescence Intensity fold change, relative to NT cells. Baf at 50nM was used as a control. 
n=20.000 cells acquired for each condition. Results are expressed as mean ± s.d. from two independent experiments. 
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Following seven consecutive days of treatment with CQ, hESc-RPE cells react by 
increasing CatD activity. This increase occurs whether or not cells were fed with POS, 
indicating a direct correlation with CQ, rather than POS feedings (Figure 4. 40). In addition, 
the active CatD seems to increase in proportion to CQ concentration. Baf establishes the 
baseline, corresponding to inactive CatD. Using the anti-CatD antibody, Western Blots 
were produced, in order to visualize the forms of CatD being expressed (Figure 4. 41). 
 
Figure 4. 41 - Chronic CQ treatment alters CatD protein profile in both hESc-RPE (hRPE) and Lonza hRPE (LRPE). 
Western Blot using anti-CatD antibody shows mature (34kDa) and immature (48 and 52kDa) forms of this Cathepsin. 
Actin was used as loading control. +P: POS-fed cells. A representative result is shown from at least two independent 
experiments. 
 
Results show a striking increase of the proCathepsin immature forms is striking in the 
images above: as CQ concentration increases, so does the higher molecular weight forms 
of CatD. In the case of hESc-RPE, on the left, this increase is of the 52 kDa forms, with 
decrease of both the 48 kDa forms and the mature 34 kDa forms. In the case of Lonza 
hRPE, on the right, there is also a reduction of the mature form of CatD, compared to non-
treated NT cells. However, in this case, the mature form remains at sufficient amounts to 
produce a clearly visible band, as opposed to the hESc-RPE case, in which the mature form 
almost vanishes (Figure 4. 41). This might indicate an extended half-life of this protein in 
Lonza hRPE. An alternative would be to consider there is still significant cleavage of 
proCathepsin into mature CatD form. In order to confirm these observations, quantification 
of representative blots was preformed (Figure 4. 42). 
 
Figure 4. 42 - Total CatD is increased by CQ chronic treatment. hESc-RPE cells (A) and Lonza hRPE (B) total Cat D 
was quantified based on Western Blot images. Band intensity was normalized according to the loading control. +P: 
POS-fed cells. Results are expressed as mean ± s.d. from independent experiments, n³3, except CQ10 (n=2). 
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Western Blot quantification suggests increase of total CatD after chronic CQ treatment. 
In the case of hESc-RPE, this increase is in proportion to CQ concentration increase. In the 
case of Lonza hRPE cells, the total CatD was only found to be increased when using CQ 
at 10µg/mL and in fact might be reduced, in the case of CQ 5µg/mL (Figure 4. 42). This 
suggests the reason why the mature form was kept visible in the blot is related to an 
extended CatD half-life, and not to proCathepsin turnover (Figure 4. 41). This is, however, 
a preliminary observation, which should be confirmed by repeated experiments and 
statistical analysis, to confirm significance. Next, the ratio between mature and immature 
CatD forms was evaluated (Figure 4. 43). 
 
Figure 4. 43 - CatD ratio is severely altered by chronic CQ treatment, of hESc-RPE cells (A) and Lonza hRPE (B). 
Ratio between mature (34kDa) and immature forms (48 and 52kDa) of CatD was obtained from Western Blot relative 
quantification. Band intensity was normalized according to the loading control. +P: POS-fed cells. Results are 
expressed as mean ± s.d. from independent experiments, n³3. 
 
Considering the previous graph indicated increase of total CatD (Figure 4. 42), the 
relative decrease of the mature form, at the expenses of the proCathepsin form is implied 
here, by this graph (Figure 4. 43). In fact, in both hESc-RPE and Lonza hRPE there is a 
dramatic reduction of the ratio between mature and immature forms of CatD, according to 
the increase in CQ concentration (Figure 4. 43).  
Together the presented data suggest that although activity is increased slightly 
(according to Bodipy™ FL flow cytometry analysis - Figure 4. 40), the CatD maturation 
step is hindered. A chronic CQ burden instigates CatD biogenesis, with increase of total 
CatD, readily noticeable in hESc-RPE, although not so clear in Lonza hRPE (Figure 4. 42). 
CatD biogenesis could account for the increased activity detected by flow cytometry. Still, 
because CatD maturation is impaired, there is more proCathepsin than mature Cathepsin, 
compared to controls (Figure 4. 43). 
There seems to be a time-frame dependent response. An acute overnight CQ treatment 
causes reduction of the activity, possibly by hampering CatD maturation (Figure 4. 32). 
Immediately the cell responds with new proCathepsin (Figure 4. 33). After the third day of 
insult, the cells are able to return to the levels of activity found in control non-treated cells, 
except for the highest CQ concentration, in POS-fed situation (Figure 4. 36). This is 
achieved in spite of an unbalanced mature/immature CatD ratio, which possibly means that 
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the active CatD is overcompensating for the lower amounts (Figure 4. 39). On the other 
hand, since there is overall increase of total CatD, it could mean that the same amount of 
mature Cathepsin is active (thus similar activity levels), and there is only more 
proCathepsin, rather than the mature form (Figure 4. 38). A week of chronic treatment 
partially depletes the cells of the mature form of Cathepsin (Figure 4. 41). This suggests a 
turnover imbalance, i.e. the previously existing mature CatD surpassed its half-life, whilst 
there was no compensatory processing of new proCathepsin into the mature form, 
effectively reducing its levels (Figure 4. 43). And this occurs despite the substantial 
increase of proCathepsin, which means it is not being cleaved (Figure 4. 41). 
 
4.8	CQ-induced	Alteration	of	Lysosomal	Acidity		
LysoTracker® (LT) consists of a weakly basic amine linked to a fluorophore. This 
acidotropic probe permeates cell membranes and concentrates at low pH organelles (pH < 
6.5). Its retention mechanism in the membranes of these organelles is not yet fully 
understood. Yet LT probes have been shown to be selective for endocytic vesicles, most 
notably lysosomes and, for this reason, they are commonly used as lysosomal markers. In 
this case, LT was used as a reporter for the presence of acidic vesicles, in an effort to 
evaluate the actual acidity of lysosomes, when the cells are subjected to CQ treatment. In 
this context, considering a selective affinity for acidic vesicles, more fluorescence of LT 
would correspond to higher numbers/bigger acidic vesicles. 
hESc-RPE cells were treated with medium either without or with POS (+POS), for 4h, 
followed by overnight incubation in medium containing increasing concentrations of CQ, 
from 1-10µg/mL. Baf was used as negative control. The next day, cells were incubated 
with LT and prepared, as described in Materials and Methods. Fluorescence was measured 
by flow cytometry and fluorescence microscopy images were obtained, in order to assess 
cellular distribution pattern of the dye (Figure 4. 44 and Figure 4. 45). 
 
Figure 4. 44 - Acute CQ treatment causes increase of LT fluorescence in hESc-RPE cells, evaluated by flow cytometry. 
The dashed line separates non-fed from POS-fed (+POS) cells. Each column represents the Mean Fluorescence 
Intensity fold change, relative to NT cells. Baf at 50nM was used as negative control. n=20.000 cells acquired for each 
condition Results are expressed as mean ± s.d. from two independent experiments. 
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Flow cytometry results depict an increase of LT fluorescence intensity, with CQ 
concentration, relative to control NT cells. Again, addition of POS alone does not seem to 
produce an effect on LT fluorescence, with the fluorescence gain appearing as a direct 
result from CQ treatment. Surprisingly, rather than reducing lysosome activity, CQ appears 
to boost it, upon acute overnight treatment. Baf, on the contrary, extinguished the signal to 
baseline levels, effectively working as negative control (Figure 4. 44). 
Representative images showing LT fluorescence intracellular distribution in hESc-RPE 
cells is shown in Figure 4. 45. 
 
Figure 4. 45 - Acute CQ treatment causes increase of LT fluorescence in hESc-RPE cells, assessed by light microscopy. 
A: Representative images displaying LT distribution in cells treated with 1-5µg/mL CQ. Scale bar 10µm. B: 
Quantification of fluorescence mean integrated intensity of representative images. Results are expressed as mean ± s.d. 
from independent images n³2 (*p<0.05; ****p<0.0001). 
 
hESc-RPE cells display LT fluorescence with a vesicular pattern, consistent with acidic 
endocytic vesicles. The number and intensity of the acidic vesicles upturns and expands 
within the cell area, upon CQ treatment, directly correlated to CQ concentration. Alike the 
flow cytometry results, cells show significant increase of fluorescence (p<0.0001), 
proportional to CQ concentration rise, as confirmed through image intensity quantification 
(Figure 4. 44 and Figure 4. 45). 
Following the protocol previously described for continued CQ treatment, cells were fed 
POS and treated with CQ overnight, for three consecutive days. LT fluorescence was 
evaluated by flow cytometry (Figure 4. 46). 
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Figure 4. 46 - Continued CQ treatment causes increase of LT fluorescence in hESc-RPE cells, evaluated by flow 
cytometry. The dashed line separates non-fed from POS-fed (+POS) cells. Each column represents the Mean 
Fluorescence Intensity fold change, relative to NT cells. Baf at 50nM was used as negative control. n=20.000 cells 
acquired for each condition represented. 
 
Three days of CQ-treatment causes a consistent increase of LT fluorescence, and thus 
acidic vesicles, compared to control non-treated cells. Again, this effect is independent of 
POS feeding, occurring whether or not the cells were fed. Baf-treated cells’ fluorescence 
levels are not very different from the control situation, indicating that, un-stimulated, cells 
normally have baseline acidity (Figure 4. 46). However, it is important to take into account 
the threshold of detection this technique offers and look at the images before reaching such 
conclusions. In non-fed CQ1 condition, emphasized in the graph, there is abnormally high 
fluorescence; this, however, may be considered as an outlier, because the cells from the 
well in question were unusually depigmented (data not shown). Although treatment 
conditions were not changed throughout the experiments, this well in particular had less 
apparent pigmentation (evaluated by eye). When analyzing fluorescence intensity, it is of 
utmost importance to regard this feature, as pigment may quench the signal and interfere 
with the results. Nonetheless, the cells were processed and analyzed, and are depicted 
merely to demonstrate potential confounding factors and caveats to this type of analysis 
(Figure 4. 46). 
The systematic increase of acidic vesicles resulting from CQ burden is unexpected, but 
could be indicative of lysosomal biogenesis or abnormal distribution within the cells. To 
evaluate that, cellular distribution pattern and microscopy images LT fluorescence 
quantification were ensued (Figure 4. 47). 
LT fluorescence increases, due to a wider distribution of acidic vesicles detected: while 
in the control image, lysosomes are spread apart, with a few more prominent at the 
perinuclear region of cells, in cells treated with CQ, the fluorescent vesicles occupy the 
whole cytoplasmic area, excluding only the membrane and the nucleus (Figure 4. 47). In 
fact, the cell’s profile becomes readily visible, with typical polygonal shape, because 
fluorescent vesicles extend from nucleus to the membrane periphery (Figure 4. 47). 
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Figure 4. 47 - Continued CQ treatment causes increase of LT fluorescence and wider distribution in hESc-RPE cells, 
assessed by light microscopy. A: Representative images show the distribution of the dye, spreading throughout the cell, 
upon CQ treatment (1-5µg/mL). Scale bar 10µm. B: Fluorescence quantification for each condition, with each dot 
representing a different image’s mean fluorescent integrated intensity, and compared to control (NT) cells. Results are 
expressed as mean ± s.d. from independent images  n³3 (*p<0.05; ****p<0.0001). 
 
The fluorescence increases upon CQ treatment, in a dose-dependent manner, for the 
lowest concentration, but rapidly reaches a plateau. Image quantification is consistent with 
flow cytometry findings, conveying a consistent intensification, in proportion to the rise in 
CQ concentration (Figure 4. 46 and Figure 4. 47). 
CQ chronic effect on hESc-RPE’s lysosomal acidity was evaluated, by feeding cells 
with POS for 4h, to load lysosomes, followed by overnight incubation with increasing CQ 
concentrations, for seven consecutive days. Following the seventh day’s overnight 
incubation, cells were exposed to LT and prepared for flow cytometry (Figure 4. 48). 
 
Figure 4. 48 - Chronic CQ burden causes increase of LT fluorescence, as measured by flow cytometry. The dashed line 
separates non-fed from POS-fed cells. Each column represents the Mean Fluorescence Intensity fold change, relative 
to NT cells. Baf at 50nM was used as control. n=20.000 cells acquired for each condition represented. 
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Chronic CQ burden yields more LT fluorescence, compared to the control situation, 
possibly indicating lysosome biogenesis. Curiously, long-term treatment of these cells with 
Baf results in fluorescence equivalent to those of control cells. This is puzzling because 
Baf is a potent V-ATPase inhibitor, and because images depicting LT in Baf-treated cells 
show absence of fluorescence (data not shown). Therefore, flow cytometry might not be 
the most sensitive technique to analyze LT fluorescence, since it reflects only whole cell 
fluorescence, not the distribution within the cell, which in this case is invaluable. 
Nevertheless, cells treated with CQ are highly fluorescent, which does indicate LT 
accumulation. Based on this data, and taking together the three time points and 
corresponding images for acute and continued treatments, CQ produces a higher number 
and wider distribution of acidic vesicles in the cells (Figure 4. 45 and Figure 4. 47). 
 
4.9	Endocytic	pathway	and	Autophagy	impairment	
As discussed in Chapter 1, CQ is known to disturb the endocytic and autophagic 
pathways, in particular by disrupting lysosomal cargo processing, thus causing it to 
accumulate in the cells. In an effort to evaluate this dysfunction and characterize the 
proposed CQ-induced hESc-RPE model of lysosomal dysfunction, a set of experiments 
was performed. Specifically, cells were imaged for the presence/distribution of 
Apolipoprotein E (ApoE), a protein found in endocytic membranes and known to 
accumulate in AMD settings (Golestaneh et al. 2017; Hamdi & Kenney 2003). 
Additionally, whole cell lysates were collected and probed for ApoE, as well as autophagy-
related proteins p62 and LC3, by Western Blot. 
hESc-RPE cells were treated with medium either without or with POS (+POS), for 4h, 
followed by overnight incubation in medium containing increasing concentrations of CQ, 
from 1-5µg/mL. IF images were obtained using an anti-ApoE antibody, and quantified 
(Figure 4. 49). 
 
Figure 4. 49 - ApoE protein levels and intracellular distribution are not altered upon acute CQ treatment of hESc-RPE. 
A: Representative IF images of the anti-ApoE staining, in control non-treated cells and in cells treated with CQ. Scale 
bar 10µm. B: Quantification of fluorescence mean integrated intensity of representative IF images. Each dot represents 
a different image’s mean fluorescent integrated intensity, compared to control (NT) cells. Results are expressed as 
mean ± s.d. from independent images, n=3. 
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ApoE staining was shown to be faint, precluding detailed analysis of its subcellular 
localization in hESc-RPE. Quantification of representative images reveal similar mean 
fluorescence intensity whether cells were treated with CQ or not (Figure 4. 49 B). 
Nevertheless, in order to further evaluate how the level of ApoE is affected in hESc-RPE 
when treated with CQ, whole cell lysates obtained in this experiment were analyzed by 
Western Blot (Figure 4. 50). 
 
Figure 4. 50 - ApoE protein levels are not altered upon acute CQ treatment of hESc-RPE. Western Blot using anti-
ApoE antibody shows two adjoining bands in each condition, representing the native 34 kDa protein and the higher 
molecular weight sialylated isoprotein (Xu et al. 1999). +P: POS-fed cells. Rap and Baf were used as positive and 
negative controls, respectively. Calnexin was used as loading control. A representative result is shown from four 
independent experiments. 
 
In this experiment, acute CQ does not seem to produce modifications in cellular ApoE 
quantities. Rap was used here as an autophagy/lysosomal inducer, and for this reason, a 
slight decrease of ApoE is to be expected. On the contrary, Baf was used to inhibit 
lysosomal degradation leading to ApoE accumulation in the cell (readily visible in the 
Baf+P condition) (Figure 4. 50). However, in order to draw conclusions, quantification of 
bands was ensued, taking into consideration results obtained in four independent 
experiments (Figure 4. 51). 
 
Figure 4. 51 - ApoE total amounts are not altered upon acute CQ treatment. Western Blot relative quantification of 
bands represents total ApoE, per condition. A: cells treated with CQ alone. B: CQ treatment after POS feeding (+P). 
Rap and Baf were used as controls. Band intensity was normalized according to the loading control. Results are 
expressed as mean ± s.d. from independent experiments, n=4. 
 
Upon quantification of representative blots, no substantial difference was found 
regarding ApoE protein content. There seem to be slightly higher amounts in cells which 
were fed with POS, which could indicate ApoE expression induction or slower degradation, 
but most likely reflects ApoE coming from the POS prep. Still, taking into account the 
large error bars, this observation might be misleading, and more experiments would be 
necessary to confirm (Figure 4. 51). 
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Next, the levels of important autophagy players p62/SQSTM1 (p62) and LC3 levels 
were evaluated in the conditions tested, by Western Blot. In NT conditions, hESc-RPE are 
express low detectable levels of p62 (Figure 4. 52). 
 
Figure 4. 52 - Acute CQ treatment alters p62 and LC3 protein levels in hESc-RPE cells, detected by Western Blot. Rap 
and Baf were used as positive and negative controls, respectively. +P: POS-fed cells. Calnexin was used as loading 
control. A representative result is shown from three independent experiments. 
 
When cells are treated with CQ they seem to gradually accumulate p62, according to 
increasing CQ concentrations. In cells treated with CQ at the highest concentration 
(5µg/mL), p62 is found at similar levels as in Baf-treated cells, suggesting there is 
impairment of its clearance (Figure 4. 52).  
Regarding LC3, its lipidated form LC3 II is visible in Baf-treated cells and in NT cells 
in both POS-fed and unfed cells. In the case of Rap, there is decrease of both LC3 I and II 
forms, which suggests induction of autophagy, as predicted. On the contrary, in Baf-treated 
cells, the decrease of LC3 I compared to NT cells seems to be at the expense of LC3 II, 
which increases significantly (Figure 4. 52). 
This indicates autophagy blockade, with accumulation of autophagosomes. In 
comparison to these control situations, CQ seems to cause accumulation of the LC3 I form, 
at similar levels to those of control NT cells in the case of POS-deprived cells. LC3 II also 
seems to accumulate, in proportion to CQ increase, in cells without POS. In POS-fed cells, 
however, there seems to be a decrease of both LC3 I and II in CQ-treated cells, compared 
to control. In fact, in this image, CQ-treated cells’ bands resemble that of Rap-treatment, 
which suggests induction of autophagy (Figure 4. 52). 
Quantification of representative images for p62 is depicted next (Figure 4. 53). 
Quantification of p62 bands suggests a slight reduction, in POS-deprived cells treated 
with CQ or with Rap and return to control levels upon Baf-treatment. To the right of the 
dashed line, in POS-fed conditions, hESc-RPE cells display generally lower p62 levels than 
NT cells (that were not POS-fed). Nonetheless, regarding POS-fed cells alone, and 
comparing NT+POS to CQ-treated cells, there is a slight increase in p62, dependent on CQ 
concentration (Figure 4. 53). 
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Figure 4. 53 - p62 protein levels are slightly increased in POS-fed hESc-RPE cells. Rap and Baf were used as controls. 
Western Blot band intensity was normalized according to the loading control. A: cells treated with CQ alone. B: CQ 
treatment after POS feeding (+P). Results are expressed as mean ± s.d. from independent experiments, n=3. 
 
This increase is more noticeable in Baf-treated cells. Together this suggests some 
impairment of p62 clearance, in POS-fed cells, caused by CQ (and, as expected, Baf). Still, 
to confirm these findings, more experiments would be needed, as the error here is 
considerable (Figure 4. 53). 
LC3 bands were also quantified from representative images and the ratio between 
lipidated and non-lipidated LC3 forms was calculated, to illustrate autophagy flux, as 
compared to Rap or Baf treated cells  (Mizushima & Yoshimori 2007) (Figure 4. 54). 
 
Figure 4. 54 - Ratio LC3 II/LC3 I is altered upon acute CQ treatment of hESc-RPE cells. Western Blot relative 
quantification of bands represents the ratio between LC3 II and LC3 I, per condition. A: cells treated with CQ alone. 
B: CQ treatment after POS feeding (+P). Rap and Baf were used as controls. Band intensity was normalized according 
to the loading control. Results are expressed as mean ± s.d. from independent experiments, n=3. 
 
Quantification reflects the increase in LC3 II, in the case of Baf-treated cells, revealed 
by increased LC3 II/LC3 I ratio (Figure 4. 54). In CQ-treated cells there is also a gradual 
increase of the ratio, in the non-fed conditions. This increase is proportional to CQ 
concentration, yet upon visualization of the blots the cause for this effect is not always 
obvious (Figure 4. 52). 
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For the continued CQ treatment, hESc-RPE cells were treated with medium either 
without or with POS (+POS), for 4h, followed by overnight incubation in medium 
containing increasing concentrations of CQ, from 1-5µg/mL, for three consecutive days. 
IF images obtained by probing cells with an anti-ApoE antibody, and the respective 
quantification are depicted in Figure 4. 55. 
 
Figure 4. 55 - ApoE protein levels and intracellular distribution are not altered upon continued CQ treatment. A: 
Representative images of anti-ApoE IF staining, in control non-treated cells and in cells treated with CQ. Scale bar 
10µm. B: Quantification of fluorescence mean integrated intensity of representative IF images. Each dot represents a 
different image’s mean fluorescent integrated intensity, compared to control (NT) cells. Results are expressed as mean 
± s.d. from independent images, n³3. 
 
Again, no significant difference is observed in the IF staining with ApoE antibody. In 
some cells, a vesicular pattern is apparent, but no differences were found in the staining 
intensity of treated versus non-treated cells (Figure 4. 55). Western Blot of cells treated in 
a similar manner as before, for three days (Figure 4. 56). 
 
Figure 4. 56 - ApoE accumulates upon continued CQ treatment of hESc-RPE cells, assessed by Western Blot. Anti-
ApoE antibody shows two adjoining bands in each condition, representing the native 34 kDa protein and the higher 
molecular weight sialylated isoprotein (Xu et al. 1999). Rap and Baf were used as positive and negative controls, 
respectively. +P: POS-fed cells. Calnexin was used as loading control. A representative result is shown from three 
independent experiments. 
 
A continued CQ treatment, for three days, causes accumulation of ApoE in the cells 
extracts, as shown by increasingly intense bands, in proportion to CQ’s concentration 
increase (Figure 4. 56). Rap treatment causes ApoE clearance, while Baf-treated cells 
accumulate ApoE (in the case of non-POS-fed cells). Quantification of representative 
images was ensued (Figure 4. 57). 
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Figure 4. 57 - ApoE accumulates in hESc-RPE upon continued CQ treatment. Western Blot relative quantification of 
bands represents total ApoE, per condition. A: cells treated with CQ alone. B: CQ treatment after POS feeding (+P). 
Rap and Baf were used as controls. Band intensity was normalized according to the loading control. Results are 
expressed as mean ± s.d. from independent experiments, n=3. 
 
Quantification of bands from three different experiments show similar results to those 
observed in Figure 4. 56: consistent increase of ApoE in CQ treated cells, depending on 
the increase in CQ’s concentration; there is a decrease in the case of Rap treatment, to NT 
control levels or lower, and increase of ApoE in the case of Baf-treated cells (Figure 4. 57). 
This indicates that lysosomal function is necessary for ApoE turnover in the cell and it is 
impaired by both CQ and Baf, after three days of treatment. 
A Western Blot image showing p62 and LC3 levels is presented next, depicting cells 
treated in the same manner (Figure 4. 58). 
 
Figure 4. 58 - p62 and LC3 protein levels show autophagy clearance after continued CQ treatment, in hESc-RPE cells. 
Rap and Baf were used as positive and negative controls, respectively. +P: POS-fed cells. Calnexin was used as loading 
control. A representative result is shown from at least two independent experiments. 
 
Western Blot results shows low levels of both p62 and of LC3. In fact, it is not easy to 
observe p62 in these conditions, as the expression is fairly low, compared to Baf-treated 
cells. Still, a continuous treatment seems not to cause increase of p62, relative to control, 
suggesting that cells are able to adapt. As for LC3, it is difficult to visualize the LC3 II 
form, except in Baf-treated cells (Figure 4. 58). This also indicates there is a general 
clearance, possibly due to lysosome biogenesis triggered by MiT TFs. Quantification is 
shown in Figure 4. 59 and Figure 4. 60. 
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Figure 4. 59 - p62 levels do not increase in hESc-RPE continuously treated with CQ. A: cells treated with CQ alone. 
B: CQ treatment after POS feeding (+P).  Rap and Baf were used as controls. Band intensity was normalized according 
to the loading control. Results are expressed as mean ± s.d. from independent experiments, n=3. 
 
Results obtained confirm low levels of p62, comparable to those found in the NT 
control situation and also lower than those found for Rap-treated cells. On the contrary, 
Baf-treated cells accumulate substantial doses of p62 (Figure 4. 59). This suggests that at 
this time-point there is no significant lysosomal dysfunction, caused by CQ treatments. 
 
Figure 4. 60 - LC3 ratio does not suggest autophagy impairment in hESc-RPE treated continuously with CQ. A: cells 
treated with CQ alone. B: CQ treatment after POS feeding (+P). Rap and Baf were used as controls. Band intensity was 
normalized according to the loading control. Results are expressed as mean ± s.d. from independent experiments, n=2. 
 
The ratio between LC3 II and LC3 I was evaluated (Figure 4. 60). Based on its 
interpretation and on visualization of a representative western blot image (Figure 4. 58), it 
is possible to determine that only in Baf-treated conditions there is substantial accumulation 
of LC3 II, indicating autophagy flux impairment. In CQ-treated cells, although in some 
cases it might look increased, relative to NT cells, LC3 ratio is not very different from Rap-
treated cells, thus precluding further conclusions (Figure 4. 60). 
In order to assess the consequences of chronic CQ burden, hESc-RPE cells were treated 
with medium with POS (+POS), followed by overnight incubation in medium containing 
increasing concentrations of CQ, from 1-5µg/mL, for seven consecutive days. In addition, 
whenever possible, Lonza hRPE and pRPE were also tested, in order to confirm findings 
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in the different cell models available. IF images were obtained by probing hESc-RPE cells 
with an anti-ApoE antibody, and the respective fluorescence was quantified (Figure 4. 61). 
 
Figure 4. 61 - ApoE gets accumulated in hESc-RPE cells treated chronically with CQ. A: Representative IF images 
represent the anti-ApoE staining, in control non-treated cells and in cells treated with CQ. Scale bar 10µm. B: 
Quantification of fluorescence mean integrated intensity of representative IF images. Each dot represents a different 
image’s mean fluorescent integrated intensity, compared to control (NT) cells. Results are expressed as mean ± s.d. 
from independent images, n³3 (*p<0.05; ****p>0.0001). 
 
After a seven-day treatment, ApoE staining starts to become more noticeable, with a 
vesicular pattern. Additionally, the cell’s profile become more evident, possibly indicating 
cytosolic ApoE. Image quantification regarding cells treated with mounting concentrations 
of CQ confirms an increase of ApoE detected by IF, upon chronic treatment with higher 
concentrations (up to 1.5x fold) (Figure 4. 61). To confirm these result, Western Blot 
analysis was performed, this time comparing hESc-RPE (hRPE) in parallel with Lonza 
hRPE (LRPE) (Figure 4. 62). 
 
Figure 4. 62 -  ApoE accumulates upon chronic CQ treatment of hESc-RPE (hRPE) and Lonza hRPE (LRPE). +P: 
POS-fed cells. anti-ApoE antibody shows two adjoining bands in each condition, representing the native 34 kDa protein 
and the higher molecular weight sialylated isoprotein (Xu et al. 1999).Actin was used as loading control. A 
representative result is shown from three independent experiments. 
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Western Blot results clearly show a consistent increase in cellular ApoE, in both hESc-
RPE and in Lonza hRPE cells, depending on CQ concentration. This suggests that a week-
long treatment with relatively low doses of CQ is sufficient to impair ApoE turnover, 
causing it to accumulate (Figure 4. 62). Although this antibody was also tested in pRPE, it 
did not recognize the porcine protein (data not shown). Representative image quantification 
is shown next (Figure 4. 63). 
 
Figure 4. 63 - ApoE accumulates severely with CQ chronic treatment of hESc-RPE cells (A) and Lonza hRPE (B).. 
Western Blot relative quantification of bands represents total ApoE, per condition. Band intensity was normalized 
according to the loading control. Results are expressed as mean ± s.d. from independent experiments, n=3 for hESc-
RPE, n=1 for Lonza hRPE. 
 
Quantification performed for several independent experiments confirms the increase in 
ApoE content of cells treated with the higher concentrations of CQ, for a period of one 
week. This was found to be true for both human RPE lines tested (Figure 4. 63). This result 
suggests impairment of ApoE degradation, since it is expected that CQ would impair 
endocytic trafficking. However, at this point, ApoE expression induction should not be 
ruled out. 
As before, Western Blot analysis was performed, in order to convey p62 and LC3 levels 
in cells treated chronically with CQ. Again, the p62 antibody used worked only in human 
cells. LC3, on the other hand, worked for the three RPE lines tested (Figure 4. 64). 
 
Figure 4. 64 - p62 (in human cells) and LC3 II accumulate after a chronic CQ treatment, in hESc-RPE (hRPE), Lonza 
hRPE (LRPE) and porcine RPE (pRPE). +P: POS-fed cells. Actin was used as loading control. A representative result 
is shown from at least two independent experiments. 
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Results obtained show that there is a concomitant increase of p62 in cells treated with 
CQ, proportional to the increase in concentrations used and for both hESc-RPE and Lonza 
hRPE. Regarding LC3, there seems to be induction of LC3 II form, with general 
maintenance of the LC3 I form, for the three RPE lines tested (Figure 4. 64). This strongly 
suggests impairment of the autophagy pathway and, considering possible LC3-associated 
phagocytosis, impairment of LAP-mediated phagocytic processing. 
In the next step, quantification of the obtained blots was performed (Figure 4. 65 and 
Figure 4. 66). 
 
Figure 4. 65 - p62 accumulates upon chronic CQ treatment of hESc-RPE cells (A) and Lonza hRPE (B). Band intensity 
was normalized according to the loading control. The dashed line separates hESc-RPE from Lonza hRPE. Results are 
expressed as mean ± s.d. from independent experiments, n³4. 
 
Quantification results of the blot images is consistent with the initial observation: p62 
accumulates regularly, depending on CQ concentration (Figure 4. 66). 
 
Figure 4. 66 - Chronic CQ treatment causes LC3 II to accumulate, relative to LC3 I, in hESc-RPE (A), Lonza hRPE 
(B) and pRPE (C) cells. Western Blot relative quantification of bands represents the ratio of LC3 II/LC3 I, per condition. 
Band intensity was normalized according to the loading control. Results are expressed as mean ± s.d. from independent 
experiments, n=6 for hESc-RPE; n=4 for Lonza hRPE; n=2 for pRPE. 
 
Regarding LC3 ratio and the representative image shown in Figure 4. 64, the previous 
observation is reinforced: LC3 II accumulates, relative to LC3 I, in the three RPE lines 
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tested. This indicates impairment of (auto)phagosome clearance by the RPE cells, upon 
chronic CQ treatment. 
Altogether, these results suggest that CQ is indeed impairing the endocytic and 
autophagic pathways, thus causing accumulation of substrates, which would otherwise be 
degraded by the lysosome. As undegraded material builds up in the cell, in association with 
increased pH and wide distribution of lysosomes, the cell may meet the conditions for 
lysosomal exocytosis (Blott & Griffiths 2002; Carmona-Gutierrez et al. 2016; Settembre, 
Fraldi, et al. 2013). This was evaluated in the next section. 
 
4.10	CQ-induced	Lysosomal	exocytosis	
Lysosomal exocytosis may be used as a membrane repair mechanism, and it has also 
been proposed to be a cellular stress-defense mechanism, transcriptionally regulated by 
TFEB (Medina et al. 2011). 
hESc-RPE cells, plated onto transwells, were fed with POS for 4h, followed by 
overnight incubation in medium containing increasing concentrations of CQ, from 1-
5µg/mL. The next day, medium was collected from the apical and the basal chambers of 
the transwells and analyzed for ß-hexosaminidade (b-hex) release, according to the 
procedure described in Materials and Methods. b-hex is a lysosomal enzyme and its 
detection is based on the enzymatic hydrolysis of its fluorescent substrate, normalized for 
the respective protein content (Figure 4. 67). 
 
Figure 4. 67 - Acute CQ treatment leads to basal release of b-hex by hESc-RPE cells. The graph shows fold increase 
of β-hex release in the supernatant from CQ-treated cells, compared to control NT cells, from the apical side and from 
the basal side of the cells. Results are expressed as mean ± s.d. from independent experiments, n = 4 (**p<0.01; 
****p<0.0001). 
 
Upon acute overnight treatment with CQ, hESc-RPE cells partially exocytose their 
lysosomal content, as evidenced by b-hex increase in the collected medium. As a polarized 
epithelium, the RPE secreted its lysosomal content mostly via the basalolateral side, with 
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CQ causing up to a 2.8x fold increase, compared to NT control. Regarding the apical 
secretion, there is also increase in the CQ 5µg/mL condition (Figure 4. 67). 
hESc-RPE cells, plated onto transwells, were subjected to the same treatment as 
previously described; treatment was repeated for three consecutive days and after the third 
day, medium was collected from the apical and the basal chambers of the transwells and 
analyzed for ß-hexosaminidade (b-hex) release. This means that the b-hex release analyzed 
corresponds only to the third day of stimulus, and not the cumulative release over those 
three days (Figure 4. 68). 
 
Figure 4. 68 - Continued CQ treatments leads to apical and basal release of b-hex by hESc-RPE. Baf was used as 
positive control. The graph shows fold increase of β-hex release in the supernatant from CQ-treated cells, compared to 
control NT cells, from the apical side and from the basal side of the cells. Results are expressed as mean ± s.d. from 
independent experiments, n = 2 (**p<0.01). 
 
hESc-RPE subjected to continued CQ burden release significant more b-hex than 
control non-treated cells, both apically and basally. Baf was used as a positive control and 
indeed resulted in higher b-hex release. In this case, comparing CQ-induced apical to basal 
release, the differences seem modest: up to 6.7x fold difference for the basal side and up to 
8x fold for the apical side, relative to their respective NT controls (Figure 4. 68). As to the 
CQ concentrations used, no significant difference was found, with all causing similar levels 
of b-hex release. 
hESc-RPE cells, polarized on transwells, were again fed with POS for 4h, followed by 
overnight incubation in medium containing increasing concentrations of CQ, for seven 
consecutive days. After stimulus, medium was collected from the apical and the basal 
chambers of the transwells and analyzed for b-hex release. Thus b-hex release from the 
seventh day of stimulus, not week-long cumulative release (Figure 4. 69). 
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Figure 4. 69 - Chronic CQ burden leads to both apical and basal release of b-hex by hESc-RPE. Baf used uses as 
positive control. The graph shows fold difference of β-hex release in the supernatant from CQ-treated cells, compared 
to control NT cells, from the apical side and from the basal side of the cells. Results are expressed as mean ± s.d. from 
independent experiments, n = 2 (*p<0.05; **p<0.01; ****p<0.0001). 
 
hESc-RPE were able to endure a chronic CQ burden, with no noticeable cell detachment 
or monolayer apparent disturbance (data not shown), but again, released significant 
amounts of b-hex. Baf was used as a positive control, only this time causing b-hex release 
at similar levels to those of CQ-treated cells, suggesting maximization of the effect (Figure 
4. 69). The steep rise of basal b-hex release indicates a dose-dependent effect, from NT to 
CQ at 2.5 µg/mL. This is accompanied by increased release through the apical side. In both 
apical and basal chambers, the CQ-induced release grows higher than that of Baf-treated 
cells. In both apical and basal chambers, the b-hex found when using CQ at 5µg/mL was 
at much lower levels. This possibly indicates an outlier caused by, for instance, an 
experimental error regarding the preparation of that particular CQ-medium solution. These 
experiments should be repeated, in order to confirm these findings. Nevertheless, a strong 
CQ-induced lysosomal exocytosis effect was shown and moreover, the outcome aggravates 
with time of stimulation. 
 
3.11	Final	Conclusion:	Model	of	CQ-induced	Lysosomal	Dysfunction	in	RPE	
Altogether, the previous results indicate that hESc-RPE lysosomal exocytosis emerges 
as a CQ stress-induced adaptation the cell resorts to, when overburden by lysosomal 
dysfunction. 
In the acute stimulus, there is impairment of rhodopsin processing (Figure 4. 15) and, 
to a small extent, of DQ-BSA fluorescence (Figure 4. 21), possibly due to CatD impairment 
(Figure 4. 32), and correspondent modest accumulation of autophagy substrates (Figure 4. 
52); this impairment leads to b-hex secretion mostly though the cells’ basolateral side 
(Figure 4. 67). This is accompanied by translocation of MiT TFs to the cells’ nuclei (Figure 
4. 10), which may account for increase of CatB and CatL activity (Figure 4. 26) 
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Upon continued CQ burden, rhodopsin remains after three days (Figure 4. 16), as well 
as DQ-BSA (Figure 4. 23); although CatB and CatL activity continue elevated (Figure 4. 
28), CatD activity is partially impaired (Figure 4. 36), possibly due to imbalance of its 
processing mechanism into the mature form (Figure 4. 37 and Figure 4. 39); LT is elevated, 
indicating presence of acidic vesicles (Figure 4. 47), possibly due to induction of lysosomal 
biogenesis (Figure 4. 11); still, ApoE moderately accumulates (Figure 4. 56); on the other 
hand, p62 and LC3 recover from initial insult (Figure 4. 58); b-hex release at this time point 
occurs through both apical and basal sides (Figure 4. 68), at maximum levels, based on 
Baf-treated cells. 
Upon chronic CQ treatment, hESc-RPE cells seem to be overwhelmed: MiT TFs appear 
widely distributed in the cell (Figure 4. 12), which may account for the CatB and L 
increased activity (Figure 4. 30), as well as for LT increase (Figure 4. 48); still, there is 
severe impairment of POS and DQ-BSA processing (Figure 4. 19 and Figure 4. 25, 
respectively), as well as accumulation of ApoE (Figure 4. 62), and p62 and LC3 II (Figure 
4. 64), which could be the result of CatD misprocessing (Figure 4. 41). At times, these 
effects were verified for Lonza hRPE and pRPE as well, reaffirming the significance of 
these results concerning RPE cell biology. Ultimately, hESc-RPE resort to lysosomal 
exocytosis (Figure 4. 69), both through apical and basal sides. 
b-hex release through apical and basal regions might indicate over-stressed cells that 
are overflown with cargo, therefore releasing to both sides, but may also reflect an effect 
of CQ in RPE polarization and on the epithelial barrier structure itself (Korthagen et al. 
2015; Beckel et al. 2018). Cellular stress and loss of epithelial integrity are fundamental 
steps in that process. This is supported by ZO1 and Lamp1 IF images obtained upon acute 
CQ treatment of these cells where stronger intensity and wider distribution of Lamp1 
stained lysosomes is observed, upon overnight CQ treatment. Moreover, tight junctions 
labeled by ZO-1 are disturbed, and it is possible to visualize cells separating from each 
other upon CQ treatment (Figure 4. 70). 
 
Figure 4. 70 - hESc-RPE lose their epithelial integrity, upon CQ treatment. IF images using anti-ZO1 and anti-Lamp1 
antibodies demonstrate cellular tight junctions and lysosomal distribution, respectively. Scale bar 10µm. 
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Still, considering the parallel between CQ-induced retinopathy and other retinal 
degenerations, namely AMD, it is reasonable to consider this mechanism as a possible 
explanation for the origins of RPE basal deposits, occurring as an emergent mechanism, of 
cells that survive the burden and bear with it. In fact, drusen-like deposits are found in both 
pathologies, CQ-induced retinopathy and AMD, and have been proposed to stem from RPE 
stress (Peters et al. 2006; Ivanina et al. 1983; Luthert 2011; Galloway et al. 2017). 
Taken together, the data presented throughout this Chapter support the reasoning 
behind this proposition of lysosomal dysfunction being the basis of age-related retinal 
degeneration in AMD. To further confirm morphology of aggregates caused by CQ-
induced lysosomal dysfunction, hESc-RPE and pRPE cells were imaged by Electron 
Microscopy. Briefly, hESc-RPE and pRPE cells, plated onto transwells, fed with POS for 
4h, followed by overnight incubation in medium containing 25 and 10 µg/mL CQ, 
respectively. Cells were fixed and prepared for Electron Microscopy imaging, according 
to the protocols described in Materials and Methods (Figure 4. 71). 
 
Figure 4. 71 - hESc-RPE treated with CQ accumulate large aggregates. Electron micrograph image shows a flattened 
cell, filled with multilamellar structures (white arrow) and multivesicular structures (black arrows). Boxed area shows 
a higher magnification of these structures, resembling a misprocessed phagosome, near the basal region. 
 
EM images of hESc-RPE after CQ acute treatment show the presence of large 
aggregates, with multivesicular structures and multilamellar bodies (Figure 4. 71). These 
could be reminiscent phagosomes, which were not fully processed and accumulate within 
the cell. pRPE subjected to an acute CQ burden of 10 µg/mL also display severely altered 
morphology (Figure 4. 72). 
pRPE treated overnight with CQ displayed multivesicular structures, at times 
containing a mixture of phagosomal reminiscent membranes together with melanosomes 
(Figure 4. 72). These are consistent with the complex granules found in AMD patients’ 
RPE and in age-related degeneration models of disease, which could be at the source of 
melanolipofuscin (Feeney-Burns et al. 1984; Boulton 2014; Ramkumar et al. 2010; 
Boulton et al. 1994; Song & Dunaief 2013; Holz et al. 2014; Wavre-Shapton et al. 2013). 
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Figure 4. 72 - pRPE cells treated overnight with CQ present complex granules and subcellular deposits. Electron 
micrograph images show a stressed cell, filled with multivesicular structures some of which containing melanosomes 
(black arrows). Underneath the cell, there are extracellular drusen-like deposits Boxed area shows a higher 
magnification of one such structure. 
 
Ultimately, both hRPE and pRPE cells present multivesicular and multilamellar 
structures, consistent with reminiscent phagosomes and dysfunctional lysosomes (Figure 
4. 71 and Figure 4. 72). Furthermore, in pRPE, acute CQ stimulus was enough to for the 
cells to form basal extracellular deposits, similar to drusen from AMD RPE cells. The RPE 
morphology and ultrastructure seen in EM images is overall consistent with CQ-induced 
retinopathy (Mahon et al. 2004) and notably with several models of aging RPE and general 
AMD-models (Ferrington et al. 2016; Yoshida et al. 2005; Yang et al. 2014; Cano et al. 
2010; Golestaneh et al. 2017; Sinha et al. 2016; Zhao et al. 2011; Rakoczy et al. 2002; 
Shang et al. 2017). Moreover, hPSc-RPE developed from AMD patients iPS cells were 
shown to recapitulate similar features in vitro, namely drusen formation and ECM 
remodeling (Galloway et al. 2017). 
 
Taken together, evidence supports the use of the proposed hESc-RPE cells as a reliable 
model to study lysosomal dysfunction, as key initiation event underlying age-related retinal 
degenerative disorders. 
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CHAPTER 5 
Conclusion and Future Perspectives 
 
The molecular underpinning of age-related disorders is very complex and ill defined. 
Mechanisms common to these diseases have been proposed as the hallmarks of aging. 
Specifically, aging leads to genomic instability, with telomere abrasion and epigenetic 
modifications, to loss of proteostasis and nutrient-sensing defects, to mitochondrial defects 
and cell senescence (López-Otín et al. 2013) (Figure 5.1). 
 
Figure 5.  1 - The hallmarks of aging functional interconnections. Adapted from (López-Otín et al. 2013). 
Notably, most of these processes are in some degree dependent on lysosomal function, 
and on the efficient continuous recycling and replacing of cellular constituents. When this 
turnover is defective or loses its efficiency, for instance in the case of long-lived postmitotic 
cells, accumulation of “cellular waste” occurs. 
The goal of the present work was to obtain an RPE model of retinal degeneration which 
closely recapitulates features of age-related degeneration, particularly focused on those that 
are common to Choroideremia and AMD.  
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The full complexity of the ocular unit is only recapitulated in the animal model system 
and genetically modified animals, such as the Chm conditional knockout mouse (ChmFLOX, 
Tyr-Cre+), permit the manipulation of the whole visual system and an in-depth study of 
the whole retinal degenerative process (Wavre-Shapton et al. 2013). With this in mind, the 
initial experiments were aimed at establishing a cell-based model from this genetically 
modified mouse. However, mouse RPE precursor cells were shown to be much harder to 
manipulate than their human counterpart. This might have been a consequence of the 
improved technical skills and manipulation dexterity, but it can also reflect on intrinsic 
characteristics of species differentiation aspects. Also, it could be related to the fact that 
mouse cells went through several rounds of additional manipulation: culture of MEFs, 
reprogramming by viral transduction and clone selection, transduction with reporters and 
re-selection, continuous passaging and expansion for characterization. Throughout these 
processes, many things might influence the differentiation potential of the cells. 
Ultimately, the use of cell-based strategies rather than animals permits a critical 
simplification of the system, while maintaining the cellular features which, in the case of 
RPE, recapitulate the in situ situation. In particular, cell models of disease allow a higher 
degree of control over experimental variables and also higher throughput. Furthermore, in 
this particular case, since the retinal degeneration disorders under study affect primarily 
the macula region, the mouse model might not be the better option. 
On the other hand, whilst first experiments contemplated an already modified cell line 
which would recapitulate Chm features, in the case of the human ESc, after differentiation, 
the disease features have to be induced. This plan-adjustment allows the ultimate goal to 
remain the same, whereas the process is simplified, more standardized and with a higher 
degree of control over variables. Nevertheless, the study of specific mechanisms involved 
in Chm disease development were not discarded, and in fact, future projects surfaced, 
which foresee using human iPS cells from Chm patients and differentiate them into RPE. 
For the present work, spontaneous and directed differentiation approaches of hES cells, 
were undertaken. While spontaneous differentiation takes around 120 days before starting 
the enrichment phase, this step is almost surpassed with the guided differentiation method. 
This happens because guided differentiation triggers all cells virtually at the same time, 
step by step, and thus renders higher purity at the end of the 14-day period. Consequently, 
the guided differentiation method takes approximately 90 days to achieve mature, pure 
RPE. After first passage, these cells can already be plated onto the appropriate wells 
destined for a certain assay; from that point on, cells take approximately two weeks to 30 
days to fully regain polarization and pigmentation, typical of mature RPE, and thus to be 
ready for experiments. 
Following differentiation experiments, characterization assays were performed, in 
order to demonstrate the reliability of hESc-RPE as a model of RPE. Morphologically, 
these cells resemble both primary RPE lines evaluated (pRPE and Lonza hRPE). hESc-
RPE are able to polarize properly and develop into a monolayer, secured by tight junctions 
and with substantial TER, resembling other RPE lines tested, or found in literature. 
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Moreover, these cells express critical markers, typical of RPE, which suggest they are 
readily functional, at least to the same extent as primary RPE and other RPE cell lines are. 
In some regards, both hESc-RPE and primary RPE (pRPE and Lonza hRPE) surpass 
standard RPE cell lines in their RPE-likeness. 
hESc-RPE actively pigment and, when passaged, suffer pigmentation dilution (as other 
RPE lines do), but regain their heavy dark color again, whereas most RPE lines do not re-
pigment. This is a factor that should be taken into account when analyzing the outcomes of 
subsequent experiments. While porcine cells are moderately pigmented with fully matured 
melanosomes, Lonza hRPE cells are only slightly pigmented (but can be stimulated to 
pigment) and hESc-RPE become heavily pigmented over time. This might be because both 
human lines (hESc-RPE and Lonza-RPE) are more similar to fetal RPE than adult, as is 
the case of porcine cells. 
Furthermore, hESc-RPE were evaluated for their secretion ability. While the results are 
preliminary and VEGF should be re-evaluated by finer techniques (such as ELISA), there 
is a strong indication that the cells are in fact secreting PEDF and VEGF in a polarized 
manner. 
Under homeostatic conditions, RPE cells work as professional phagocytes, taking part 
in the daily visual cycle by engulfing and digesting POS. RPE cells are post-mitotic, 
meaning they endure proteolytic processing of an estimated billion photoreceptor disks 
over a 70-year lifetime(Kevany et al. 2010; Mazzoni et al. 2014; Keeling et al. 2018). For 
this reason, lysosomal burden and dysregulation of endocytic and autophagic cargo 
handling are considered crucial for retinal degeneration disorders. Age-related 
accumulation of POS-derived products has been proposed to occur as the result of a slower 
rate of POS processing, stemming from lysosomal dysfunction. In this context, the ability 
of RPE cells to digest POS was evaluated thoroughly. Although hESc-RPE were able to 
promptly process their phagocytic cargo, single-pulse experiments using primary culture 
RPE (porcine and human) revealed that POS may take more than one week to be fully 
processed. Moreover, upon continuous feedings of hESc-RPE, reminiscent rhodopsin was 
found to increase, suggesting accumulation of unprocessed material from one feeding to 
the next. Building on this notion, autofluorescence granules derived from POS lysosomal 
processing were found to appear following POS feedings and remain within cells for long 
periods of time. Emergence of autofluorescent granules is typically found in the human 
eye, from adulthood, and aggravated with aging and notably in retinal disease settings. 
Another important feature is pigmentation. Specifically, contrary to other more 
established RPE cell lines such as ARPE19, D407 or hTERT-RPE01, hESc-RPE actively 
produce and retain their pigment. Pigmentation is another critical aspect, particularly when 
studying lysosomal function. This is due to the fact that melanosomes are lysosome-related, 
meaning the same molecular players involved in fundamental aspects of melanosome 
biology are shared with typical degradative lysosomes. And more importantly, pigmentary 
changes are often observed in disease settings (Rakoczy et al. 2002; Rimpelä et al. 2016; 
Juuti-Uusitalo et al. 2017; Arunkumar et al. 2018). 
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These two properties (autofluorescence and pigmentation) establish these RPE lines as 
promising models that recapitulate important clinical features, therefore useful to dissect 
the molecular mechanisms underlying these diseases. The fact that autofluorescence is 
easily detected in models of RPE, opens new avenues of research, namely using the 
chemically defined byproduct of POS degradation which is thought to be responsible for 
the autofluorescence granules, A2E. As discussed in Chapter 1, A2E is the main component 
of lipofuscin and it is found heavily accumulated in Stargardt’s patients RPE cells (Luthert 
2011; Moreno-García et al. 2018). A2E is uptaken by RPE cells and causes ill-
characterized lysosomal dysfunction (Keeling et al. 2018). Because of similarities between 
Stargardt’s early onset macular degeneration and late-onset AMD, the study of lysosomal 
dysfunction triggered by A2E accumulation appears as an interesting research avenue. A2E 
autofluorescence can be readily identified (either by microscopy or flow cytometry), 
namely using the herein established RPE models (data not shown). This potentiates the use 
of the newly established hESc-RPE cells to underpin the molecular mechanisms underlying 
A2E-derived lysosomal dysfunction and the importance of these processes for retinal 
degenerative disorders’ early events. 
In comparison to primary cultures, whether from human or from porcine origin, hESc-
RPE offer virtually endless clonality. And, because of this potentially endless dividing-
capacity of stem cells, hESc-RPE pave the way for high throughput drug screenings, 
aiming at restoring RPE function, particularly lysosomal function. This is imperative, 
taking into account the scarce sources for human RPE, but also to ensure standardization 
of experimental variables, by using practically the same cells from one experiment to the 
next. Furthermore, induced Pluripotent Stem cell-derived RPE cells from macular 
dystrophies’ patients were recently shown to recapitulate critical features of the diseases. 
Such is the case of drusen formation and also the ability of these cells to modulate their 
extracellular matrix (ECM) constitution and turnover (Galloway et al. 2017). Still, the 
molecular mechanisms underlying these events have not been fully elucidated. 
In an effort to explain the initial events which trigger AMD-hallmark drusen formation, 
CQ-based model of lysosomal dysfunction was proposed and characterized thoroughly. 
Initially, viability studies and comparison between the three RPE cell lines were 
important to establish the range of CQ concentrations used in the following studies. 
Although the three RPE lines displayed different thresholds of cytotoxicity, a pattern of 
response was inferred: when subjected to low CQ concentrations, there was a modest 
cytotoxicity (increase of LDH secretion), followed by a return to normal (non-treated 
control) values. This first increase may be attributed to the early death of more fragile cells, 
which are not able to endure the insult, releasing LDH into the medium. The remaining 
cells, however, were shown able to withstand a low-dose CQ burden for a week. 
Regarding the differences between the three RPE lines, it became obvious that pRPE is 
more sensitive to CQ than human RPE. This characteristic may be attributed to species 
inherent differences, but also to the fact that these porcine cells are adult cells, while both 
human RPE lines are more closely related to embryonic RPE. In fact, human RPE lines 
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were obtained from fetal RPE primary cultures (Lonza hRPE) and from human Embryonic 
Stem cells differentiation (hESc-RPE). As previously discussed, RPE cells are kept 
virtually unchanged throughout life, meaning that porcine cells endured a pig’s lifetime of 
challenges, which can result from a wide range of factors, from typical light-induced 
oxidative stress to abnormal life-style related variables. For instance, prior to collection, 
porcine RPE cells exerted their phagocytic function of POS, necessary for the pig’s visual 
function. In theory, because Lonza hRPE was collected at embryonic stage, this RPE 
virtually never participated in the visual process, as it was retrieved before birth. As for 
hESc-RPE, since it was derived through a directed differentiation approach, these cells 
effectively never came into contact with POS before experiments. On the one hand, the 
“age-related” differences of the three RPE lines add an extra level of complexity to the 
subsequent studies, with many new variables to consider. On the other hand, the fact that 
we have these three different lines allows for a deeper understanding of the general RPE 
biology. Specifically, our RPE systems range from a completely naïve hESc-RPE to an 
adult pRPE, essentially allowing us to deeply ponder every inference and more confidently 
extrapolate conclusions from the results. 
Following the establishment of CQ dosages and stimulus timeline, experimental 
conditions were set. Specifically, the experimental layout consisted on daily 4h POS pulse, 
followed by overnight CQ treatment. At this point it is important to mention that during 
the course of the daily POS feeding, cells were kept in medium supplemented with 
10%FBS and without CQ. This experimental setup was implemented for two reasons: 1) 
RPE cells’ phagocytic ability relies on stimulated receptor engagement (possibly from 
serum-contained ligands) and also on high energy levels; for this reason, low serum/serum 
free RPE cultures run out of energy and cease phagocytosis and digestion; 2) in order to 
avoid confounding factors, such as a possible CQ-induced effect on POS uptake by the 
cells, CQ was added to the medium only after the 4h POS pulse; this was a way to assure 
the phagocytic cargo reached the lysosome and that tentatively only the degradation step 
was hindered. When setting up a new experimental protocol, there are many parameters 
that should be taken into account. On this regard, the fact that CQ regimen is stopped every 
day, for the duration of the POS pulse, could mean that the cells have a short time-window 
to partially recover from the insult. Nevertheless, this potential experimental bias was 
always taken into account during the discussion of results. Furthermore, CQ-induced 
effects were significantly different throughout time, suggesting that cells are not able 
recover completely, thus experiencing a chronic dysfunction. 
These time-dependent responses were characterized in depth, beginning with MiT TF 
subcellular characterization. Overall, the results obtained in this regard indicate that CQ 
burden, over time, induces observable changes in MiT TFs subcellular localizations. CQ 
remains in the cells for long periods, even after treatment discontinuation, which may 
account for a cumulative effect over time. An acute overnight treatment with CQ at 5µg/mL 
is sufficient to cause translocation of TFEB, TFE3 and MITF to the nuclear area of the 
cells (Figure 4.9). After three consecutive days of continued treatment, the nuclear 
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localization of the TFs is even more obvious (Figure 4.10). After a week of chronic 
stimulation, the whole cell area is stained with these TFs (Figure 4.11). These results 
suggest there is potential induction of lysosomal biogenesis and of the TFs themselves, 
which must be confirmed, for instance through qPCR to evaluate expression of MiT-driven 
lysosomal genes. 
Finally, crucial lysosomal functions were evaluated, in an effort to describe the 
lysosomal disturbance produced by CQ burden.  
Impairment of phagocytic cargo processing was demonstrated by the presence of 
reminiscent rhodopsin granules which accumulate intracellularly, depending on CQ 
concentration and becoming more and more severely accumulated over time. Deficiency 
of cargo processing was further demonstrated, through the decline of DQ-BSA proteolytic 
breakdown, and consequent fluorescence decrease. The damage is not very pronounced 
with the acute treatment, but explicit in the continued situation, using higher CQ 
concentrations, and in the chronic CQ-treatment, for all concentrations used. This indicates 
that although the effects using low CQ dosages are less pronounced, it is a question of time 
until they accumulate sufficiently to cause damage. Finally, ApoE, p62 and LC3 protein 
levels were evaluated and shown to be disturbed upon chronic CQ treatments, in hESc-
RPE and in Lonza hRPE and, in the case of LC3, in pRPE as well. 
ApoE can be found in endocytic membranes and, in fact, it has been described to be 
involved in sorting of endocytic amyloids, within pigmented cells, to melanosomes and to 
exosomes (van Niel et al. 2015). In the proposed model of CQ-induced hESc-RPE 
degeneration, ApoE was shown to accumulate concomitantly with the increase in CQ 
concentration the cells were subjected to. This accumulation is rapidly induced using Baf, 
as shown by the acute treatments. After continued CQ treatment, ApoE accumulation is 
already at similar levels than those found in Baf-treated cells. And this buildup is more 
severe after a week-long treatment. ApoE accumulation was evaluated here only 
considering whole cell lysates, or imaging cells in glass coverslips. Because of the way 
lysates were collected, directly from the well, there is no distinction between intracellular 
and extracellular ApoE content, i.e. drusen-like deposits. And, in fact, the extracellular 
matrix content of this protein might not be enough for a prompt detection. In any case, 
accumulation of ApoE in this model agrees with the parallel with AMD-related retinal 
degeneration, where ApoE builds up in drusen deposits (Hageman et al. 2001; Wang & 
Neufeld 2010; Klaver et al. 1998). 
p62 was found to accumulate consistently, when cells were treated with CQ for long 
periods of time. It is interesting to notice that, alike in the case of CatD, there seem to be 
different time-dependent adaptations. Specifically, there is initial accumulation of the 
protein, in the acute treatment, followed by partial resolution, after three days of continued 
treatment and, finally, the cells can no longer cope with the insult and, in the chronic 
situation, there is strong accumulation again. It is worth mentioning that it is not easy to 
probe p62 in non-treated cells, by western blot, as basal levels are low; in fact, in some 
cases, the only readily visible band is that of Baf-treated cells. When processing images to 
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quantify, this should be taken into account, to avoid over interpretation of results. Still, in 
CQ-chronically-treated cells, p62 is readily visible, with a progressive increase, depending 
on CQ concentration. 
Furthermore, in order to determine LC3 and thus (auto)phagosome turnover, the ratio 
of lipidated to non-lipidated forms was evaluated. According to established guidelines, the 
total amount of LC3 II is directly correlated to the number of autophagosomes that will 
fuse with the lysosome for degradation. Still, to evaluate autophagic flux at a given point, 
each of the control situations should be considered and established as boundaries 
(Mizushima & Yoshimori 2007). In the acute situation, the blots suggest that CQ causes 
an impairment of autophagy clearance, with increase of LC3 II. In the case of POS-fed 
cells, even though there is also, perhaps, LC3-associated phagocytosis-cargo, it seems to 
be readily processed instead of accumulating as LC3 II (auto)phagosomes. In accordance 
to p62 findings, at the third-day time point of CQ-treatment, LC3 II levels are lower, at 
times hard to detect. At the continued time point, fewer membranes were measured 
precisely because detection was difficult. This indicates that the levels are low, but also 
stresses the need to optimize the protocol and repeat the experiments. Still, at the seventh-
day time point, there is a clear accumulation of LC3 II, suggesting autophagy blockade, 
consistent with p62 findings. 
Accumulation of all these different types of cargo may be attributed to proteases 
malfunction and, regarding this aspect, CatD proteolytic activity and protein levels were 
assessed. CatD was shown to be affected by the acute CQ treatment and, despite a 
compensatory response of overexpression, was shown not to be fully processed. When 
CatD is synthesized, it undergoes numerous proteolytic cleavages. The 52 kDa 
procathepsin is the result of the initial removal of a signal peptide. This procathepsin is 
targeted to lysosomes where it is cleaved into the 48 kDa single-chain molecule and then 
cleaved again into the mature two-chain (Laurent-Matha et al. 2006). CQ could, therefore, 
be impairing correct trafficking of procathepsin and delivery into the lysosome or it could 
inhibit proteolytic activity of enzymes responsible for procathepsin processing, within the 
lysosome. Both the 48 kDa procathepsin and the mature 34 kDa forms are reduced after 
one week of CQ treatment, suggesting not only impairment of single-chain molecule 
cleavage to produce the mature form, but also disruption of the previous step where the 52 
kDa form is cleaved into the 48 kDa form. Regarding the role of CatB and CatL in the later 
steps of CatD processing, these two cysteine proteases are not involved in the first steps of 
precursor processing (Laurent-Matha et al. 2006). Furthermore, CatD processing has been 
described to be independent of its own catalytic function, which indicates CQ is effectively 
disrupting the activity of other proteases, responsible for initial CatD processing events. It 
is interesting to note that CatD mutations are sufficient to cause retinal degeneration (Zhang 
et al. 2005). Specifically, CatD mutant animal models accumulate undigested material, 
most notably, POS, and develop degeneration of the RPE, similarly to AMD, presenting 
drusen-like deposits (Rakoczy et al. 1996; Rakoczy et al. 2002; Myllykangas et al. 2005). 
Because CQ produced an effect regarding CatD maturation, it would be interesting to 
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modulate this protease alone and verify whether the other CQ-induced could be traced back 
to the inactive CatD. Because the present work demonstrated the possibility of studying 
CatD maturation impairment in the cell-based RPE models, there are now plans being put 
in place, in that regard. Specifically, CatD dominant negative mutants are now being 
developed, in an effort to deepen our understanding of the molecular mechanisms behind 
this specific trigger for RPE degeneration (data not shown). 
Coming back to the present study, CatB and CatL proteolytic activity assessment results 
may sound counter-intuitive considering the rhodopsin and DQ-BSA proteolytic 
processing results. However, these cathepsins might not be the main players in these 
substrates degradation. Furthermore, it is worth mentioning that cathepsins can be 
permissive in their target amino acid sequence and recognize substrates of other proteases. 
CQ causes a raise of lysosomal pH, sufficient to disrupt some proteases’ activity (for 
instance CatD), but this was shown not to be the case of CatB nor CatL. In addition, the 
dogma in the field is that LT’s fluorescence is reduced in the presence of lysosomotropic 
compounds (such as CQ), but in fact the present study shows contradictory results to that 
statement. This was also the case of a recent study (using RPE cells), which reports that 
upon prolonged CQ burden there is actually increase of LT and of Magic Red fluorescence. 
In fact, this study includes results showing lower LT fluorescence levels upon short 
(30min-1h) treatments with lysosomotropic drugs (including CQ) and subsequent increase 
of LT fluorescence detected in cells treated for longer periods of time (4h-24h) (Lu et al. 
2017). These are consistent with the results presented herein, obtained using hESc-RPE. 
The difference is that, in the present study, 24h incubation is considered as an acute rather 
than chronic stimulation, in which case cells were burdened for one week. 
Contrary to what was expected, LT fluorescence increases upon CQ treatment, which 
lowers lysosomal pH. This is perplexing because in fact, both LT and CQ work by 
accumulating within acidic organelles. However, LT’s retention mechanism in the 
membranes of these organelles is not yet fully understood and although this dye is widely 
used to label generic acidic vesicles, the manufacturer reports that it exhibits fluorescence 
“largely independent of pH” (Invitrogen 2007). 
Lysosomal pH is a difficult property to measure because lysosomes are intrinsically 
dynamic and, for the V-ATPase to pump protons into the lysosomal lumen, a gradient is 
required, which can be rapidly dissipated in dying cells (Guha, Coffey, et al. 2014). For 
this reason, lysosomal pH should be assessed in living cells. Still, reliable pH reporters are 
hard to come by and more complex techniques are difficult to implement in a standardized 
manner. For instance, it is possible to assess pH through ratiometric measurements of pH 
sensitive to pH insensitive fluorophores. Fluorescein, Oregon Green and rhodamine 
derivates, for instance, can be used to this effect. Yet, these techniques require extensive 
calibration procedures, which may not always be straightforward (Kissing et al. 2017). 
Other methods, such as the DAMP assay, which consists on labeling acidic organelles with 
DAMP (3-(2,4-dini- troanilino)-30-amino-N-methyldipropylamine) and fixing samples for 
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electron microscopy, could be used but still pose drawbacks similar to those of LT (Kissing 
et al. 2017). 
The use of LT is sometimes controversial; thus analysis of the results should always be 
subjected to a detailed critique for proper clarification. Firstly, detection of LT’s 
fluorescence conveys either an increase/decrease of pH or a change in the number or area 
of labeled structures that occupy the cells. This includes smaller to swollen lysosomes and 
also few lysosomes to cytoplasm-filled cells variations (Guha, Coffey, et al. 2014). For this 
reason, LT is not considered the most sensitive probe and, particularly in flow cytometry 
experiments, data are harder to interpret. Whenever using LT, it is important to keep in 
mind that it is sensitive to a relatively high range of pH. In addition, it accumulates with 
time within those vesicles and can itself raise the organelle’s pH. For this reason, low 
concentrations and short pulse periods should be implemented, to prevent unwanted 
effects. Specifically regarding the presented experiments, LT was added only before signal 
acquisition, thus should represent relatively low pH compartments (not exclusively 
lysosomes) at that time. 
A crucial aspect of the analysis is the pigmentation confounding factor. Although it is 
expected that cells treated in the same manner will behave the same, this is not always the 
case. In fact, as shown prior, hESc-RPE are continuously pigmenting, even more so when 
they are subjected to CQ or Baf treatments. This is to be expected, given the role of MiT 
TFs in pigmentation and also the role of the V-ATPase and lysosomal pH in their regulation 
and vice-versa (Napolitano & Ballabio 2016). For this reason, in order to confirm the 
results obtained, these experiments must be repeated. Nevertheless, in this case, 
pigmentation would, in theory, quench the fluorescence signal. Even if there is more 
pigmentation in cells treated with CQ, LT fluorescence still increases. This excludes 
fluorescence-quenching as a confounding factor in this case, and reaffirms a CQ-mediated 
upsurge (and wider distribution) of labeled vesicles. 
Finally, lysosomes are known to fuse with the plasma membrane, thereby releasing 
their content through a processed termed lysosomal exocytosis. This property was initially 
attributed to professional secretory cells with specialized lysosome-related organelles. 
However, unspecialized cells are also able to secrete their lysosomal contents, upon 
stimulation. The molecular machinery required for lysosomal exocytosis includes 
SNAREs, Ca2+ sensors and Rab proteins, among others (Blott & Griffiths 2002). 
Additionally, autophagy-related proteins have been associated with polarized secretion of 
lysosomes (DeSelm et al. 2011). Because lysosomal positioning is tightly regulated and 
relative to their intraluminal pH, lysosomal exocytosis was evaluated here. The reasoning 
behind these experiments lies with the idea of different lysosomal pools exerting specific 
functions within the cell, dependent on both their position and luminal pH (Cabukusta & 
Neefjes 2018; Korolchuk et al. 2011; Johnson et al. 2016). As such, less acidic lysosomes 
would stay at the cell membrane periphery, possibly secreting their content, and overall 
regulating extracellular exchange of material, important namely for ECM remodeling. The 
experiments presented herein support that idea. In fact lysosomal exocytosis was found to 
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occur, towards the basal side, after acute CQ insult of hESc-RPE cells. Furthermore, 
consistent with this line of thought, extracellular basal deposits were found in pRPE cells, 
upon acute CQ treatment. 
Overall, throughout this work, several aspects of lysosomal biology were shown 
perturbed by overburden (Table IV). 
Table IV: Summary of findings regarding the hESc-RPE CQ-induced lysosomal dysfunction model. 
 
 
More importantly, clinically relevant features of AMD, namely autofluorescence, 
pigmentation differences and drusen-like deposits were found in the presented cell-based 
models of RPE (Figure 5.2). 
Concerning the CQ model specifically, seemingly conflicting results arose. If, on the 
one hand, lysosomal dysfunction was shown by the accumulation of undegraded cargo and 
CatD misprocessing, on the other hand, MiT TFs nuclear translocation also occurred, as a 
result of CQ treatments. TFEB in particular is a well-known modulator of lysosomal 
function and stimulation of its function has been proposed to resolve lysosomal storage 
diseases (Spampanato et al. 2013; Decressac et al. 2013; Polito et al. 2014; Tsunemi et al. 
2012), as discussed in Chapter 1. Therefore, MiT subcellular localization dysregulation 
after prolonged CQ treatments is puzzling. Nevertheless, TFEB was shown to become 
abnormally activated in the context of LSDs (Marco Sardiello et al. 2009), which may 
conflict with the idea of using it as a therapeutic agent.  
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Figure 5.  2 - RPE model of chloroquine-induced lysosomal dysfunction. Chloroquine accumulates in mildly acidic 
compartments; MiT transcription factors translocate to the nucleus; Phagocytic, endocytic and autophagy-cargo 
accumulate; Lysotracker-labeled CatB and CatL-active lysosomes accumulate; CatD processing is impaired; 
Lysosomal exocytosis occurs and basal extracellular deposits are formed. 
 
Ultimately, the present work confirmed the complex regulation of lysosome biology, 
and highlighted some undetermined mechanisms, now under study. 
Perhaps in the CQ model the lysosomal dysfunction is too complex to easily dissect. 
Still, from these assays, it was possible to find isolated targets, altered as a consequence of 
CQ treatment, which by themselves are interesting to dissect. From this point on, a more 
targeted approach may be undertaken, specifically to dissect the roles of MiT TFs and CatD 
in phagosomal processing, using the novel now established cell-based models of RPE. 
 
Looking back to the very beginning of the PhD, a significant amount of effort was 
adjudicated to construct a pathway from RPE studies done in mice and in mouse iPS cells 
up to studies in reliable human RPE cells, namely those derived from stem cells, but also 
in the Lonza hRPE. In particular, state of the art research projects came out from these first 
experiments and are paving the way into industry and pre-clinical settings. Specifically, 
there are projects underway, aiming at developing a complex in vitro system recapitulating 
not only the RPE, but also the Bruch’s membrane and the choroidal vascular network and 
also collaborations based on the use of these cell-based models to test pharmaceutical 
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components to reverse and/or prevent AMD. Overall, the present work opened up a whole 
new perspective concerning the work currently being developed in the lab. In particular, 
several new lines of research came out of it, with promising targets of study and with 
reliable new models with which to dissect them.
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ABSTRACT	
The Retinal Pigment Epithelium (RPE) is a highly specialized layer of cells, representing 
a fundamental component of the visual unit. A disturbance of the delicate balance of RPE 
functions can give rise to retinal degeneration with progression to blindness. 
RPE’s role in disease onset and progression has been shown critical, particularly 
regarding VEGF secretion control. VEGFR2, a known regulator of pro-angiogenic 
signaling in endothelial cells, is also expressed by RPE cells and its intracellular 
trafficking is regulated by RabGTPases. Through Rab-regulated endocytosis of VEGFR2, 
RPE cells are capable of titrating available VEGF in the retinal milieu. 
Keywords: VEGF, RabGTPases, VEGFR2, RPE 
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INTRODUCTION	
Our sense of vision relies on three highly interdependent layers of the retina: the 
neuroretina, the retinal pigment epithelium (RPE) and the choroid(Sung & Chuang 2010). 
The RPE in particular establishes a morphological and functional barrier, assuring the 
integrity and interaction of the entire visual unit (Song & Bharti 2016; Strauss 2005b). 
On the apical side, the RPE provides nutrients to the neuroretina, transports ions and 
metabolic waste and extends microvilli to phagocytose the photoreceptors’ outer 
segments and recycle the visual pigment. On the basolateral side, the RPE contacts with 
the choroid capillaries through the Bruch’s membrane, posing as the selective blood-
retina barrier(Strauss 2005b). In order to communicate with the adjacent layers, the RPE 
secretes different factors and expresses several transmembrane receptors in a polarized 
manner(Marmorstein 2001).  
The Vascular Endothelial Growth Factor (VEGF), namely VEGF-A, is one of such 
vital factors, both during retinal development and for choroid maintenance throughout 
life. VEGF has been a target of study, particularly due to its role in the pathogenesis of 
retinal degeneration disorders, as a mediator of neovascularization and barrier 
disruption(Knatokie M Ford et al. 2011; Penn et al. 2008). A disturbance of these tightly 
controlled processes can cause RPE degeneration, photoreceptor death and 
choriocapillaries atrophy or overgrowth, ultimately leading to blindness(Strauss 2005b). 
RPE dysfunction has been shown crucial to retinal degenerative disorders onset and 
progression, particularly due to RPE’s role in VEGF secretion control. It has been 
previously described that RPE cells express both VEGF and its receptors: VEGFR1 and 
VEGFR2(Knatokie M. Ford et al. 2011). Both these receptors contain an extracellular 
VEGF-binding domain, but while VEGFR1 has been suggested to be a “decoy” receptor 
that sequesters VEGF, VEGFR2 mediates pro-angiogenic signaling, culminating in 
survival, proliferation and migration of cells. This is true for endothelial cells, however, 
when considering the RPE, proliferation and migration are kept to a minimum throughout 
life, in healthy conditions(Fuhrmann et al. 2014). This suggests there could be another 
function and outcome of VEGF intake by RPE, such as titration of the extracellular 
soluble VEGF. Furthermore, we know Rab GTPases are key regulators of intracellular 
trafficking and have been described as molecular players in VEGFR2 endocytic 
trafficking, in endothelial cells(Jopling et al. 2009). 
In an effort to explore the mechanisms by which the RPE controls VEGF secretion and 
uptake, we sought out to clarify the Rab-regulated endocytic pathway’s involvement in 
this process.  
Understanding how Rab proteins functions’ disruption could affect VEGF secretion 
and uptake, possibly contributing to angiogenesis, would ultimately contribute to find 
new therapeutic agents. With this study we aim to shed light on the RPE role as VEGF 
regulator, through Rab-regulated endocytosis of VEGFR2, and open the door to possible 
new therapies, targeting specifically RPE cells and VEGFR2 trafficking. 
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RESULTS	
B6-RPE07 as an RPE model to evaluate VEGF regulation 
Expression and secretion of VEGF have been well documented, both in RPE primary 
culture cells and RPE cell lines(Geisen et al. 2006; Klettner et al. 2012). These cells have 
also been shown to express VEGFR2(Wang et al. 2011; Ford et al. 2011; Guerrin et al. 
1995). Furthermore, research suggests a crucial role for VEGF/VEGFR2 interplay in 
fundamental RPE functions(Ablonczy & Crosson 2007; Dahrouj et al. 2015; Guerrin et 
al. 1995; Dahrouj et al. 2014), and clinical observations revealed RPE-derived VEGF to 
be essential to choroid health(Marneros et al. 2005; Penn et al. 2008). 
B6-RPE07 mouse RPE cell line has previously been reported to produce cytokines and 
chemokines, including VEGF(Hombrebueno et al. 2014). The present study confirms not 
only expression and secretion of VEGF, but also expression of VEGFR2 and 
endocytic/recycling RabGTPases Rab4a, Rab4b, Rab5a, Rab5b, Rab7a, Rab11a and 
Rab11b (Fig.1). 
 
 
This set of RabGTPases was selected based on previous studies, and to further 
elucidate their potential involvement in soluble VEGF secretion by RPE cells. Rab 
expression levels were found similar to those of RPE primary culture lines, except for 
Rab5a and Rab5b, with B6-RPE07 displaying a relatively higher expression (Fig.1A). 
VEGF and VEGFR2 expression levels were similar for all cells tested (Fig.1B). Finally, 
B6-RPE07 were shown to secrete VEGF to the culture medium (Fig.1C), as soon as 6h 
after plating and in a regular manner up until 48h after plating, indicating B6-RPE07 as a 
suitable model for the study of VEGF and VEGFR2 regulation in the RPE. 
 
A. B. 
C. 
Figure  1- RPE cells express Rab4a, Rab4b, Rab5a, Rab5b, Rab5c, Rab7a, Rab11a, Rab11b and VEGF and VEGFR2. 
A. Electrophoretic analysis of RT-PCR products of Rab4a, Rab4b, Rab5a, Rab5b, Rab5c, Rab7a, Rab11a and Rab11b 
in B6-RPE07 cell line and RPE primary cultures. B.  Electrophoretic analysis of RT-PCR products of VEGF and 
VEGFR2 in B6-RPE07 cell line and RPE primary cultures. HPRT expression was used as control transcript. C. 
Evaluation of VEGF secretion in the conditioned medium of B6-RPE07 cells along the time (n=4). 
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miR-silencing adenoviruses efficiently knock down Rab GTPases  
In order to evaluate RabGTPases’ influence in VEGF intracellular trafficking, we first 
sought out to knock down (KD) each endocytic rab individually. To this end, ssDNA 
oligos, were designed and cloned into adenoviral vectors to create silencing molecular 
tools for the target proteins, as previously described in Material and Methods section. For 
each target protein, 1 to 3 sequences were designed. In order to efficiently reproduce the 
ability of infectious adenoviral vectors to create quantifiable biological events, all viral 
preparations were titrated prior to usage.  
Adenoviruses were added and transduction was left to occur overnight. The next day, 
cells were fed with fresh serum-free medium for 8h, after which cells were given fresh 
medium with 1%FBS. 48h after, cells were harvested in lysis buffer and prepared for 
Western Blot analysis. All data are expressed as pg/ml of VEGF secreted by 9x104 B6-
RPE07 cells, referring to the initial cell seeding density. No evidence was found as to 
differences in proliferation or death between all conditions (data not shown). The level of 
endogenous Rab proteins’ KD was assessed by probing membranes with specific 
polyclonal antibodies against each rab isoform and using either calnexin or bactin as 
loading control, as presented in Fig. 2.  
For each individual rab, a representative western blot image is presented, showing a 
downregulation of that specific protein, relatively to a non-transduced cell lysate (NT) 
and also to a cell lysate from cells transduced with a control miR (Scr). Efficiency of KD 
was quantified by comparison of band intensities of endogenous Rab KD to negative 
control (Scr), by densitometric analysis. No significant differences were found between 
non-transduced (NT) and negative control cells (Scr). For all Rab proteins tested KD 
levels were 50% or higher. Note: polyclonal antibodies specific for every rab isoform 
were used, except for rab4; i.e. anti-rab4 antibody recognizes both rab4a and rab4b. 
Nonetheless, a statistically significant reduction of rab4 (either a or b isoforms) was 
detected, using the miR specifically designed to target each isoform. Therefore, it was 
considered that a precise knock down of each isoform was attained, detected by a decrease 
of expression of total Rab4 (to 20% for rab4a KD and 50% for rab4b KD). 
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Figure  2 miR-silencing adenoviruses efficiently knock-down target Rab GTPases in RPE cells. Representative western blot 
image and densiometric evaluation of Rab expression, normalized for calnexin or β-actin. Data are expressed as percentage 
of expression (mean±SEM, n≥ 3). Significance was determined using One-way ANOVA. * P<0.05, **P<0.01, ***P<0.001. 
No significant changes were observed between non-transduced cells (NT) and cells transduced with an adenovirus 
expressing an irrelevant mir control (Scr). Rab4a (n=5), Rab4b (n=5), Rab5a (n=3), Rab5b (n=3), Rab5c (n=5), Rab7a (n=4), 
Rab11a (n= 3) and Rab11b (n=4) 
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Endocytic Rab GTPases in RPE negatively regulate extracellular sVEGF 
Screening of individual Rab GTPases’ involvement in VEGF secretion by B6-RPE07 cells 
was performed using the conditions described in Experimental Procedures section. Soluble 
VEGF (sVEGF) levels were measured by ELISA and normalized to total amount of protein. Cells 
transduced with miR-Negative adenovirus (Src) secreted VEGF in comparable amounts to non-
transduced cells, indicating that miR-Negative adenovirus did not interfere with VEGF secretion 
(data not shown). Each endocytic rab KD resulted in an increase of VEGF detected in the 
conditioned medium. The amount of VEGF released to the medium upon rab KD increased 
significantly (between 1.3-2.3x fold increase), with Rab4b and Rab5c being the most striking 
examples of sVEGF upregulation (Fig.3). 
 
The opposite experiment, where the same RabGTPases were individually overexpressed, 
revealed coherent results: a decrease in the conditioned medium’s VEGF. B6-RPE07 cells were 
transduced overnight with adenovirus carrying a GFP-tagged version of Rab protein. Cell lysates 
were collected the next day and prepared for western blot analysis, to verify overexpression 
profiles. The use of these constructs has been described before (Lopes, Ramalho, et al. 2007; 
Lopes da Silva et al. 2012). Differences between non transduced cells and cells transduced with 
Ctr negative overexpression vector (containing GFP alone) affected cells, causing a 1.2x fold 
increase in measured VEGF in culture medium corresponding to Ctr (data not shown). 
Nevertheless, when comparing each rab’s overexpression to Ctr, a consistent decrease of VEGF 
amounts in the conditioned medium was found. Specifically, 1.2x fold decrease (rab4a or rab5b) 
to 1.5x fold decrease (rab4b, or 11b). 
Figure  4 Overexpression of Rab GTPases diminishes the release of VEGF by RPE cells. Data are expressed as fold 
change of VEGF secreted by 9 x104 B6-RPE07 cells (mean±SEM, n = 3). Significance was determined using One-
way ANOVA. *p<0.05, **P<0.01, ***P<0.001. 
Figure  3 Knock-down of individual Rab GTPases increases secretion of VEGF by RPE cells. Data are expressed as 
fold change of VEGF secreted by 9 x104 B6-RPE07 cells (mean±SEM, n≥ 3). Significance was determined using One-
way ANOVA. *P<0.05, **P<0.01, ***P<0.001. No significant changes were observed between non-transduced cells 
and cells transduced with an adenovirus expressing an irrelevant mir control (Scr). 
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The less evident effect of overexpression of endocytic and recycling rabGTPases (as compared 
to their knockdown) can be attributed to the fact that in OE experiments, conditioned medium 
was collected the day after transduction, while in KD experiments, medium was collected ~3 days 
after adding the adenoviruses, as described. Moreover, the limiting rate of endocytosis/recycling 
pathways could influence the outcome, considering only one player is being overexpressed at a 
time; in the case of the KD experiments, when one player of the pathway is missing/reduced, the 
whole pathway is perturbed. Finally, there could be functional redundancy of isoforms, and thus 
the effect of a single KD or OE could be less evident. Altogether, these results propose an 
important role for endocytic and recycling Rab proteins on the regulation of VEGF secretion by 
RPE cells. 
 
sVEGF is regulated by Rab-mediated trafficking of VEGFR2 in RPE 
Immunofluorescence co-localization staining did not provide definitive evidence of direct 
involvement of these rab proteins in the trafficking of VEGF (data not shown). Moreover, KD of 
rabs caused VEGF up regulation (data not shown) and release (Fig. 3), suggesting a negative 
feedback effect. 
Ultimately, the following hypothesis was proposed: RabGTPases act as indirect regulators of 
VEGF production and secretion, through intracellular trafficking of VEGFR2. The approach 
undertaken consisted in producing VEGFR2 KD B6-RPE07 cell lines. Lines #4162 and #4163 
were constructed, using lentiviral vectors to deliver constitutive miR targeting specifically 
VEGFR2. Efficient VEGFR2 KD was confirmed by PCR (data not shown) and Westen Blot 
(Fig.5 A). As presented, VEGFR2 protein levels were reduced from 20% (#4162) to less than 
10% (#4163), relatively to endogenous expression (B6).  
VEGF levels detected in the conditioned medium, by ELISA, were increased up to 3.8x fold 
when VEGFR2 was knocked down. Increased levels of detected sVEGF were proportional to 
VEGFR2 KD, meaning the less VEGFR2, the more sVEGF found in the medium. This suggests 
a direct causal effect of VEGFR2 KD and also correlates with the results found for rab KD. When 
each endocytic or recycling rab was individually knocked down, a similar, though weaker, result 
was observed. This lesser effect could be explained considering rab isoforms’ functional 
redundancy as well as other compensatory mechanisms of endocytic/recycling trafficking 
pathways. Previous studies using endothelial cells corroborate the direct involvement of rab4, 
rab5, rab7 and rab11 in the trafficking of VEGFR2(Jopling et al. 2014; Jopling et al. 2009). The 
present findings, however, suggest different signaling pathways are activated in RPE, rather than 
Figure  5 VEGFR2 knockdown leads to accumulation of secreted VEGF by RPE cells. A. Western blot representative 
image of stable VEGFR2 knockdown B6-RPE07 derived cell lines. Densiometric evaluation of VEGFR2 expression, 
normalized for β-actin. Data are expressed as percentage of expression (mean±SEM, n≥ 3). Significance was 
determined using One-way ANOVA (***P<0.001). B. Quantification of VEGF in the conditioned medium (sVEGF) 
of B6-REP07 cells (B6) and VEGFR2 knockdown lines. Data are expressed as fold increase of sVEGF produced by 9 
x 104 cells (mean±SEM, n = 3). Significance was determined using One-way ANOVA (***P<0.001). 
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(endothelial cells’) proliferation and migration. Here, there is indication of a VEGFR2 functional 
role as a sensor or negative regulator of sVEGF levels. 
A relevant note should be taken as to the different functions of these rab proteins inside the 
cell: while rab4 and rab11 are generally considered as part of the fast and slow recycling 
pathways, respectively, rab5 is a marker for early endosomes and rab7 for late 
endosomes/lysosomes. Because each rab protein isoform was analyzed individually, no specific 
trend was observed as to their functional role in the pathway. 
In order to further explore these results, a double KD was attained, by knocking down each of 
these endocytic/recycling rabGTPase in the VEGFR2 KD cell line B6-#4163. sVEGF levels 
detected by ELISA, in the conditioned medium, revealed no significant additive effect, with the 
exception of Rab5b (Fig.6). 
sVEGF levels measured during this experiment were notably higher (5x to 11x fold), 
comparing to the levels detected upon Rab KD on B6RPE07 original cell line. These large 
differences can be attributed to the accumulation of VEGF in the medium, since in KD 
experiments medium is collected ~3 days after adding the adenoviruses, and as observed 
previously, B6-#4163 secretes up to 3.8x fold comparing to B6 (Fig.5). As a result, the Rab knock 
down effect could be diluted, as it is less pronounced. Ultimately, VEGFR2 knock down is the 
determining factor contributing to soluble VEGF accumulation in the conditioned medium.  
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Figure  6 Knock-down of individual Rab GTPases on top of VEGFR2 KD (B6-#4163 line) increases secretion of VEGF 
by RPE cells. Data are expressed as fold increase of VEGF secreted by 9 x104 B6-#4163 cells (mean±SEM, n≥ 3). 
Significance was determined using One-way ANOVA. **P<0.01. 
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DISCUSSION	AND	CONCLUSION	
RPE regulates VEGF through VEGFR2 autocrine loop. 
Retinal pigmented epithelium cells have been shown capable of sustaining their own basal 
growth by synthesizing and binding VEGF (Guerrin et al. 1995). More recently, Okabe and 
colleagues described retinal neurons using VEGF uptake as a means to titrate sVEGF, during 
development (Okabe et al. 2014). Additionally, in the mouse eye, while VEGFR2 expression is 
gradually decreased in the neuroretina, after 1 week post-birth(Okabe et al. 2014), VEGFR2 
expression in RPE increases from postnatal days 6.5 to 8.5(Ford et al. 2011). Both these reports 
suggest an autocrine loop as a way of sensing VEGF through VEGFR2. In the developing retina, 
blood vessels grow, according to the VEGF gradient, determined first by neuronal cells and at 
later stages, by RPE. Loss of this VEGFR2 leads to overgrowth of blood vessels into the retina, 
and thus vision disturbance(Okabe et al. 2014; Ford et al. 2011). Like neuronal cells, we propose 
RPE to have a sensing mechanisms to titrate VEGF’s availability and thus control how choroid 
blood vessels are limited to the outside of the RPE barrier. 
Importantly, Klettner and colleagues reported that inhibition of VEGFR2 leads to a decrease 
of apical sVEGF(Klettner et al. 2015). VEGFR2 inhibition by SU1498, in this case, caused apical 
sVEGF decrease in RPE/choroid organ culture, but no effect in RPE cell culture alone. Even 
though our results seem contradictory, the two studies were preformed differently: on the one 
hand, a polarized RPE system was not used in the present study; on the other hand, the use of an 
RPE/choroid organ culture could be a confounding factor, since there could be paracrine 
regulation by choroidal endothelial cells or others (Klettner et al. 2013). Nevertheless, both 
studies coincide in the notion of an autocrine regulation of sVEGF, by RPE’s apical expression 
of VEGFR2. As a future step, the present study would greatly benefit from the use of a polarized 
RPE system, with barrier function. 
 
Polarized VEGF secretions is the result of apical sensing, through VEGFR2. 
RPE has been shown to secrete more VEGF through its basolateral side than from the apical 
side(Klettner et al. 2015; Ablonczy & Crosson 2007; Ford et al. 2011). Furthermore, VEGFR2 
has been shown to be expressed preferentially at the apical side of the polarized RPE 
monolayer((Ablonczy & Crosson 2007)). 
When RPE is subjected to an increase in apical VEGF, its barrier function is 
compromised(Ablonczy & Crosson 2007; Dahrouj et al. 2014; Dahrouj et al. 2015). These studies 
suggest VEGF excess to be disruptive and possibly a trigger for RPE dismantlement. Another 
study, showed that VEGF neutralization causes degeneration of RPE and loss of fenestration of 
choriocapillaries(Ford et al. 2011). 
Altogether, these studies reinforce the importance of a polarized VEGF regulation by the RPE. 
 
By blocking endocytosis of VEGFR2, the RPE cannot sense VEGF 
A recent study suggests that, for endothelial cells, if constitutive endocytosis of VEGFR2 is 
impaired, the receptor is cleaved at the plasma membrane, rendering less VEGF sensitivity to the 
cell(Basagiannis & Christoforidis 2016). One of the strategies used by these authors for the 
inhibition of endocytosis was the use of mutant forms of Rab5, either causing inhibition of 
endocytosis or retention of cargo at the early endosome. When VEGFR2 becomes trapped at the 
membrane, shedding occurs and thus, removal of the VEGF binding domain could cause the cell 
to become less sensitive to sVEGF amounts. Shedding of VEGFR2 could render RPE insensitive 
to sVEGF amounts and account for its increased secretion, as demonstrated in the present study. 
Furthermore, consequent events could trigger choroidal cells to invade the retina. In either case, 
VEGFR2 endocytic regulation is of utmost importance for homeostasis maintenance of the RPE 
and the whole visual unit. 
 
Importance of new therapies 
At the moment, there are three types of molecules being routinely used as therapeutic agents 
in retinal neovascular disease: 1. anti-VEGF-A antibody (bevacizumab), 2. a fragment of such an 
antibody (ranibizumab) or 3. an engineered protein that carries the binding domains of two VEGF 
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receptors, VEGFR1 and VEGFR2 (aflibercept) (Strauss 2016). In fact, anti-VEGF therapies 
constitute the first effective treatment for Age-related Macular Degeneration, as well as other 
retinal degenerative disorders. In fact, patients who receive this treatment show structural and 
functional retinal improvement, as measured by increased visual acuity and quality of life indices 
(Strauss 2016; Ford et al. 2011). Recent observations, however, raise questions about treatment 
efficacy after 2 years, as well as adverse effects, such as retinal tear, RPE atrophy and systemic 
circulation of VEGF-A neutralizing agents (Ford et al. 2011; Strauss 2016). 
Although anti-VEGF therapy has been shown beneficial, it generally works to manage 
symptoms and disease progression, rather than treat or prevent vision loss.  
By knowing more about the mechanisms by which the RPE regulates VEGF production and 
release, we would become more capable of interfering with it. i.e. by becoming able to target 
VEGFR2 function in the RPE, we can better understand disease and come up with better solutions 
to locally repair the damaged eye. 
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EXPERIMENTAL	PROCEDURES	
Cell culture  
Mouse RPE cell line B6-RPE07 was kindly provided by Dr. Heping Xu (Queen’s University 
Belfast, Ireland) (Chen et al. 2008) and cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
(Lonza) supplemented with 10% Fetal Bovine Serum (FBS) (Life Technologies), 100 U/mL 
penicillin and 100 µg/mL streptomycin (Life Technologies) (complete medium). Cells were 
maintained at a humidified cabinet at 37oC and 5% CO2.  
 
Generation of adenoviruses 
microRNA (miRNA) adenoviral constructs were engineered using an expression vector 
system (BLOCK-iT Pol II miR RNAi; Life Technologies) according to the manufacturer’s 
protocol. Single-stranded oligonucleotides were designed and annealed to form an engineered 
pre-miRNA sequence structure that targets unique sequences in mouse Rab GTPases selected 
isoforms. Double-stranded oligonucleotides were cloned into pcDNA™6.2-GW/EmGFP-miR for 
generation of expression clones. As a negative control (miR-Negative) pcDNA™6.2-
GW/EmGFP-miR-neg control plasmid (Life Technologies) was used. The resulting EmGFP-
miRNA cassettes from expression constructs were subsequently cloned in the pAd/CMV/V5-
DEST™ adenoviral vector (Life Technologies).  
Adenoviruses were produced in a packaging cell line (293A) using ViraPower™ Adenoviral 
Gateway® Expression Kit; Life Technologies) according to the manufacturer’s recommended 
protocol. Briefly, cells were transfected with 5 µg of PacI-digested vector using Lipofectamine 
2000 as transfecting reagent (Life Technologies). Medium containing cells and mature adenoviral 
particles was collected when approximately 80% cytopathic effect was visible (10-13 days post-
transfection). To obtain a crude viral lysate 3 cycles of freeze/thaw were performed, followed by 
centrifugation at 4100 g for 10 minutes to pellet cell debris. This first lysate was used to prepare 
re-amplifications of viral particles. The re-amplified supernatant was collected and prepared as 
the crude initial lysate.  
Titration of adenoviral stocks was performed using B6-RPE07 cells. Cells were plated at a 
known density and transduced with serial dilutions of adenoviral stock. After 24 hours cells were 
harvested and washed in PBS/BSA 0.1%.  Cell pellet was fixed in PBS/BSA 0.1%/PFA 0.4% and 
kept at 4oC until acquisition. The percentage of transduced cells was determined by counting 
GFP+ cells (total of 30000 events) using FACSCalibur (BD Biosciences). Data was analyzed with 
the program FlowJo (Tree Star) and the viral titer was expressed as green fluorescent units per 
mL (gfu/mL). 
 
Western Blotting  
Samples were mixed with Laemmli buffer in the appropriate ratio, sonicated for a few seconds, 
boiled for 5 minutes at 95ºC and subjected to SDS-PAGE. Polyvinylidene fluoride (PVDF) 
membranes were used for blotting (Immobilon, Millipore). The blots were blocked in 4% 
Ovalbumin/PBS-Tween20 0.02% (PBST buffer) for 60 minutes at room temperature. Primary 
antibodies were diluted as described in table I, in PBST. 
Membranes were incubated for 60 minutes at room temperature or overnight at 4ºC. Proteins 
were visualized using HRP-conjugated secondary antibodies (Sigma, 1:20000) diluted in 4% 
nonfat dried milk/ PBS-Tween20 0.02% and ECL Plus Western Blotting Detection Reagent (GE 
Healthcare) in a ChemiDoc software (BioRad). Western Blot analysis was performed using Fiji 
software. 
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Table I 
Antibody Source Catalog number Raised in Dilution 
a-GFP Sicgen AB66-200 goat 1:500 
a-calnexin Sicgen AB41-200 goat 1:2000 
a-VEGF Abcam ab3109 mouse 1:200 
a-VEGFR2 Sicgen AB142-200 goat 1:500 
a-Rab4 Sicgen AB238239-200 goat 1:500 
a-Rab5a Sicgen AB10-200 goat 1:500 
a-Rab5b Sicgen AB12-200 goat 1:500 
a-Rab5c Sicgen AB24-200 goat 1:500 
a-Rab7a Sicgen AB33-200 goat 1:500 
a-Rab11a Sicgen AB34a-200 goat 1:500 
a-Rab11b Sicgen AB82-200 goat 1:500 
a-actin Sicgen AB145-200 goat 1:2000 
 
Real-time quantitative PCR 
Total RNA was extracted using RNAse Mini kit (Qiagen) according to the manufacturer’s 
instructions. One µg of RNA was converted into complementary DNA using random primers and 
SuperScript II reverse transcriptase (Life Technologies). Real-time quantitative PCR (RT-qPCR) 
was performed in ABI Prism 7900HT system using ABI Power SYBR Green PCR Master Mix 
(Applied Biosystems). Messenger RNA (mRNA) levels were normalized against actin. Results 
were expressed as the relative expression using the delta-delta Ct method. Experiments were 
performed in triplicate and results are presented as mean fold-increase ± SD.  
 
sVEGF detection by ELISA  
The concentration of secreted VEGF (sVEGF) in culture supernatant was determined 
quantitatively with a Quantikine ELISA kit (R&D Systems) according to the manufacturer’s 
instructions. The capture antibody VEGF was diluted in PBS to 0.4 µg/mL and immobilized 
overnight in proper 96-well ELISA plates. The biotinylated detection antibody was used at a 
concentration of 100 ng/mL. Enzyme-catalyzed chromogen formation was quantified by 
measuring the visible absorbance at 45nm using a calibration curve plotted with recombinant 
mouse VEGF (in pg/mL, normalized to the total amount of protein). Experiments were performed 
at least 6 times and results are presented as mean average value ± SD. The bicinchoninic acid 
(BCA) colorimetric method was used for whole cell lysates proteins’ quantification according to 
the manufacturer’s instructions (Pierce). Optical density was measured at 595 nm (iMark, 
BioRad). RayBiotech mouse VEGF ELISA Kit (ELM-VEGF) was used in one of the experiments 
– rab KD in B6-#4163 cells –, and sample overlap was attained, in order to compare results from 
both kits. All reagents were prepared as described in the protocol. Supernatant sample dilution 
was 1:2. According to the instructions, optical density was measured at 450nm. 
 
Generation of lentivirus for VEGFR2 knock down 
Lentivirus were produced in a packaging cell line (STAR-Rdpro), by co-transfection of 3rd 
Generation Packaging System plasmids (Addgene) and pLenti/V5-GW/miR. The plasmids 
pMD2.G, pMDLg/pRPE and pRSV-Rev encode for more advanced packaging and envelope viral 
proteins and are crucial for the improvement of lentiviral stocks’ quality. DNA mixture was 
prepared using 3ug of purified plasmid DNA of pLenti/V5-GW/miR expression construct, 1.5ug 
of pMD2.G, 2ug of pMDLg/pRPE and 1ug of pRSV-Rev. The DNA-liposomal complexes were 
set up and incubated at room temperature for 45 minutes. Transfection of confluent STAR-Rpro 
cells proceeded; supernatants were collected 72 hours post-transfection and centrifuged at 4100g 
for 10 minutes to pellet cell debris. Aliquots of viral stocks were stored at -80ºC. Two VEGFR2 
knockdown B6-RPE07 cell lines were obtained: B6-#4162C28 and B6-#4163C34. Briefly, 90% 
confluent B6-RPE07 cells were transduced with lentiviral vectors carrying VEGFR2 miRNAs 
and a blasticidin resistance gene. After blasticidin selection of transduced cells, knockdown was 
verified by PCR and western blot. 
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